Discovery of proteins involved in the interaction between prebiotics carbohydrates and probiotics &amp; whole proteome analysis of the probiotic strain Bifidobacterium animalis susp. lactis BB-12 by Gilad, Ofir
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 17, 2017
Discovery of proteins involved in the interaction between prebiotics carbohydrates and
probiotics & whole proteome analysis of the probiotic strain Bifidobacterium animalis
susp. lactis BB-12
Gilad, Ofir; Jacobsen, Susanne; Svensson, Birte; Stuer-Lauridsen, Birgitte
Publication date:
2010
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Gilad, O., Jacobsen, S., Svensson, B., & Stuer-Lauridsen, B. (2010). Discovery of proteins involved in the
interaction between prebiotics carbohydrates and probiotics & whole proteome analysis of the probiotic strain
Bifidobacterium animalis susp. lactis BB-12. Kgs. Lyngby, Denmark: Technical University of Denmark (DTU).
Enzyme and Protein Chemistry (EPC) works within protein biochemistry, carbohydrate biochemistry,  molecu-
lar biology, microbiology and plant biochemistry. The main activities of EPC are related to food and raw ma-
terials for food, but the methods and main strategies are relevant to various biotechnological issues. The aim 
is to explain the molecular mechanisms and interactions relevant for functionality and quality of foodstuffs 
and raw materials and to identify the biochemical mechanisms connected to health promoting and nutrition 
related effects of food.  
Ofir Gilad
Ph.D. Thesis
July 2010
Discovery of proteins involved in the interaction between prebiotic 
carbohydrates and probiotics & Whole proteome analysis of the 
probiotic strain Bifidobacterium animalis subsp. lactis BB-12 
O
fir G
ilad
D
iscovery of proteins involved in the interaction betw
een prebiotic carbohydrates and probiotics &
 
W
hole proteom
e analysis of the probiotic strain Bifidobacterium
 anim
alis subsp. lactis BB-12 
Enzyme and Protein Chemistry   
Department of Systems Biology 
Bøge Allé 10-12
DK-2970 Hørsholm
Denmark
Phone: +45 45 74 74 74
Fax: +45 45 74 88 88
Web:    www.chr-hansen.com
Enzyme and Protein Chemistry
Department of Systems Biology
Technical University of Denmark
Søltofts Plads, Building 224
DK-2800 Kgs. Lyngby
Denmark
Phone: +45 45 25 2693
Fax: +45 45 88 4148
Web:    www.epc.bio.dtu.dk
ISBN-nr: 978-87-91494-07-9
Chr. Hansen
     
 Discovery of proteins involved in the interaction between   
                  prebiotic carbohydrates and probiotics  
                                    &  
Whole proteome analysis of the probiotic strain   
  Bifidobacterium animalis subsp. lactis BB-12 
 
 
                    Ofir Gilad, Ph.D. Thesis, 2010 
 
 
  Enzyme and Protein Chemistry, Department of Systems Biology,    
                       Technical University of Denmark 
                                                       & 
                 Department for Identification, Chr. Hansen A/S 
 
         
 
Supervisors: 
x Assoc. Prof. Susanne Jacobsen & Prof. Birte Svensson, Enzyme and Protein 
Chemistry, Department of Systems Biology, Technical University of Denmark 
x Research scientist Birgitte Stuer-Lauridsen, Department for Identification, Chr. 
Hansen A/S 
 
1
Copyright©: Ofir Gilad & Chr. Hansen A/S
 July 2010 
ISBN: 978-87-91494-07-9
Print: J&R Frydenberg A/S
 København
 Febuary 2012
Address: Enzyme and Protein Chemistry 
 Department of Systems Biology
 Technical University of Denmark
 Søltofts Plads, Building 224
 DK-2800 Kgs. Lyngby
 Denmark
Phone: +45 4525 2731
Fax: +45 4588 6307
Web: www.epc.bio.dtu.dk
Bøge Allé 10-12
DK-2970 Hørsholm
Denmark
Phone: +45 45 74 74 74
Fax: +45 45 74 88 88
Web:    www.chr-hansen.com
Chr. Hansen
 
 
i 
 
Preface 
 
This thesis represents the results of an industrial-PhD study carried out at the Enzyme and Protein 
Chemistry group (EPC), Department of Systems Biology, Technical University of Denmark (DTU) and 
at the Department for Identification, Chr. Hansen A/S for the period of March 2007 to July 2010. The 
project was partly founded by Danish ministry of Science, Technology and Innovation, the Danish 
Research Council for Natural Science and the Centre for Advanced Food Studies.   
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Summary 
Probiotic bacteria, which primarily belong to the genera Lactobascillus and Bifidobacterium, are live 
microorganisms that have been related to a variety of health-promoting effects. Prebiotics are indigestible 
food components that specifically stimulate the growth of probiotic organisms in the human 
gastrointestinal tract. Despite an increased scientific focus within this field, the mechanisms behind the 
beneficial effects exerted by pre- and probiotics are still far from fully understood.  
 The purpose of the present industrial-PhD project was to identify proteins involved in 
interactions between the widely-used, extensively-studied probiotic strain Bifidobacterium animalis 
subsp. lactis BB-12 and potentially-prebiotic carbohydrates. The project was initiated with a screening 
phase in which more than 40 carbohydrates were tested for their ability to promote the growth of the 
bacterium. The results showed that BB-12 can utilise a wide range of oligosaccharides like galacto-, iso-
malto malto-, soybean-, xylo- and possibly also fructo-oligosaccharides.  
 Xylo-oligosaccharides (XOS) have been selected for further studies with respect to the proteins 
that play a role in their catabolism in BB-12. These studies included comparative transcriptome and 
proteome analysis of samples obtained from BB-12 cultures grown on XOS (with glucose as a 
reference). These analyses indicated that the expression of a putative gene cluster with relevance for XOS 
catabolism is increased during growth on XOS. Based on these results and on chromatographic analysis 
of XOS consumption in BB-12 cultures, a model for XOS utilisation in BB-12 was established.  
 The subsequent phase of the PhD project included extracellular proteome analysis, giving rise to 
the identification of 86 unique proteins. Of these proteins, 33 are potentially related to interactions 
between the bacterium and host intestinal cells. These interactions consist of adhesion, recruitment of 
human plasminogen and immunomodulation. In addition, proteins related to nutrient uptake and cell wall 
turnover were also found to be secreted by the bacterium.  
 The final part of the project included the identification of 250 proteins (86 of them contain 
transmembrane segments) from the bacterial membrane fractions, including 61 proteins associated with 
transport systems with various predicted substrates such as oligosaccharides, amino acids and inorganic 
ions. In addition, 7 of the 8 subunits of the H+-ATPase enzyme complex and the majority of the proteins 
that embody the translocation machinery were identified.  
 The results obtained in the present study may have an impact at both the scientific and the 
industrial levels. In addition to knowledge acquired regarding XOS catabolism in BB-12 and the 
implications on the design of a synbiotic preparation based on the two, the proteins identified in this 
study that are predicted to be involved in molecular mechanisms underlying probiotic effects or other 
essential physiological processes can serve as promising targets for detailed investigations, whose results 
may be of great relevance from both the applicable and scientific perspective. 
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Dansk Resumé 
Probiotiske bakterier, som primært tilhører taksonerene Lactobacillus og Bifidobacterium, er levende 
mikroorganismer som ved indtagelse medfører sundhedsfremmende virkninger. Præbiotika er 
ufordøjelige fødevarekomponenter, som specifikt stimulerer væksten af probiotiske organismer i tarmen. 
På trods af et øget videnskabeligt fokus på området er mekanismerne bag disse funktionelle 
fødevarekomponenters gavnlige effekter stadig langt fra fuldt forstået. Formålet med dette erhvervs-PhD 
projekt var at kortlægge de proteiner, der er involveret i samspillet mellem den bredt-anvendte og 
velstuderede probiotiske stamme Bifidobacterium animalis subsp. lactis BB-12 og potentielt-præbiotiske 
kulhydrater. Projektet blev indledet med en screeningsfase, hvor mere end 40 kulhydrater blev testet for 
deres evne til at fremme væksten af BB-12. Resultaterne viste, at bakterien kan omsætte en bred vifte af 
oligosakkarider som galacto-, iso-malto-, malto-, soybønner-, xylo- og måske også fructo-
oligosakkarider. Xylo-oligosakkarider  (XOS) er blevet valgt for videre studier af proteinerne, som spiller 
en rolle i oligosakkaridernes omsætning i BB-12. Studierne omfattede komparativ transkriptom- og 
proteomanalyse af prøver fremstillet af BB-12 kulturer dyrket på XOS (med glukose som reference). 
Analyseresultaterne viste, at genekspression af et formodet gencluster med relevans for XOS omsætning 
er forøget under vækst på XOS. Baseret på disse studier samt kromatografisk analyse af XOS omsætning, 
er der blevet etableret en model for XOS-katabolisme i BB-12. Den efterfølgende del af projektet havde 
fokus på de proteiner som bakterien secernerer til omgivelserne. Denne ekstracellulære proteomanalyse 
har ført til identificering af mange proteiner med potentielle funktioner i samspillet mellem BB-12 og 
værtens tarmceller. Projektets sidste del omfattede identificering af 250 proteiner (86 af dem indeholder 
transmembran-doegmenter) fra bakteriens membranfraktion. Disse bestod af transportører for f.eks. 
oligosakkarider, aminosyrer og uorganiske ioner. Resultaterne opnåede i dette projekt kan have en 
betydning på både den videnskabelige og den anvendelsesmæssige plan. Den opnåede viden omkring 
XOS katabolismen kan anvendes i en eventuelt synbiotisk præparation baseret på XOS og BB-12. 
Ydermere, kan mange af de identificerede proteiner, som potentielt er involveret i de molekylære 
mekanismer bag probiotiske effekter og andre essentielle fysiologiske processer, bruges som subjekter 
for målrettede studier, der kan have stor relevans fra både det anvendelsesmæssige og det videnskabelige 
perspektiv. 
" ְכָח ֵהנְק הָמְכָח תיִשׁאֵרלָכְבוּ הָמ-ָהניִב ֵהנְק ˃ְָנְינִק." )ד ילשמ;'7(  
"Wisdom is the principal thing; therefore get wisdom: and 
with all thy getting get understanding". (Proverbs 4; 7) 
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Chapter 1. Introduction            
1.1. Probiotic bacteria 
The human gastrointestinal tract (GIT) is harbored (or transiently colonised) by more than a 1,000 
phylotypes belonging to 8 primary phyla (Rajilić-Stojanovic et al. 2007), which represent at least 
800 genera and 16,000 species, with genera like Bacteriodes, Bifidobacterium, Eubacterium, 
Clostridium, Fusobacterium and Ruminococcus being most abundant. This dense microflora 
exhibits a larger genetic diversity compared with the human genome (Gil et al. 2006). In addition, 
these microorganisms provide the host with highly-valuable physiological traits such as utilisation 
of complex carbohydrates, vitamin biosynthesis, regulation of fat storage (Candela et al. 2010) 
and modulation of the host immune system (Sansonetti and Medzhitov 2009). Moreover, the 
intestinal microbiota serves as a barrier against colonisation of host epithelial cells by pathogenic 
microorganisms and induces the regeneration and barrier functions of the epithelium (Neish 
2009). The gut microflora acquires nutrients from two major sources – 
endogenous mucus glycans secreted by host epithelial cells and plant-derived complex 
carbohydrates that escape digestion in the upper GIT. 
During the past couple of decades, the awareness to the quality and the nutritional 
content of food has markedly increased. This enhanced interest has been accompanied with 
dedication of growing attention and resources to the field of functional food, which aims at 
introducing health-promoting ingredients as supplements to daily nutrition. Two of the pivotal 
elements within this area are probiotic and prebiotics (prebiotics are described in more details in 
Section 1.2). Probiotic microorganism are defines as “live microorganisms, which when 
administered in adequate amounts, confer a health benefit on the host.” (FAO/WHO 2002). In 
spite of the fact that probiotics have been consumed in fermented food products like yogurt, 
sausages and pickles for thousands of years, the attention of the scientific community started 
arising only in the beginning of the 20’th century. The majority of probiotic microogranims 
belong to the genera Lactobacillus and Bifidobactreium, but a few strains were also documented 
in other genera such as Streptococcus, Ruminococcus, Enterococcus, Lactococcus, Leuconostoc, 
Pediococcus, Saccharomyces and a single strain from Escherichia (Shah et al. 2007; Ewaschuk 
and Dieleman 2006). The numerous health-promoting effects ascribed to probiotics include 
prevention and treatment of GIT infections and inflammatory bowel diseases (IBD), 
immunomodulation, which is related both to prevention of allergy-associated diseases and 
prevention and treatment of GIT infections and inflammatory bowel diseases (IBD), 
immunomodulation, which is related both to prevention of allergy-associated diseases and 
12
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stimulation of the immune system through the use of adjutants in vaccination (Borchers et al. 
2009), treatment of genitourinary infections (e.g. bacterial vaginosis; Krauss-Silva et al. 2010) 
and prevention of dental caries (He et al. 2009). Recent studies suggest that probiotics may also 
contribute to combating liver diseases like low-grade inflammation, hepatic fat infiltration and 
hepatitis (Gratz et al. 2010),  and to reduction in the levels of carcinogens in rats (Gratz et al. 
2006) and biomarkers associated with liver cancer risk (El-Nezami et al. 2006).  
 The health-benefiting effects introduced by probiotic bacteria are derived therefore either 
from their direct interactions with host cells and proteins in the lower GIT, or indirectly, via 
inhibition of the growth of pathogenic bacteria. Such inhibition mechanisms consist of production 
of short-chain fatty acids (SCFA) that lower the pH and thus attenuate the growth of some 
harmful intestinal strains, competitive adhesion to host intestinal epithelial cells or tissues like 
collagen and laminin, and production of antimicrobial toxins, also known as bacteriocins (Gillor 
et al. 2008). In addition to that, since the bifidobacterial species identified so far lack the enzymes 
urease, azo- and nitro-reductase, β-glucuronidase and α-dehydrolase, whose action result in 
introduction of toxic conounds (Sánchez et al. 2010). 
 The principal rationale underlying the administration of probiotics, prebiotics, and the 
combination of the two – synbiotics, is to alter the human (or animal) GIT microbiota in favor of 
probiotic strains on the expense of pathogenic microorganisms like certain strains of the species 
Clostridium difficile, Clostridium perfringens, Salmonella enterica, Salmonella flexneri, 
Campylobacter jejuni, Bacteroides fragilis, Escherichia coli, Helicobacter pylori, Vibrio 
cholerae  and some Bacillus species (Schauder and Bassler 2001). 
1.1.1. Bifidobacteria 
Bifidobacteria are non-motile, non-sporulating, non-gas-producing, rod-shaped, facultative 
anaerobic, saccharolytic, high G+C Gram-positive bacteria belonging to the Actinobacteria class 
and the Bifidobacteriaceae family (Ventura et al. 2007c). Bifidobacteria have been isolated from 
five different ecological niches: the intestine, the oral cavity, fermented food, the insect gut, and 
sewage  (Ventura et al. 2007c). Of the mucosa-adherent bacteria in the intestine, bifidobacteria 
are among the most abundant commensal groups, accounting to nearly 10% of the microbiota in 
adults. Noticeably, the bifidobacterial population seems to be significantly different amongst 
different individuals (Turroni et al. 2008). As late as January 2009, 30 species were identified 
from the genus Bifidobacterium, which are divided to 6 phylogenetic clusters: B. longum, B.  
13
Chapter 1                                                                                                                                      Introduction  
3 
 
Figure 1.1. Phylogenetic tree of the genus Bifidobacterium based on 16S rRNA gene sequences. The tree was 
rooted using Nocardia farcinica IFM 10152. The bar designates 0.02 substitutions per nucleotide position. 
Adapted from Ventura et al. (2006). 
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pseudolongum, B. adolescentis, B. boum, B. asteroides and B. pullorum, (Fig. 1.1; Ventura et al.  
2007c). The genomes of bifidobacteria are 1.9 to 2.9 Mb in size and resemble typical bacterial  
chromosomes with respect to general architectural features such as co-orientation of gene 
transcription and DNA replication (McLean et al. 1998) and a presumptive origin of 
replication region (ORF) (Qin et al 1999). 
 Currently, the genome sequences of over 20 strains from 10 different species (e.g. B. 
longum, B. bifidum, B. adolescentis, B. animalis, B. breve, B. dentium, B. angulatum, B. 
pseudocatenulatum, B. catenulatum and B. gallicum) have been made publically available. 
Comparison of the identified strains led to the observation that the genus Bifidobacterium exhibits 
a low level of phylogenetic and genomic diversity (Ventura et al. 2006), yet a few exceptions 
from this syteny, where inversions, deletion or insertion of DNA regions uniquely found in a 
single genome have been identified. The majority of these genetic elements, which were probably 
incorporated into bifidobacterial genomes by horisontal gene transfer, consist of prophage-like 
elements, restriction modification systems, integrative plasmids and genes associated with 
exopolysaccharides (EPS) biosynthesis, as well as genes related to phage defense. Whole genome 
comparison also illustrated that the adaptation of bifidobacteria to the human GIT is not 
exclusivly related to their developed fermentative capabilities for complex carbohydrates, but also 
to their ability to obtain essential nutrients like vitamins, amino acids and nucleotides (Ventura et 
al. 2007b).  
 As described above, numerous bifidobacterial strains have been documented to be 
associated with probiotic effects.  Consequently, the number of studies concerning these effects, 
as well as investigations of the physiology (as seen by the genomic and proteomic features) of 
probiotic stains of the genus Bifidobacterium has been remarkably increasing during the past two 
decades. Searching the term “Bifidobacterium” in NCBI’s Pubmed http://www.ncbi.nlm.nih.gov/ 
pubmed?term=Bifidobacterium, for instance, gives currently (10 June 2011) rise to 3751 hits to 
publications related to members of this genus.  
 The catabolic enzymatic arsenal of bifidobacterial strains isolated from neonates seems 
to be oriented towards utilisation of milk oligosaccharides, whereas in strains prevalent in adults 
the majority of the sugar-degrading enzymes have plant oligosaccharides as substrates (Sela et al. 
2010).  These complex carbohydrates, some of which regarded as prebiotics, can be administrated 
in combination with probiotic cultures or as an independent preparation, with the aim to elevate 
the levels of bifidobacteria (along with other probiotic strains) in the intestine. The utilisation of 
these carbon sources is facilitated primarily through their degradation by a wide battery of 
glycoside hydrolases that cover a broad range of potential substrates like galacto-, fructo-, iso-
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malto-, malto- and xylo-oligosaccharides (GOS, FOS, IMO, MOS and XOS, respectively), as 
well as other hydrolases active against starch. In addition to glycosidases, the breakdown of poly- 
and oligosaccharides also involves the action of glycosyl transferases, which transfer sugar 
moieties from a donor molecule to a sugar acceptor. In the case of insoluble polysaccharidic 
substrates, carbohydrate-binding modules (CBMs; Boraston et al. 2004), which are distinct amino 
acid sequence within a carbohydrate-active enzyme that has a discreet protein fold with 
carbohydrate-binding activity, can facilitate binding to these substrates (van den Broek et al. 
2008a). 
 In addition to their versatile catabolic arsenal, bifidobacteria also possess a plentitude of 
transport system, mostly for di- and oligosaccharides. The majority of the sugar transport systems 
in bifidobacteria are of the ATP-binding cassette (ABC)-type (see section 3.2 for a more detailed 
description), and to a lesser extent the phosphoenol pyruvate-dependent  phosphotransferase 
system (PTS), in which transport is accompanied by concomitant phosphorylation. Another  type 
of transporters found in bifidobacteria are those of the major facilitator superfamily (MFS), which 
are ubiquitous single-polypeptide secondary carriers capable exclusively of translocating small 
solutes in response to chemiosmotic ion gradients (Pao et al. 1998). 
 Bifidobacteria are predicted to utilise two primary strategies for uptake of sugars, both 
associated with the combined action of the carbohydrate-acting enzymes and transporters. The 
principal difference between the two strategies is related to whether carbohydrate degradation 
takes place intracellularly or extracellularly. According to the first mechanism, poly- and 
oligosaccharides are bound at the cell surface (potentially via CMBs), cleaved by membrane- or 
cell wall-bound hydrolases, and the resulting monosaccharides and short-chain oligosaccharides 
(depending on the mechanism of action of the enzyme) are subsequently transported across the 
membrane. Such a strategy was described for arbino-xylan catabolism in B. longum biotype 
longum (van den Broek et al. 2008a).  
 According to the second strategy, at the absence of extracellular hydrolases or 
transferases, degradation of carbohydrates takes place intracellularly as a following step to sugar 
transport, as was suggested for GOS utilisation in B. animalis subsp. lactis DR10 (Gopal et al. 
2001). A similar model for XOS catabolism is described in Section 3.4.  
 The monosaccharides resulting from carbohydrate degradation are then incorporated into 
the fructose-6-phosphate shunt, the central carbohydrate metabolic pathway characteristic for 
bifidobacteria, also known as the bifid shunt (Fig. 1.2). The key enzyme of this pathway is 
fructose-6-phosphate phosphoketolase, which catalyzes the conversion of D-fructose-6-phosphate 
(F6P) into D-erythrose-4-phosphate and acetyl phosphate, and the primary end products of the 
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pathway are lactate and acetate. The bifid shunt produces three moles of acetate, two moles of 
lactate and five moles ATP per two moles utilised hexose. However, studies have shown that the 
theoretical ratio of 1.5 mole acetate/lactate may depend on the abundance of the carbon source 
and its consumption rate, such that catabolism is diverted in favor of generation of formate and 
acetate when the carbon source levels become scarce, as was reported for B. animalis IPLA 4549 
(Ruas-Madiedo et al. 2005) and B. animalis subsp. lactis BB-12 (Van der Meulen et al. 2006), 
probably since this shift increases the ATP yield of the shunt.  
1.1.1.1. Bifidobacterium animalis subsp. lactis BB-12 
B. animalis subsp. lactis BB-12 is an extensively used commercial probiotic strain isolated from 
fermented milk and cultured in 1983 by Chr. Hansen A/S. The strain is included in a variety of 
food applications and dietary supplements, and is ascribed various probiotic effects such as 
treatment of allergy, prevention and treatment of diarrhea, improvement of oral vaccination, 
reducing cholesterol levels in vitro (Alhaj et al. 2010) and several immunomodulative effects 
(Schiffrin et al. 1995; Isolauri et al. 2000; Mitsuma et al. 2008; Ouwehand et al. 2008). In  
addition, combined probiotic preparations of BB-12 and Lactobacillus acidophilus NCFM 
showed enhanced bowel movement frequency (Alm et al. 1993). 
 As a strain used in orally-administered probiotic preparations or as a food additive, BB-
12 possesses two pivotal physiological traits that promote its ability to survive the transition 
through the highly acidic gastric juice (pH of approx. 2.0 [Campbell 1996]) in the stomach and 
the high bile salt levels in the intestine. Among five bifidobacterial strains tested for their acid  
tolerance, BB-12 was the only strain whose survival rates were not significantly altered upon 
exposure to high acid concentrations (pH 2; Vernazza et al. 2006). The acid resistance of BB-12 
is thought to be related to the action of a F0F1-ATPase complex (Sánchez et al. 2007), which is a 
pH-inducible proton pump facilitating the export of hydrogen ions (see also Chapter 5). 
 Bile salts are cholesterol-derived detergent-like compounds synthesised in the liver and 
stored as amino acid conjugates in the gall bladder. Subsequent to digestion, they are secreted 
into the intestine where they assist in emulsification and absorption of lipids. As a result of their 
amphiphilic nature, bile salts are also potent antimicrobial agents through the damaging of 
bacterial membranes, and were also described to impose oxidative stress on bacterial DNA 
(Bernstein et al. 1999). The two primary enzymes involved in bile salt tolerance in BB-12 are 
choloylglycine hydrolase (also known as bile salt hydrolase; EC 3.5.1.24) that hydrolyses six 
major human bile salts (Kim et al. 2004) and the oxalate-degrading oxalyl coenzyme A 
decarboxylase (EC 4.1.1.8; Federici et al. 2004). Additional possible mechanisms for bile salt  
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Figure 1.2. Schematic illustration of the fructose-6-P shunt (bifid shunt). Abbreviations: AckA, acetate 
kinase; Adh2, aldehyde-alcohol dehydrogenase 2; Aga, α-galactosidase; Agl, α-glucosidase; GalE1, UDP-
glucose 4-epimerase; Gap, glyceraldehyde-3-phosphate dehydrogenase C; GlkA, glucokinase; Gnt, 6-
phosphogluconate dehydrogenase; Gpi, glucose 6-phosphate isomerase; Ldh2, lactate dehydrogenase; Pgm, 
phosphogluco-mutase; Pfl, formate acetyltransferase; Tal, transaldolase; Tkt, transketolase; UgpA, UTP-
glucose-1-phosphate uridylyltransferase; Xfp, xylulose-5-phosphate/fructose-6-phosphate phosphoketolase; 
Zwf2, glucose-6-phosphate 1-dehydrogenase; Pi, phosphate. Adapted from Sánchez et al. (2007). 
 
tolerance, as suggested for B. animalis subsp. lactis IPLA 4549, include: (i) induction of the bifid  
shunt and its diversion towards the acetic branch to increase ATP yield; (ii) enhancement of the 
degradation of oxalate with the subsequent formation of formate; (iii) up-regulation of redox 
active proteins like methionine synthase, ketol-acid reductoisomerase and Oacetyl-homoserine 
sulfhydrolase; (iv) over-production of general stress response proteins like the chaperones DnaK, 
ClpB, GrpE, GroES and GroEL; (v) induction of proteins related to DNA repair (e.g. 
carbamoylphosphate synthase); and (vi) alteration of lipid metabolism, which may also have an 
impact on the lipid composition of cell membranes (Sánchez et al. 2007).  
 Another important feature that is pivotal in the context of the present study is the ability 
of BB-12 to ferment a variety of oligosaccharides, as documented by in vitro growth experiments 
(Chapter 2). These phenotypic findings are in accordance with the genomic content of the 
bacterium, whose genome contains a large number of genes coding for a variety of potential 
oligosaccharidic-degrading enzymes. The capability of BB-12 to ferment a variety  
of carbon sources is described in detail in Chapters 2–3. 
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1.2. Prebiotic carbohydrates 
A prebiotic substrate was initially defined as a "nondigestible food ingredient that beneficially 
affects the host by selectively stimulating the growth and/or activity of one or a limited number of 
bacteria in the colon, and thus improves host health." (Gibson and Roberfroid 1995). As the 
scientific and industrial interest rose with the years, many plant poly- and oligosaccharides were 
claimed to possess prebiotic properties. To obtain an unambiguous definition of the term that 
could remove doubts regarding whether a given component can be regarded as prebiotic, 
Roberfroid formulated a more stringent definition, according to which "a prebiotic is a selectively 
fermented ingredient that allows specific changes, both in the composition and/or activity in the 
gastrointestinal microflora, that confer benefits upon host well-being and health" (Roberfroid 
2007). In addition, Roberfroid also added three criteria to the definition: (i) resistance to gastric 
acidity, to hydrolysis by mammalian enzymes, and to gastrointestinal absorption; (ii) fermentation 
by intestinal microflora; and (iii) selective stimulation of the growth and/or activity of those 
intestinal bacteria that contribute to health and well-being. According to these new definition and 
criteria, only two types of prebiotic candidates accomplish the requirements – oligufructans 
(inulin and FOS) and GOS (Roberfroid 2007), yet data concerning other carbohydrates like XOS, 
IMO, lactosucrose, gluco- and soybean oligosaccharides (SOS), as well as polydextrose, are 
pointing towards the addition of a few candidates (regarded as “emerging prebiotics”) to the list, 
when the results of clinical studies will be sufficiently solid. The investigation of other potential 
prebiotic components like gluconic acid, resistant starch, melibiose-, mannan- pectin- and N-
acetylchitin-derived oligosaccharides, lactose-, glutamine- and hemicellulose-rich substrates, as 
well as germinated barley foodstuffs, oligodextrans and lactoferrin-derived peptides may also give 
rise to the discovery of novel prebioitic sources (Gibson et al. 2004). 
1.2.1. Prebiotics substrates for Bifidobacteria 
Since Bifidobacterium is one of the two major probiotic genera, they have been extensively 
investigated with respect to screening for potential prebiotic candidates with bifidogenic 
properties. The majority of these studies have been carried out using in vitro growth experiments 
with single bifidobacterial strains, while recent, more complex experiments involve fecal inocula 
and or the use of a colon simulator (Mäkeläinen et al. 2009a,b). A representative list of studies 
documenting bifidogenic substrates is designated in Table 1.1. As can be seen from the table (and 
mentioned in Section 1.1.1.), bifidobacteria are capable of fermenting a wide range of poly- and 
especially oligosaccharides. Some studies have shown that the catabolising specificities of 
bifidobacteria is not only species-specific, but also strain-specific, as reported in a study by 
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Vernazza and co-workers (2006), where only one of the two B. longum strains tested grew on 
FOS and the specific growth rate of two strains varied considerably upon growth on XOS, IMO, 
lactulose, and a mixture of FOS and inulin. The fermentative capabilities of BB-12 are described 
in detail in Chapters 2 and 3. 
 It should be stressed, however, that the bifidogenic carbohydrates listed in Table 1.1 do 
not necessarily meet all of the three requirements to be classified as prebiotics (formulated by 
Roberfroid), as they also have to withstand digestion and hydrolysis in conditions mimicking the 
human upper GIT, and meet an even more challenging requirement related to specific stimulation 
of growth of probiotic microorganism without induction of growth of pathogenic microorganisms. 
In this context it should be clarified that usage of the term “prebiotic(s) in this report is of 
practical reasons, and does not necessarily mean that the respective carbon source meet the 
aforementioned criteria to be regarded as prebiotics. 
1.3. Genomics and proteomics in bifidobacteria 
1.3.1. Transcriptomics-based screening for prebiotics-active proteins                                   
As a consequence of the continuously increasing interest in the field of pre- and probiotics, 
extensive resources have been invested in broadening the knowledge related to their mode of 
action. The vast advancements that have been simultaneously taking place in genomic and 
proteomic technologies provide researchers with highly-valuable bioinformatics tools utilised to 
study genes/proteins that seem to play a role in a given molecular mechanism. 
 The first substantial progress in bifidobacterial genomics took place when Schell and 
colleagues (2002) published the genome sequence of B. longum NCC2705, the first 
Bifidobacterium strain whose genome sequence became publicly accessible. Unraveling the 
genomic content of this important human GIT-derived strain demonstrated that it seems to have 
adapted to its biological niche, in the form of an extensive repertoire – both in variety and 
quantity – of enzymes capable of degrading complex carbohydrates. Analysis of the genomes of 
NCC2705 and B. adolescentis ATCC 15703 showed that 8% of their genomic content is 
dedicated to carbohydrate metabolism, which is comparable with that found in Bacteroides, 
another commensal genus isolated from the GIT, but 30% higher than non-GIT bacteria like 
Lactococcus lactis and other intestinal microorganisms as Escherichia coli or Enterococcus 
faecium (Ventura et al. 2007c). Further investigation of the transport systems of NCC2705 lead to 
the identification of 19 putative transport systems for mono-, di- and oligosaccaharides, 13 of 
which belonging to the ABC-type transport systems (Parche et al. 2007). These transport systems 
are clustered in distinct operon organisation consisting of sugar-binding and permease proteins,  
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glycoside hydrolases, and in some cases a regulator gene located adjacent to the target operon. 
 Along with sequence-based homology searches against known transport proteins, Parche 
et al. also performed comparative cDNA microarrays analysis of selected genes (with glucose as a 
reference carbon source) predicted to belong to the above-mentioned transport systems. The 
results showed that the all of the genes coding for proteins related to carbohydrate transport were 
expressed, and some of these genes were up-regulated on some of the carbon sources tested 
(lactose, maltose, raffinose and FOS; genes up-regulated on raffinose and FOS are listed in Table 
1.2). The fact that a few of these genes were induced by both lactose and FOS suggests that the 
respective transport system may be promiscuous. 
 The effect of growth on human milk-derived oligosaccharides of the human infant strain 
B. longum LMG 13197 on the physiology of the strain and mechanisms associated with probiotic 
effects were investigated. Samples obtained from cultures grown on human breast milk (HMB), 
milk formula and GOS were subjected to microarray hybridisation assay, with glucose as a 
reference (González et al. 2008). A few putative genes related to degradation of mucin and human 
milk oligosaccharides, as well as to N-acetylglucosamine degradation, were up-regulated upon 
growth on HBM compared to milk formula. The expression patterns obtained in the GOS samples 
were similar to those of the HMB samples, giving rise to increased expression of genes predicted 
to encode cell surface type 2 glycoprotein-binding fimbriae that may be involved in attachment 
and colonization in the intestine. Similar proteins were identified from extracellular protein 
samples of BB-12 (Section 4.3.3.3.2.). The similar expression patterns observed in the HMB and 
the GOS cultures may indicate that the bifidogenic effect in human milk is related to its rich 
oligosaccharide content. The results of this study were supplemented by transcriptional profiling 
based on a mixed species microarray analysis applied to bifidobacterial RNA isolated from 
rapidly processed fecal samples from neonates fed with HBM or a formula containing a mixture 
of GOS and FOS (Klaassens et al. 2009). In accordance with the study by González et al. (2008), 
the majority of the transcripts identified were associated with carbohydrate metabolism. In 
addition, 18 genes related to degradation of plant- or mucin-derived oligosaccharides were 
identified, including genes coding for enzymes with potential substrates as starch, GOS, XOS, 
arabino-oligosaccharides, lacto-N-biose, fucose, and N-acetylgalactosamine (Klaassens et al. 
2009). The successful application of the mixed-bifidobacteria microarrays approach shows that 
unsequenced bifidobacterial strains can also be analysed using this methodology, as long as a 
complete genome sequence of a related strain is available and hence enables mapping of the 
intestinal transcriptome of bifidobacteria. 
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Table 1.1. Selected carbohydrates supporting the growth of bifidobacteria. 
Prebiotic 
candidate Methodology Strain Reference 
Inulin in vitro; single strain 
- B. breve 15698 
- B. infantis 17930 
- B. adolescentis 15706 
- B. longum 15708 
Huebner et al. 2007 
- B. longum KN29.1 
- B. catenulatum KD14 
- B. animalis KD12 
Bielecka et al. 2002 
- B. animalis subsp. lactis BB-12 Vernazza et al. 2006 
FOS 
in vitro; single strain 
- B. breve 15698 
- B. infantis 17930 
- B. adolescentis 15706 
- B. longum 15708 
- B. bifidum NCI 
Huebner et al. 2007 
- B. adolescentis DSM20083 
- B. animalis subsp. lactis BB-12 
- B. longum 46 
Vernazza et al. 2006 
in vitro; fecal inucula 
- B. pseudolongum KSI9 
- B. bifidum KD6 
- B. animalis KD10 
- B. catenulatum 
- B. globosum 
- B. angulatum 
Bielecka et al. 2002 
GOS in vitro; single strain 
- B. breve 15698 
- B. infantis 17930 
- B. adolescentis 15706 
- B. longum 15708 
Huebner et al. 2007 
- B. bifidum CECT 870 Pérez-Conesa et al. 2005 
- B. adolescentis DSM20083 
- B. infantis DSM20088 
- B. animalis subsp. lactis BB-12  
- B. longum 46 
Vernazza et al. 2006 
 
Lactulose in vitro; single strain 
- B. longum. H5-2 Tu et al. 2008 
- B. adolescentis DSM20083 
- B. infantis DSM20088 
- B. animalis subsp. lactis BB-12  
- B. longum 46 
Vernazza et al. 2006 
 
IMO in vitro; single strain 
- B. adolescentis DSM20083 
- B. infantis DSM20088 
- B. animalis subsp. lactis BB-12  
- B. longum 46 
Vernazza et al. 2006 
 
 
IMO 
 
 
 
           in vitro; single strain 
- B. adolescentis DSM20083 
- B. infantis DSM20088 
- B. animalis subsp. lactis BB-12  
- B. longum 46 
 
 
Vernazza et al. 2006 
 
in vitro; fecal inucula - Bifidobacteria¶ Rycroft et al. 2001 
Polydextrose in vitro; single strain  
- B. adolescentis DSM20083 
- B. infantis DSM20088 
- B. longum 46 
 
Vernazza et al. 2006 
 
Polydextrose 
clinical studies; fecal microflora 
enumeration - Bifidobacteria Jie et al. 2000 
in vitro; fecal inucula - Bifidobacteria Rycroft et al. 2001 
Pectin, Pectic-
oligosaccahrides in vitro; fecal inucula - Bifidobacteria Olano-Martin et al. 2002 
SOS in vitro; fecal inucula - Bifidobacteria Rycroft et al. 2001 
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¶ Quantitative-PCR based counts for strains of the bifidobacteria group. 
‡ Quantitative-PCR based counts for strains of the B. animalis subsp. lactis group.  
  
Until recently, genetic studies of bifidobacteria at the molecular level have been relatively limited, 
as a result of hurdles introduced by some of their physiological characteristics (e.g. strict 
anaerobicity, nutritional fastidity and instability of DNA cloning in E. coli). In parallel with the 
increasing knowledge within both novel molecular techniques and the sequencing of an 
increasing numbers of bifidobacterial strains, cloning vectors based on a cryptic plasmid 
from Bifidobacterium catenulatum L48 have been developed (Alvarez-Martín et al. 2008). Such 
vectors may be utilised for the design of plasmids used delivery of antigens and tumor- 
 
Raffinose 
 
in vitro; single strain 
- B. adolescentis MB 239 Amaretti et al. 2006 
- B. longum H10-6 Tu et al. 2008 
- B. animalis subsp. lactis BB-12 
- B. longum 2 
- B. infantis 420 
Jaskari et al. 1998 
XOS 
in vitro; single strain 
- B. infantis Bb-02 
- B. adolescentis VTT E-981074 
- B. angulatum ATCC 27535 
- B. bifidum Bb-11 
- B. breve VTT E-81075 
- B. catenulatum ATCC 27539 
- B. gallicum ATCC 49850 
- B. infantis VTT E-97796 
- B. animalis subps. lactis BB-12 
- B. longum VTT E-96664 
- B. pseudocatenulatum ATCC 27919 
- B. pseudolongum 25526 
Crittenden  et al. 2002 
colon simulator; fecal inocula - B. animalis subsp. lactis group
‡ 
- Bifidobacteria  Mäkeläinen et al. 2009a 
Arabinoxylan clinical studies; fecal microflora enumeration 
- B. adolescentis VTT E-991436 
- B. longum VTT E-96664 Jie et al. 2000 
AXOS 
(arabinoxylan 
oligosaccharides) 
in vitro; single strain 
- B. adolescentis ATCC 15703 
 
Van Laere  et al. 2000 Arabinogalacto-
oligosaccharides 
- B. adolescentis ATCC 15703 
- B. longum ATCC 15707 
- B. breve ATCC 15700 
- B. infantis ATCC 15697 
Arabino-
oligosaccharides - B. longum ATCC 15707 
Panose colon simulator; fecal inocula - Bifidobacteria  - B. animalis subsp. lactis group 
 
Mäkeläinen et al. 2009b 
Resistant starch in vitro; single strain 
- B. adolescentis ATCC 15703 
- B. angulatum ATCC 27535 
- B. breve ATCC 15699 
- B. longum Lafti B22 
Crittenden et al. 2001 
Starch, 
amylopectin, 
pullulan 
in vitro; single strain 
- B. breve NCFB 2258 
- B. dentium NCFB 2243 
- B. infantis CCUG 45868 
- B. pseudolongum NCIMB 2244 
- B. thermophilum JCM 7027 
Ryan et al. 2006 
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Table 1.2. Bifidobacterial genes coding for carbohydrate-active proteins up-regulated on different carbon 
sources (compared to glucose) according to cDNA microarrays analysis. 
Strain 
Carbon 
source 
Predicted 
substrate for 
operon Encoded protein Locus tag Reference 
B. longum 
NCC2705 
FOS 
Ribose 
Sugar ABC transporter solute-binding protein BL0033 
Parche et 
al. 2007 
ABC transporter permease BL0035 
Sugar ABC transporter permease BL0036 
Maltose Arabinosidase BL0146 
lactose, FOS Solute binding protein of ABC transporter system BL0262 
FOS Solute binding protein of ABC transporter system BL0425 
lactose, FOS Sugar ABC transporter solute-binding protein BL1164 Sugar ABC transporter solute-binding protein BL1165 
FOS 
 
Solute binding protein of ABC transporter for sugars BL1638 
Permease of ABC transporter for sugars BL1639 
Permease of ABC transporter for sugars BL1640 
multiple 
sugar, 
mannos, 
fructose 
Sugar binding protein of ABC transporter for pentoses BL1694 
ABC transporter permease BL1696 
sucrose 
β-fructofuranosidase BL0105 
Galactoside permease BL0106 
LacI-type transcriptional regulator BL0107 
Lactose LacZ BL0978 
raffinose 
Raffinose 
Sugar binding protein of ABC transporter system BL1521 
Sugar permease of ABC transporter system BL1522 
Sugar permease of ABC transporter system BL1523 
multiple 
sugar, 
mannose, 
fructose 
ABC transporter permease BL1696 
Lactose LacZ (β-Galactosidase) BL0978 
B. longum  
LMG 13197 
human 
breast 
milk; 
GOS 
 
FOS Solute binding protein of ABC transporter for sugars BL1638 
González 
et al. 2008 
Permease of ABC transporter for sugars BL1639 
Unknown Glycosyltransferase BL1674 
Unknown LacZ (β-Galactosidase) BL0978 
N-acetyl-
glucos-amine 
N-Acetylglucosamine-6-phosphate deacetylase BL1344 
Glucosamine-6-phosphate deaminase BL1343 
lactose, FOS Sugar ABC transporter solute-binding protein BL1164 Sugar ABC transporter solute-binding protein BL1165 
Unknown Glycosyltransferase BL0672 
Lactose Galactoside symporter  BL0976 
Unknown Probable α-1,4-glucosidase BL0529 
Unknown α-L-arabinosidase BL0544 
lactose, FOS Sugar ABC transporter permease BL1169 
 
B.adolescentis 
ATCC 15703 
human 
breast 
milk 
Unknown Pullulanase BAD_0708  
 
 
Klaassens 
et al. 2009 
Unknown Probable sugar kinase BAD_1412 
Unknown Endo-1,4-β-xylanase BAD_1527 
Unknown β-Galactosidase BAD_1605 
 
B. longum 
NCC2705 
(A)XOS, FOS Possible arabinosidase BL0146 
unknown Narrowly conserved HP possibly involved in xylan degradation BL0421 
unknown Probable-1,4-glucosidase; maltase-like enzyme BL0529 
unknown Sucrose phosphorylase BL0536 
unknown α-L-Arabinosidase BL0544 
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unknown Glycogen phosphorylase BL0597 
unknown Glycosyl hydrolase (LacZ) BL0978 
unknown Possible glycosyltransferase BL1104 
mucin sugars 
Solute-binding protein of ABC transporter for sugars BL1638 
Permease of ABC transporter for sugars BL1639 
LNB phosphorylase BL1641 
Galactose-1-phosphate uridylyltransferase   BL1643 
UDP-glucose 4-epimerase BL1644 
¶ Genes identified by microarrays hybridization human breast milk; no comparative expression was 
considered in this context. 
suppressing substances (Rossi et al. 1996; Fujimori 2006) and enhancing beneficial detoxifying 
activities (Park et al. 2007). Efficient systems for introduction of the gene of interest into these 
expression systems have, however, yet to be further developed. 
 
1.3.2. Proteomics in bifidobacteria  
To complement findings obtained at the transcriptional level, a proteomic analysis is commonly  
applied. Studies at the proteomic level can both corroborate results from transcriptional studies  
and yield results not detected at the gene level, thereby contributing to a more comprehensive 
understanding of the role bifidobacterial proteins play in probiotic effects or physiological related 
to colonisation of the host GIT and survival in this environment. 
 Despite of its limitations, e.g. bias against protein with low abundance, proteins with 
extreme mass and iso-electric points and hydrophobic proteins like membrane proteins, two-
dimensional gel electrophoresis (2-DE) is a central approach for deciphering concrete 
physiological conditions in the cell, by providing a snapshot of the protein expression pattern at 
the analysed condition (Beranova-Giorgianni 2003; Fountoulaki et al. 2004; Conrotto and 
Souchelnytskyi 2008). Proteomics is also useful for studying the amount and subcellular location 
of individual proteins and for identification of genes that are affected by regulatory proteins.  
 The application of proteomic techniques for the analysis of the protein content of 
bifidobacteria has advanced in parallel with improvements related to the marked increase in 
information derived from databases. Thishas been facilitated by both the growing number of 
bifidobacterial genomes sequence being made available, and the introduction of highly sensitive 
mass spectrometers. These advances, especially with regard to instrumentation, made it feasible to 
identify hundreds (in some cases thousands) of proteins from a biological sample using a high-
throughput approach. A few studies regarding implementaion of proteomic-based methodologies 
are described below and listed in Table 1.3. 
 The first application of proteome analysis in general and a high-throughput method in 
particular in bifidobacteria was illustrated in a study carried out by Vitali and coworkers (2005) 
B. lonum 
NCC2705 
Klaassens 
et al. 2009 
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regarding proteome analysis of Bifidobacterium infantis. The authors utilised the so-called 
multidimensional protein identification technology (Mudpit; Link et al. 1999), according to which 
proteins are separated by strong cation exchange (SCX) chromatography implemented as a 
primary separation technique, followed by reversed-phase chromatography concomitant with 
electrospray ionisation (ESI) tandem mass spectrometry. Applying this shotgun approach, 136 
proteins were identified, including proteins with high mass and basic isoelectric point (pI) that are 
commonly underrepresented in gel-based proteomic studies. The majority of the proteins 
identified in this study, which are considered to be the most abundant under exponential growth 
of the bacterium, were related to cell survival, replication and energy metabolism. The production 
of proteins associated with stress defense mechanisms in the absence of any stress stimuli 
implicate that bifidobacteria constitutively produce these proteins, probably to attain rapid cellular 
response. 
 A metaproteomic approach involving 2-DE and matrix-assisted laser desorption/ 
ionization-time of flight mass spectrometry (MALDI-TOF MS) was utilised to identify proteins 
isolated from infant fecal microbiota (Klaassens et al. 2007). The analysis showed that the 
proteomic content of the fecal micobiota changed over the course of time, and peptides obtained 
from tryptic digestion of the proteins extracted from the spots on the gels showed sequence 
similarity to bacterial proteins, a viral protein, and four eukaryal proteins, but none of these 
peptides gave rise to significant database hit, which can be explained by the fact that the majority 
of the microbiota has not been cultured yet. A single peptide sequence detected, however, was 
homologous to bifidobacterial transaldolase, thus providing experimental evidence to the presence 
of bifidobacterial strains in the human neonate intestine. 
 To broaden the knowledge into the mechanisms of bile salt tolerance in bifidobacteria, 2-
DE followed by MALDI-TOF MS was applied on protein samples from B. longum NCIMB 8809 
and B. animalis subsp. lactis IPLA 4549 and its bile tolerance deficient mutant 4549dOx grown in 
the presence of bile or without it. These studies gave rise to the identification of 37 and 34 
differentially-abundant proteins for 8809 and IPLA 4549, respectively. As mentioned in section 
1.1.1.1., these analyses showed that the strains induce several complementing physiological 
mechanisms upon exposure to bile (Sánchez et al. 2005; Sánchez et al. 2007). 
Another investigation of bile tolerance in bifidobacteria, which incorporated more advanced 
methodologies, was performed by Ruiz et al. (2009). This study utilised differential fractionation 
and digestion of bacterial cell wall and membrane fractions followed by two-dimensional 
differential gel electrophoresis (2D-DIGE) and stable isotope labelling of amino acids in cell 
culture (SILAC) to map the cell envelope proteome of the above-mentioned 8809 strain grown in  
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Table 1.3. Selected studies applying proteomic approaches in bifidobacteria. 
Feature analysed Bifidobacterial strain(s) Analysis method Reference 
Shotgun protein identification B. infantis BI07 MudPIT Vitali et al. 2005 
Effects of bile on protein expression 
patterns 
B. longum  NCIMB  8809 2-DE Æ MALDI-TOF MS Sánchez et al. 
2005 
Effects of bile on protein expression 
patterns 
B. animalis subsp. lactis 
IPLA 4549 & 4549dOx 2-DE Æ MALDI-TOF MS 
Sánchez et al. 
2007 
Identification of extracellular 
proteins 
B. longum  NCIMB  8809 2-DE Æ MALDI-TOF MS Sánchez et al. 
2007 
Metaproteomic analysis of infant 
fecal microbiota   2-DE Æ MALDI-TOF MS 
Klaassens et al. 
2007 
Proteome analysis of cell envelope 
under bile exposure 
B. longum  NCIMB  8809 
2D-DIGE ÆLC-LTQ MS 
& SILAC Æ MALDI-TOF 
MS 
Ruiz et al. 2009 
Identification of regulated proteins 
in co-culture compared to pure 
cultures                                   
Co-culture of B. longum  
NCIMB 8809 and B. breve 
 NCIMB8807 
2-DE Æ MALDI-TOF or 
LC-ESI MS 
Ruiz et al. 2009 
Proteome analysis & comparison of 
samples from glucose and fructose-
grown cultures 
B. longum  NCC2705 2-DE Æ MALDI-TOF MS Yuan et al. 2006 
 
an in vitro bile environment. 2D-DIGE, which was also applied in the present study (Chapter 3), 
is based on the same electrophorating principals as 2-DE, and utilises the sensitive protein- 
binding properties of flourophoric cyanin dyes which enable the analysis of two biological 
samples and an internal standard in a single gel run (Marouga et al. 2005). The SILAC approach 
applies radiolabeling-based quantitative analysis of samples, an approach that may be highly 
valuable for the analysis of membrane proteins whose resolving in traditional gel-based  
methods is difficult (Ong et al. 2002). The results of this study are described in detail in Section 
5.2. 
 Another example for the application of 2-DE supplemented with MALDI-TOF MS was 
illustrated by an analysis of the effect of co-culturing of B. longum NCIMB8809 and B. 
breve NCIMB8807. Comparison of the protein content of cytosolic extracts from early stationary 
phase cells showed that the abundance of 16 proteins was altered when the strains were co-
cultures compared to growth in pure cultures. These included 10 ribosomal proteins (7 of which 
up-regulated), a transcriptional regulator involved in regulation of stress-related proteins, a 
phosphoketolase and a UDP-N-acetylglucosamine: LPS N-acetylglucosamine transferase (MurG),  
a glycosyltransfe-rase essential to peptidoglycan biosynthesis and cell division. The activity of the  
latter against paraǦnitrophenyl (pNP)-N-acetyl-β-D-glucosamine was increased in B. 
longum NCIMB8809 grown in the presence of B. breve NCIMB8807. 
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 An analysis of extracellular proteins in bifidobacteria was applied on culture 
supernatants of B. longum NCIMB 8809 (Sánchez et al. 2008b). Seven-teen protein spots 
detected on the 2-D gel yielded identification of 10 unique proteins, including solute-binding 
proteins, proteins homologous to bacterial conjugation proteins, a protein with sequence similarity 
to an invasion-associated protein and putative enzymes involved in peptidoglycan metabolism. 
 The application of 2-DE coupled with MALDI-TOF and liquid chromatography (LC)-
ESI MS was also applied in the comprehensive proteome analysis of B. longum NCC2705, which 
in addition conferred comparison of the protein abundance patterns of cultures grown on fructose 
and glucose (Yuan et al. 2006). This study resulted in the identification of 369 proteins associated 
with a variety of cellular pathways that account for 30% of the predicted proteome. It was also 
reported that although fructose and glucose are utilised via the same degradation pathway, 
fructose uptake may be mediated by a specific transport system whose two of its components 
showed increased abundance on fructose compared to glucose. Another example for the 
utilisation of comparative proteomics for inference of sugar catabolism is described in detail in 
Chapter 3, whereas identification of extracellular and membrane proteins in BB-12 is discussed in 
Chapters 4 and 5, respectively. 
1.4. The objectives of the study 
Probiotic bacteria are incorporated in food or food supplements due to their well documented 
health benefits, especially with respect to the human GIT. Prebiotics are food components that 
specifically stimulate the intestinal growth of probiotic microorganisms. The attention given to 
prebiotics, probiotics and synbiotics is continuously increasing from both the industrial and 
academic point of view. With respect to carbohydrates considered as prebiotic candidates, only 
GOS and fructans (FOS and inulin) meet the criteria required to be regarded as prebiotics, yet a 
handful of plant-derived oligosaccharides seem to have promising potential to be added to this 
list.    
 As a first step for evaluating possible prebiotic candidates able to support the growth of 
the widely studied and extensively used probiotic strain B. animalis subsp. lactis BB-12, a few 
dozens of carbon sources were tested by in vitro growth experiments. The results of these studies 
are described in Chapter 2. 
 Another aspect of the interaction between pre- and probiotics concerns the catabolic 
mechanisms that facilitate the utilisation of prebiotic carbohydrates by probiotic bacteria. A wide 
battery of glycoside hydrolases has been characterised from bifidobacteria (van den Broek et al. 
2008b), and it is therefore expected that BB-12 also possesses similar enzymes that play a role in 
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degradation of oligo- and polysaccharidic substrates. The objective of the next step in the present 
study was thus to identify proteins involved in the catabolism of the selected carbon sources, with 
the aim to pinpoint candidates for further characterisation. Such genes/proteins predicted were 
identified by comparative transcriptomic and proteomic analyses of samples grown on the 
selected substrates (with glucose as the reference), and corroborated by qPCR. The combination 
of the results from this analyses and biochemical characterisation of the corresponding proteins 
was utilised for establishment of a model for the catabolism of these carbon sources by BB-12, as 
discussed in Chapter 3. 
 Another central aspect within the field of probiotics is the mechanisms underlying their 
health-promoting effects, which are, still far from fully deciphered. The objective of Chapter 4, 
which deals with the secreted proteome of BB-12, is thus to shed more light into the proteins that 
may take part in the interactions with the host GIT, as well as the identification of extracellular 
proteins with other physiological roles (e.g. nutrient uptake and cell wall metabolism). 
 Finally, Chapter 5 focuses on the membrane proteome of BB-12. As membrane proteins 
play pivotal role in a variety of cellular mechanisms like transport, signal transduction and 
communication with the exterior of the cell, mapping the membrane proteome is expected to 
 broaden the knowledge regarding other physiological processes taking place in the bacterium. 
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Chapter 2. Screening for prebiotic candidates supporting the growth 
of Bifidobacterium animalis subsp. lactis BB-12 
 
2.1. Summary 
As the first step of the present study regarding prebiotics-related proteins of the probiotic strain 
Bifidobacterium animalis subsp. lactis BB-12, a variety of carbohydrates were tested for their 
performance in supporting the growth of the bacterium in vitro, yielding a detailed list of possible 
prebiotic candidates containing different oligosaccharidic species (e.g. iso-malto-, malto-, galacto-
, transgalacto-, xylo- and soy-oligosaccharides). The experimental results were compared with the 
predicted catabolic capabilities of BB-12 as inferred from its genome sequence, as well as with 
studies regarding the utilisation of complex carbohydrates other bifidobacteria.  
2.2. Introduction 
Bifidobacteria isolated from the human lower gastrointestinal tract (GIT) seem to have gone 
through a genome reduction causing a shift in their metabolic capabilities from biosynthesis to 
metabolism of an extensive number of carbon and nitrogen sources (Barrangou et al. 2009). 
Complex carbohydrates that are not digested by the degradative enzymes of the host are the most 
abundant nutrients in the lower GIT, the ecological niche of bifidobacteria. The adaptation of 
bifidobacteria to this milieu is reflected by a wide spectrum of glycoside hydrolases capable of 
degrading these substrates (van den Broek et al. 2008b). Comparison of the variety and quantity 
of three publicly available bifidobacterial genome sequences shows that although B. animalis 
subsp. lactis Bl-04 has a lower number of glycoside hydrolases and also a smaller genome, the 
diversity of glycoside hydrolases in this strain is similar to that found in B. adolescentis ATCC 
15703 and B. longum subsp. longum NCC2705 (Barrangou et al. 2009). However, the predicted 
substrate specificities of the glycoside hydrolases present in these strains are different, giving rise 
to diverse catabolic capabilities. 
 The environmental adaptation of bifidobacteria is also illustrated by the extent and 
variety of transport systems utilised in uptake of oligosaccharides, as exemplified by analysis of 
the genome sequence of B. longum subsp. longum NCC2705 (Schell et al. 2002; Parche et al. 
2006). Oligosaccharide transport in this strain is predicted to be facilitated by 15 transport 
systems, the majority of which are ABC-type transporters capable of importing di- and 
oligosaccharides, and to a lesser extent by MFS or PTS transporters. An ABC transport system 
commonly consists of a sugar-binding protein attached to the cell membrane facing towards the 
surrounding medium, a couple of permease proteins creating a pore in the membrane, and a 
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couple of ATP-binding proteins that supply the energy required for the action of the transport 
system through ATP hydrolysis (Davidson et al. 2008). A handful of bifidobacteria have been 
reported to obtain higher cell yields and higher specific growth rates when cultivated on 
oligosaccharides compared to the respective monosaccharides (van der Meulen et al. 2004). 
These observations may be explained by efficient transport systems specific for di- and 
oligosaccharides.  
 A few of the aforementioned glycosidic enzymes and transport systems have been 
studied throughout the last decade. Proteins from species like B. adolescentis, B. animalis, B. 
bifidum, B. breve, B. longum and B. pseudolongum have been identified and cloned. These 
proteins were recombinantly produced (commonly in E. Coli) and subjected to molecular 
characterisation (Van den Broek et al. 2008b). 
 In spite of the growing knowledge of the metabolic features of different bifidobacterial 
species with regards to complex carbohydrate catabolism, the insight into the mechanisms by 
which bifidobacteria in general, and BB-12 in particular, utilise these substrates, is somewhat 
limited. In the present study, a variety of carbohydrates were tested for their ability to support the 
growth of BB-12. The in vitro approach was supplemented by mining the genome sequence of 
BB-12 for genes coding for proteins that may play a role in prebiotics catabolism (some of which 
clustered together in putative operons), as well as an overview of the current knowledge of the 
prebiotics-related catabolic capabilities of closely related bifidobacterial strains. The results of 
this study served as the basis for choosing substrates that were further analysed with respect to the 
proteins predicted to play a role in the catabolism of the chosen carbohydrates. The identification 
of these proteins will, in turn, broaden the insight into the mechanisms behind probiotics-
prebiotics interactions in BB-12.  
2.3. Results  
2.3.1. Correlation between CFU/ml and OD600 
In order to rule out the possibility that some of the turbidity in the tested cultures is a result of 
non-viable cells, a dataset of 20 data points (after discarding of outliers; taken from cultures 
grown on different carbon sources and different cell morphologies, as was observed by 
microscopical studies) was established. A few outliers that deviated significantly from the general 
trend, were excluded from the correlations. For each measured OD value a corresponding viable 
count value was obtained by performing a dilution series and plating out the diluted cultures. 
These data point pairs were then used to plot the concentration of the viable cells in CFU×108/ml 
as a function of OD600 (Fig. 2.1), and a linear correlation (taking all 20 data points into account) 
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of 1×OD = 9.5×108 CFU/ml was obtained, with R2 = 0.9762. This correlation is very similar to the 
value obtained (for several bifidobacterial strains) by Pérez-Consa et al. (2005), according to 
which 1×OD600 = 9.8×108 CFU/ml. 
Figure 2.1. Correlation between CFU/ml and OD600 in BB-12 grown on a variety of carbon sources. The 
linear trend line, the obtained linear correlation and the correlation factor (R2) are designated. 
2.3.2. Growth experiments 
The carbohydrates (2% w/v) were tested for their performance in supporting the growth of BB-12 
cultures grown on a rich medium. The growth was monitored as OD600 readings along a 24 h 
period, or based on the ratio between the viable counts after 24 h of incubation and prior to 
inoculation. 
2.3.2.1. Triplicate growth experiments of selected carbohydrates 
The performance of selected prebiotic candidates was testes by three biological replicates of the 
24 h-long growth experiment. The OD values measures for each time point in the three 
experiments were averaged, and these values, as well as the standard deviation (represented by 
vertical error bars) are illustrated in the following graph (Fig. 2.2): 
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Figure 2.2. Growth experiments of BB-12; the carbon sources correspond to the following numberes in the 
carbohydrate table (Table 2.2); Glu, glucose, reference carbon source; FOS, fructo-oligosaccharides, #1; GOS, 
galacto-oligosaccharides, #23; Raf, raffinose, #28; Inu, fructose enriched inulin, #3; Inu/FOS, 1:1 w/w mixture 
of inulin and FOS, #4; HM-MRS, MRS-like reconstituted medium with no carbon-source. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Exponenetial growth phase of BB-12 cultures grown on a variety of carbon sources, as well as 
positive (MRS and HM-MRS+glucose) and negative (HM-MRS) controls. The logarithm of the OD600 values of 
growth curves is plotted as a function of time (a representative set of growth curves is shown). The linear trend 
line obtained and the R2 (correlation factor) are designated. HM-MRS, home-made MRS; Glu, glucose; Raf, 
raffinose; Inu, inulin. 
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Kinetic Calculations 
The results of the growth rate calculations are based on the OD values obtained in the triplicate 
growth experiments described above, and are summarised in Figures 2.3–2.4 and Table 2.1. 
Table 2.1. The doubling times and specific growth rates (and the standard deviation thereof) of the selected 
media/carbon sources. 
 
 
 
 
 
 
** The growth curve of HM-MRS culture did not give rise to an exponential growth profile, such that the linear 
correlation of the curve was relatively poor. It is never the less included in the calculation as sugar-free control.  
. 
Figure 2.4. Specific growth rates obtained for the cultures corresponding to the growth curves shown in 
Figure 2.2. The red bar designates the growth rate obtained for glucose, the reference carbon source. 
 
2.3.2.2. Screening for prebiotic candidates - remaining carbohydrates  
The results of the growth experiments of the remaining carbohydrates (Table 2.2) demonstrate 
that only a limited number of carbohydrates (galacto-, isomalto-, malto- and soy-oligosaccharides, 
#23-27, 8-9, #18 and #33-34, respectively in Table 2.2) gave rise to higher cellular yield after 24 
h than glucose, the reference carbon source. Other carbon sources that performed moderately well 
Medium/C-source Doubling time, min Growth rate, 10×(1/h) 
MRS            102 ± 6.1  5.9 ± 0.34 
HM-MRS            225 ± 7.6**  2.9 ± 0.89 
HM-MRS+Glucose            148 ± 25  4.1 ± 0.71 
HM-MRS+FOS            112 ± 14  5.4 ± 0.74 
HM-MRS+GOS              69 ± 16              8.9 ± 2.0 
HM-MRS+Raffinose            100 ± 8.9  6.0 ± 0.52 
HM-MRS+Inulin            110 ± 16  5.9 ± 0.34 
HM-MRS+Inulin/FOS              99 ± 13  6.2 ± 0.87 
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consisted of (in decreasing order) are melibiose, raffinose, and XOS (# 29, 28 and 35-36 in Table 
2.3, respectively). The fructans FOS and inulin, which are repeatedly regarded as bifidogenic 
carbohydrates, gave rise only to an OD value of ~2 after 24 h. The significantly higher cellular 
yield obtained on GOS compared to most of the other carbohydrates tested could be explained by  
its 17.5% w/v content of protein, thereby supplying the bacterium with additional source for 
peptides. 
Relating the results of the growth experiments to the current knowledge of prebiotic-related 
proteins and enzymes in the genus Bifidobacterium, as well as to the genome sequence of BB-12 
(Gariggue et al. 2010), can supply some insights into the carbohydrates that support the growth of 
BB-12. Relevant enzymes and proteins identified and characterised from other bifidobacterial 
strains are listed as well. A few of the substrates that seem promising as growth stimulators for 
BB-12 were be further investigated via proteome and/or transcriptome analyses of samples 
isolated from cultures cultivated on these carbon sources. 
2.3.3. Fructans 
2.3.3.1. Putative fructan-active proteins in BB-12 
To predict which genes/proteins are expected to be up-regulated upon growth on FOS and inulin, 
the genome of sequence of BB-12 was searched for genes that code for proteins related to the 
utilisation of these fructans. The results of this search showed that the bacterium possesses two 
putative gene clusters that may play a role in transport and metabolism of oligofructans (Fig. 2.5). 
The first putative gene cluster consists of a regulatory protein (BIF_00490), a sucrose-6-
phsophate hydrolases (formerly annotated as β-fructofuranosidase; BIF_01865) and a pair of 
transport proteins (sucrose permease [BIF_00489] and BIF_00743). An ORF of approxiametly  
200 nucleotides in length that is located between the genes coding for BIF_00489 and BIF_00490 
is coding for a hypothetical protein (BIF_01864). The second putative fructan operon includes a 
ribose repressor (BIF_01423), sucrose phosphorylase (BIF_02090) and a transport protein of the 
MFS superfamily (BIF_01422).  
 A sucrose utilisation gene cluster with an identical organization with respect to three of 
the four genes in the above-mentioned predicted fructans/raffinose operon was identified in B. 
animalis subsp. lactis (Trindade et al. 2003). This cluster encodes a sucrose phosphorylase (ScrP), 
a GalR-LacI-type transcriptional regulator (ScrR), and a sucrose transporter (ScrT). Recombinant 
ScrP was found to be induced by sucrose, raffinose, or oligofructose and repressed by glucose. 
The enzymatic activity of a β-fructofuranosidase detected in permeabilised cells of B. animalis 
MB 103 was more than 5-fold higher upon growth on FOS compared with glucose (Rossi et al. 
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Table 2.2. Chemical structure and performance in supporting the growth of BB-12 of the tested carbohydrates.  
Carbohydrate Chemical structure 
Analysis 
method & 
scale 
OD600 after 
24h 
glocuse (MRS, ready-made broth, 
Difco Laboratories, Detroit, MI.)  
  α-D-glucose 3×50 ml 5.0-5.7 
glocuse (Merck; dissolved in HM-
MRS; reference carbon source) 
  α-D-glucose 3×50 ml 4.4 
Fructans 
1 Raftilsoe P95 (FOS, Orafti, 
Belgium) 
a mixture of α-D-glucose-(1,2)-[β-fructose-(1,2-]n and [β-D-
fructose-(1,2-]n, n=2-8; FOS 93.2%; glucose + fructose + 
sucrose 6.8% 
3×50 ml 1.8; 2.12 
2 Fibrulsoe 97 (FOS, Cosucra 
S.A, Belgium) 
α-D-glucose-(1,2)-[β-fructose -(1,2-]n n=2-9 2×10 ml 1.9-2.3 
3 Beneo Synergy1 (FOS-enriched 
Inulin, Orafti) 
Inulin (α-D-glucose-(1,2)-[β-D-fructose-(1,2-]n n=2-60) 90-
94%;  glucose + fructose + sucrose 6-10% 
3×50 ml 1.5-2.4 
4 1:1 w/w mixture of inulin (#3) 
and FOS (#1) 
See #1 & #3 3×50 ml 1.6 
5 fibruline XL (99% inulin, 
Cosucra S.A.) 
α-D-glucose-1,2[β-D-fructose-(1,2)]n; n > 10 2×VC7 n.g.o.3,4 
6 Fibruline Instant (90% inulin, 
Cosucra S.A.) 
not disclosed by the manufacturer contains 
microbes 
 
7 FOS (95%, Qingdao Reach 
International, China) 
a mixture of different DP6 FOS: 95%; glucose + fructose + 
sucrose 5%; Predominant DP: 3-5 
2×10 ml 3.5 
Glucans 
8 IMO 900P (isomalto-OS1, 
Hayashibara, Japan) 
[α-D-glucose-(1,6)-]n n=2-5; IMO 85%; isomaltose 10-27%; 
isomaltotoriose (5-15%) 
2×10 ml; 
3×100 ml; 
1×250 ml 
5.2-6.6 
9 (IMO) IsoMalto-OS 90% 
(Qingdao) 
isomalto-oligosaccharides 90% 2×10 ml 6.5 
10 Premidex (dextrin, 
AMD,USA) 
randomized glucose linked starch 2×10 ml 1.9; 6.54 
11 Cyclodextrin (Sigma) [α-D-glucose-(1,4)]n, n=6-8 2*×10 ml n.g.o. 
12 Oat β-glucan (NSI, USA) a mixed-linkage (1,3), (1,4)-β-D-glucan 10% β-glucans; 
cellulose [(1,4)-β-D-glucose]n and magnesium stearate (filling 
and lubricating agent) 
VC 7.235; 6.64. 
5.45 
13 Nutriose Dextrin  0.852 
14 Glucagel Barley β-glucan 
(GraceLinc, NZ) 
(1,3)/(1,4)-β-D-glucan 83.2%; starch 6%; protein 4.1%; fat 
1.1% 
2×10 ml n.g.o. 
15 Barley β-glucan (Birte 
Svensson, privat collection) 
(1,3)/(1,4)-β-D-glucan VC 5.14 
16 High amylose starch (Penford, 
USA) 
starch enriched with the linear poly[α-(1,4)-D-glucose] 
backbone 
VC n.g.o. 
17 
mechanically modified potato 
starch (Penford, USA) not disclosed by the manufacturer VC n.g.o. 
18 Malto-OS (Qingdao) malto-OS 60% [α-D-glucose (1,4)-α-D-glucose]n;  2×10 ml 7.3 
20 Palatinose (Senn chemiacal, 
Switzerland) 
6-O-α-D-glucopyranosyl-D-fructofuranose 2×10 ml n.g.o. 
21 Sorbitol (chew-tech) Hexane-1,2,3,4,5,6-hexaol (reduced glucose) 2×10 ml n.g.o. 
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22 Cellobiose (Senn chemiacal, 
Switzerland) 
4-O-β-D-glucopyranosyl-D-glucose 2×10 ml n.g.o. 
 Galactans    
23 Vivinal GOS (Frieslands 
Foods, the Neatherlands) 
TGOS (trans-galactooligosaccharides with β-(1,4) glycosidic 
bonds and β-(1,6) glycosidic bonds) 28%, mono and di-
saccharides 46.5%; protein 17.5%; minerals 3.1%; fat 1% and 
moisture 4%. 
3×50 ml 5.8 
24 Vivinal GOS syrop (Frieslands 
Foods) 
75% w/v of  #22  4.32 
25 GOS 70% (Qingdao) GOS 40%; lactose 35-40%; glucose 20-25%; galactose 1% 2×10 ml 4.6; 3.62 
25 GOS 70% (Qingdao) GOS 40%; lactose 35-40%; glucose 20-25%; galactose 1% 2×10 ml 4.6; 3.62 
26 Herba Lycopi (Chinese herb) 
GOS (Qingdao) 
GOS (Verbascose [galactose-(1,6)]3-(1,6)-O-α-D-glu-(1,2)-β-
D-fructose] + stachyose [β-D-fructose-[O-α-D-galactose-
(1,6)]2-(1,6)-α-D-glucose] + raffinose 72 %; 
2×10 ml 4.8 
27 Bi²muno (trans-GOS, 
Calsado,UK) 
TGOS (β-(1,4) and β-(1,6) linked galactans) 51.8%; GOS: β-
(1,3) 26%; β (1,4) 23%; β (1,6) 51%;  DP2: 52%: DP3: 26%; 
DP4: 14%; DP5: 8%; lactose 27.9%; glucose (including 
maltodextrin) 9.1%; galactose 5.6%; Gum Arabic 4.4%; 
Proteins 1.2%; Moistrure 3% 
1×100 ml 6.2; 6.02 
28 Raffinose (sigma) α-D-galactose-O-α-D-glucose(1,6)-β-D-fructose 3×50 ml 2.7 
29 Melibiose (Sigma) α-D-galactose-α(1,6)-D-glucose 22×10 ml 4.2-4.7 
30 Lactulose (Sigma) 4-O-(β)-D-galactopyranosyl-D-fructofuranose 2×10 ml n.g.o. 
31 Pectin (Sigma) esterified D-galacturonic acid  2×10 ml; 
VC 
n.g.o. 
32 Lactitol (Senn chemiacal, 
Switzerland) 
4-O-β-D-galactopyranosyl-D-glucitol 2×10 ml n.g.o. 
33 Stachyose (Qingdao) β-D-fructose-O-α-D-galactose-(1,6)-O-α-D-galactose-(1,6)-α-
D-glucose; stachyose + raffinose 80% 
2×10 ml 5.3 
34 Soy OS (Qingdao) stachyose + raffinose 80% 2×10 ml 5.5 
 Xylans    
35 
XOS 95P (Shandong Longlive 
Bio-Technology, China) 
XOS 95%; D-xylose and D/L-arabinose 5%; [β-D-xylose-(1-
,4)]n; n=2: 30%; n=3: 28%: 4<n<=7 
2×10 ml 3.7; 3.62 
36 XOS (Qingdao) XOS 95%; [β-D-xylose -(1,4)]n, n=2-7 2×10 ml 4.3; 3.72 
37 Xylitol (uknown manufacturer) 1,2,3,4,5-pentahydroxypentane 2×10 ml n.g.o. 
38 
Rye flour Arabinoxylan 
(Megazyme, Ireland) 
arabinose 38%; xylose 59%; other sugars 3%. VC n.g.o.5 
Mannans 
39 Partially hydrolised Guar gum 
(Novartis Nutrition, U.S.A.) 
soluble, shorter chains then Guar Gum 2×10 ml; VC4 n.g.o. 
40 CitriStim Mannan-OS (ADM, 
USA) 
not disclosed by the manufacturer. contains 
microbes4. 
n.g.o 
41 Manno-OS, (Qingdao) not disclosed by the manufacturer. 2×10 ml; VC7 n.g.o. 
42 Guar gum (sigma) (1,4)-linked β-D-mannopyranose backbone, branched by a 
(1,6) to α-D-galactopyranose); mannose/galactose = 1.5-2.0; up 
to 10,000 residues. 
VC n.g.o.5 
Itlaicized font: carbohydrates that gave rise to an OD ≥ 2 after 24 h; 1. OS: oligosaccharides; 2. a single 10 ml 
experiment; 3. n.g.o.: no growth observed; 4. tested by duplicated viable counts of cultures containing 0.5% 
w/v carbon source, which were plated on MRS-agar plates and recovered at t = 0 and t = 24 h; 5. The same 
experimental outline as in #4, with 2% carbon source. Values represent the ratio between the viable counts at 
t=0 and t = 24 h, respectively; 6. DP: degree of polymerization, i.e. number of monomers in the oligosaccharide 
structure; 7. VC, viable counts. 
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Figure 2.5. Putative FOS/raffinose operons in the genome of BB-12. Numbers correspond to BIF locus tags.  
 
2005). An induction of β-fructofuranosidase during growth on FOS, sucrose and to a greater 
extent fructose, was observed in B. infantis ATCC 15697 (Perrin et al. 2001). 
 The genome sequence of BB-12 contains numerous genes coding for putative oligo- and 
polysaccharide-active proteins, yet the experimental data show that only a limited number of 
these proteins were up-regulated by FOS (compared with glucose; see section 3.2.2 below) at the 
transcriptional level, and none of them was induced at the translational levels (data not shown).  
2.3.3.2. DNA microarrays analysis of BB-12 cultures grown on FOS  
RNA samples derived from BB-12 cultures cultivated on FOS were subjected to comparative 
transcriptional analysis using DNA microarrays. 165 genes were up-regulated (fold change 
FOS/glucose > 2) and 140 genes were down-regulated (fold change glucose/FOS > 2; Table 2.3; 
Table A.1).  
 As expected, up-regulation on FOS was observed for most of the genes that constitute 
the two putative fructan operons (Table 2.3.A.) This trend is partially supported by the fact that in 
a similar analysis of BB-12 cultures grown on MRS medium supplemented with 1% w/v FOS (the 
same carbon source that was used in this study), the transcription of only two genes, BIF_01865 
and BIF_00489, was induced. The fact that more genes were up-regulated on FOS in the present 
study may be explained by FOS being the primary carbon-source, in contrast to the earlier study 
where it was used as a supplement to a similar growth medium containing 2% w/v glucose. 
Parche and colleagues (2007) have also reported that homologous genes from B. longum 
NCC2705 were induced by FOS.  
 Three genes that code for proteins that may be associated with transport of 
oligosaccharides – MalG, MalC and a transporter, MFS superfamily (BIF_01618, BIF_01619 and 
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Table 2.3.A. Genes encoding putative fructan-acting proteins in BB-12.  
Locus tag Description 
Fold-
change 
Organism where a homologous protein was described 
(reference) / additional information 
BIF_00490 Transcriptional repressor N.V.* -B. longum NCC2705 (up-regulated on FOS; Parche et al. 
2007) 
BIF_01865 Sucrose-6-phsophate hydrolases 
(formerly annotated as β-fructofurano- 
sidase)  
15 -B. animalis subsp. lactis BB-12 (Garrigues et al. 2005) 
-B. animalis subsp. lactis DSM10140 (Ehrmann et al. 
2003) 
-B. animalis subsp. lactis (Trindade et al. 2003) 
-B. adolescentis G1 (Muramatsu et al. 1992) 
-B. breve UCC2003 (Ryan et al. 2005). 
-B. longum biotype infantis ATCC15697 (Warchol et al. 
2002) 
BIF_00489 Raffinose permease 18 -B. animalis subsp. lactis BB-12 (Garrigues et al. 2005) 
BIF_00743 Transporter 2.1 -Conserved domain: periplasmic binding protein (PBP)b 
super family (cl11400), E value=3.1e-56 
BIF_01423 Ribose repressor (formerly annotated as 
sucrose operon activator) 
0.60 - B. animalis subsp. lactis (Trindade et al. 2003) 
BIF_01473 Transporter, MFS superfamily 2.6 -homologous to sucrose transporter (ScrT) from 
Bifidobacterium animalis subsp. lactis, induced by sucrose 
and raffinose, repressed by glucose (Trindade et al. 2003) 
BIF_01618 MalG 13  
BIF_01619 MalC 6.0  
BIF_02090 Sucrose phosphorylase 2.5 -B. adolescentis DSM20083 (Van den Broek et al. 2004) 
-B. animalis subsp. lactis  (Trindade et al. 2003) 
-B. longum biotype longum SJ32 (Kim et al. 2003) 
BIF_01422 Transporter, MFS superfamily (formerly 
annotated as sucrose-6-phsophate 
transporter ScrT)  
6.0 -B. animalis subsp. lactis (Trindade et al.2003) 
* No values obtained in the analysis 
 
Table 2.3.B. Genes with putative role in complex carbohydrate catabolism that were up-regulated on FOS 
according to DNA microarrays analysis.  
Locus tag Description 
Fold-
change 
Organism where a homologous protein was described (reference) 
/ additional information 
BIF_00132 1,4-α-glucan branching enzyme 4.6 EC 2.4.1.18 
BIF_01252 β-Galf-β-1,5-Galf transferase/β-
Galf β- 1,6-Galf transferase 
2.3 EC 2.4.1.-/2.4.1.- 
BIF_01579 β-D-Glcp-β-1,4-glucuronosyl-
transferase 
2.5 homologous to β-D-Glcp β-1,4-galactosyltransferase (EC 2.4.1.-; E 
value=1.70e-30) from Streptococcus thermophilus (Stingele et 
al.1999) 
BIF_01607 β-glucosidase (EC 3.2.1.21) 3.4  
BIF_01617 Pullulanase 7.5  
BIF_01864 Hypothetical protein 25 located in the middle of a putative FOS operon 
39
Chapter 2                                                                   Gene mining & Screening for prebiotic candidates  
29 
 
BIF_01473, respectively; Table 2.3.A) were also up-regulated on FOS. The two former proteins, 
along with a gene coding for the starch-degrading enzyme pullulanase (BIF_01617) are located in 
tandem on the bacterial chromosome and may form another oligosaccharide-related operon (Fig. 
2.7). MalG and MalC are homologous to the sugar permease of ABC transporter system from B. 
longum NCC2705 (BL00190 and BL0424, respectively). The former belongs to a FOS operon, 
the latter to an unknown operon (Parche et al. 2007), whereas BIF_01473 shows sequence 
similarity to the aforementioned ScrT. Since it is postulated that ABC-type transport systems for 
oligosaccharides may have broad substrate specificity (Parche et al. 2007), it is not unlikely that 
these proteins may also be involved in FOS uptake. The extensive up-regulation (fold-change=25) 
of the gene coding for hypothetical protein BIF_01864, for which no homologous proteins were 
found, may be a result of co-transcription, as this gene is located within the putative FOS operon 
(Fig. 2.5), whose constituents (except for BIF_00490) were up-regulated also during growth on 
XOS. 
 Six additional genes are predicted to be involved in complex carbohydrate metabolism 
(Table 2.3.B), yet they do not seem directly related to fructan utilisation. The remaining up-
regulated genes (Table A.1, Appendix) consist of genes with a broad variety of putative functions, 
with high representation of ribosomal proteins.  
 With regard to the predicted mechanism for fructan catabolism in BB-12, the results of 
this study suggest that fructans are translocated across the cell membrane via oligosaccharide 
transporters of either an ABC or MFS type, and are degraded intracellularly by a sucrose-6-
phsophate hydrolases (BIF_01865). The latter, which is also known as a β-fructofuranosidase (EC 
3.2.1.26), hydrolyses the terminal non-reducing β-D-fructofuranoside residues in β-D-
fructofuranosides as FOS and inulin. The products of this reaction, glucose and/or fructose 
(depending on whether the fructans, which are composed of backbone of fructose monomers 
linked through β-(2,1)-glycosidic bonds [the Fn type], which can alternativly contain a glucose 
moiety at the non-reducing end [GFn type]), are then incorporated into the bifid shunt. 
Comparative sequence analyses of different bifidobacterial β-fructofuranosidases showed no 
secretion or membrane-anchoring sequences, suggesting that the enzyme may be acting 
intracellularly (Ryan et al. 2005) and that the bottleneck in inulin and medium-length sized FOS 
utilisation could be their import into the cell. This hypothesis is in line with the fact that 
BIF_01865 was not identified in 2D-DIGE analysis of the extracellular protein fraction of BB-12 
(O. Gilad, unpublished data). In addition, the gene coding for this protein was highly up-regulated 
(15 fold) on FOS, as seen by DNA microarrays (Table 2.3.A).  
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2.3.3.3. Discussion 
FOS and Inulin are widely used prebiotics, especially in Europe. Their performance in this study, 
however, was relatively poor. Cultures of BB-12 were propagated on both FOS, inulin or a 
mixture of the two attained more than 50% higher growth rates compared to glucose, yet the 
growth yields after 24 h were markedly lower (Fig. 2.2-2.4; Table 2.1). Similar growth patterns 
on FOS and inulin were observed for B. animalis DN-173 010 (Van der Meulen et al. 2004). The 
cultures grown on glucose, on the other hand, attained a lower growth rate, but grew continuously 
until the experiment was terminated after 24 h. This could be related to limited activity of the β-
fructofuranosidase towards longer oligofructan chains. Another possible explanation is related to 
the structure of the oligofructans, some of which containing a glucose-[Fructose]n 
oligosaccharidic chains. If the glycosidic bond between the first and the second fructose 
monomers in the GFn is cleaved first (it is however, unclear whether this cleavage is catalysed by 
the β-fructofuranosidase, which is not predicted to have an endo-mechanism, or by another 
glycoside hydrolases), the resulting sucrose, which is a preferred carbon source to glucose (data 
not shown), may be utilised first and when the cells run out of sucrose they will continue to 
degrade the FOS chain yielding free fructose monomers, a process that is evidently less 
energetically favorable then either sucrose or glucose utilization. The higher growth on sucrose 
and fructans (probably of the GF2 and GF3 type, which are composed of terminal glucose linked 
to two or three fructose monomers, respectively), can be explained by more efficient transport 
systems for di- and oligosaccharides compared with monosaccharides. Similar degradation 
patterns of FOS were reported for B. infantis ATCC 15697 (Perrin et al. 2001). The slightly 
higher growth rate obtained in the inulin-cultivated cultures compared with FOS may be related to 
the composition of the substrates, where the inulin mixture may contain higher fraction of GF2 
and GF3 than FOS. 
 Comparable growth features were also observed by Rossi et al. (2005), who tested the 
growth of 55 bifidobacterial strains on FOS and inulin. Their study demonstrated that when B. 
adolescentis MB 239 was cultivated in a semi-synthetic medium supplemented with either FOS, 
glucose or fructose,  the growth rates obtained on FOS were 3 or 4 fold higher compared with 
glucose or fructose (0.60, 0.19 and 0.15 h−1, respectively). Similar specific growth rates to these 
values were obtained in the current study with BB-12 cultures grown on 2% w/v of either FOS, 
inulin or a 1:1 w/w mixture of the two (Fig. 2.2-2.4; Table 2.1).  
 The relatively poor growth of BB-12 on the long chain fructo-oligosaccharide inulin is 
also in agreement with the results obtained by Rossi et al. (2005). Among the 13 bifidobacterial 
strains of animal origin tested, only B. thermophilum ATCC 25866 grew on inulin, and HPLC-
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based carbohydrate profile of the cultures throughout the course of the growth experiments 
showed that this strain is capable of degrading FOS up to 10-15 fructan monomers, while the 
longer chain fructans present in inulin remained intact (Fig. 2.6). It can therefore not be ruled out 
that the same utilisation pattern for fructans also applies for BB-12, yet this has to be verified by 
investigating the sugar profiles, as performed in the above-mentioned study (Rossi et al. 2005). 
  
 
 
 
 
 
Figure 2.6 Comparison of HPAEC-PAD patterns of culture medium containing 10 g/l FOS or inulin at the 
inoculation and after 48 h of incubation with B. thermophilum ATCC 25866. The peaks correspond to the 
selectively eluted fructans with increasing DP. Adapted from Rossi et al. (2005). 
 
A hypothetical explanation for the moderate stimulation of growth of BB-12 on oligofructans 
could be associated with the fact that the bacterium is only capable of utilising relatively short 
chain FOS, such that after these are hydrolysed extracellularlyor imported into the cell, the 
bacterium is incapable of utilising oligofructans of higher DP. It should be noted that BB-12 
cannot ferment fructose, suggesting the lack of efficient transport system for this hexose. As a 
result, extracellular degradation of this substrate may result in accumulation of monomeric 
fructose at the exterior of the cell, yet the limited knowledge regarding the enzymes involved in 
FOS degradation makes these predictions very hypothetical. 
 Based on the up-regulation of several genes upon growth on FOS observed in DNA 
microarrays, some of the proteins predicted to play a role in fructan catabolism were identified. 
These predictions could be corroborated by characterisation of the aforementioned proteins and 
by knock-out studies. The results of this study indicate that despite of the well established 
documentation concerning the bifidogenic effect of FOS and inulin, these substrates do not seem 
to be very efficient growth stimulators for BB-12. One could, however, test the growth of the 
strain on FOS of lower DP (GF2-GF4), as it is possible that BB-12 can preferentially metabolise 
these oligosaccharides. 
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2.3.4. Galactans 
2.3.4.1. Putative galactan-active proteins in BB-12 
Since BB-12 was isolated from yogurt, where lactose is the primary carbon source, it is not 
surprising that within the putative operons associated with complex carbohydrate catabolism, 
GOS are the carbon sources for which the largest numbers of operons was predicted. Four 
putative galactan/raffinose operons consisting of 12, 10, 7 and 4 ORFs, respectively, are found in 
the genome of BB-12 (Fig. 2.7). With the exception of the latter, these gene clusters also contain 
genes with putative role in the utilisation of other sugars like N-acetylglucoseamine and gluco-
oligosaccharides, as well as genes coding for predicted ABC- and MFS- type transporters, sugar 
binding proteins and both α- and β-galactosidases. The relatively high cellular yield obtained 
upon growth of BB-12 on GOS may be associated with the large number of β-galactosidases 
predicted to be involved in their degradation, as these enzymes are represented by as many as 8 
ORFs in the genome of the bacterium (Fig. 2.7; Table 2.4). β-Galactosidases catalyse the 
degradation of the disaccharide lactose and galacto- and transgalacto-oligosaccarides, while α-
galactosidases degrade melibiose, the trisaccharide raffinose and the soybean-derived 
oligosaccharide stachyose. The relatively large number of β-galactosidases may be related to 
complementary substrate specificity of the different enzymes, as shown for B. 
bifidum NCIMB41171 (Goulas et al. 2008). 
 
2.3.4.2. Results and Discussion 
Galactose-containing sugars were found to be relatively good substrates for the growth of BB-12 
(Table 2.2). This applies especially for TGOS, GOS, soy-oligosaccarides and to a lesser extent 
also melibiose and raffinose. In addition, the specific growth rate attained for the GOS cultures 
was markedly the highest within the sugars for which the growth rate was calculated (Fig. 2.2– 
 
 
 
Figure 2.7. Putative gluco- and galacto-oligosacharides operons in the genome sequence of BB-12.   
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2.4), ans is yet supported by studies undertaken by Gopal et al. (2001) who reported higher 
growth of Bifidobacterium lactis DR10 on GOS compared to glucose, yet may be partly related to 
the protein content in the GOS powder.  
 Both α- and β-galactosidases were identified and characterised from a handful of 
bifdobacterial species (Table 2.4). Parche and colleagues (2007) predicted three potential lactose 
permeases in B. longum NCC2705, implying that this species confers a capacity to both degrade 
galactans and to transport them into the cell. It is still unknown, however, whether the degradation 
of the galacto-oligosaccharide chain takes place intra- or extracellularly. 
 Another interesting finding in this regard is related to the up-regulation of a putative 
ABC uptake system for raffinose when grown on solid agar-containing MRS medium in 
comparison with liquid MRS medium (Garrigues 2006). The expression of three genes of this 
uptake system was increased 51, 42 and 66 fold, for the two raffinose transport system permease 
proteins BIF_1592 and BIF_1593, as well as for the raffinose-binding protein (BIF_1594), 
respectively (Garrigues 2006). Agar is a seaweed-derived substance, consisting of a mixture of 
the galacto-polysaccharides, agaropectin and agarose. Noticeably, the genes coding for the B. 
longum NCC2705 proteins homologous to BIF_01592–94, which are predicted to belong to a 
raffinose operon with identical genetic organization, were over-expressed during growth on 
raffinose (Parche et al. 2007), suggesting that the BB-12 proteins encoded by the raffinose/α-GOS 
operon may be active against both agar and raffinose. The up-regulation of these raffinose-related 
genes, as well as the neighboring gene encoding an α-galactosidase (BIF_00525), which was 
induced 7-fold under growth on agar, is in agreement with the bifidogenic properties of GOS 
seen in the present study. In addition to that, some of the genes that embody the putative glu/gla-
oligosaccharides operon – BIF_1617-19, were up-regulated on FOS according to DNA 
microarrays, implicating that this putative operon may have broad substrate specificity. 
 In comparison to the GOS, melibiose and raffinose gave rise to slower growth of BB-12. 
This could be explained by a possible switch in substrate utilisation; the galactose moieties are 
consumed first and the glucose monomers are utilised only after the depletion of galactose, as 
reported for Bifidobacterium longum NCC2705 (Parche et al. 2006). GOS, on the other hand, are 
in most cases exclusively composed of galactose moieties that may be preferably utilised by BB-
12 compared to the glucose and GF (sucrose) moieties present in melibiose and raffinose, 
respectively. The higher specific growth rates observed in the GOS and raffinose cultures may be 
related to some lactose content in the GOS preparation, as it was shown that BB-12 grows faster 
on lactose than on FOS (Van der Meulen et al. 2006), yet is more likely to be associated with 
more efficient transport systems for oligo- and dissacharides compared with those utilized for  
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glucose uptake, as observed for both FOS, inulin and XOS (section 3.4).  
 With respect to glucose uptake, the identity of the proteins facilitating glocuse tranport is 
unclear. Possible candidates can be the MFS superfamily transporter, BIF_01334, which is 
slightly homologous to the D-glucose-proton symporter from B. longum NCC2705 that is 
repressed by lactose (Parche et al. 2006). No data was obtained for the expression of the gene 
encoding this protein in DNA microarrays analysis. Another putative glucose transporter may be 
the glucose uptake protein homolog (BIF_00684). The sequence of the latter is identical to the 
corresponding protein from B. animalis subsp. lactis DSMZ 10140, whereas the sequence of B. 
animalis subsp. lactis Bl-04 protein has a single SNP that diminishes the ability of the strain to 
grow on glucose, which is transported via facilitated diffusion (Briczinski et al. 2008). It is 
possible that this mechanism, which depends on the intra- and extracellular glucose concentration, 
is slower compared with the sugar-permease ATP hydrolysis-driven system predicted to be 
utilised for oligosaccharides. However, the expression of the gene coding for BIF_00684 was 
increased during growth on FOS compared to glucose, a finding that contradicts this hypothesis. 
Table 2.4.  Genes encoding putative GOS-acting proteins in the genome of BB-12.  
 * Protein annotated as glycosyl hydrolases, formerly annotated as α-galactosidase. 
 
 
Locus tag Description 
Organism where a homologous protein was described (reference) / 
additional information 
-BIF_00311 Lactose permease  
-BIF_00489 Raffinose permease  
-BIF_00525 
-BIF_01595* 
-BIF_01624 
α-galactosidase -B. adolescentis DSM 20083 (Leder et al. 1999; Van den Broek et al. 1999) 
-B. breve 203 (Sakai et al.1986) 
-B. longum biotype infantis ATCC15697 (Roy et al.1992) 
-B. longum biotype longum CRL 489 (Garro et al. 1994) 
-BIF_00647 
-BIF_00799 
-BIF_00909 
-BIF_01474 
-BIF_01526 
-BIF_00909 
-BIF_01952 
-BIF_01953 
β-galactosidase -BIF_00647 is homologous to lacZ of B. longum NCC2705 that is up-
regulated by lactose, maltose and FOS (Parche et al. 2007) 
-B. adolescentis DSM 20083 (Van Laere et al. 2000) 
-B. adolescentis Int-57 (Lee et al.1997) 
-B. bifidum A3 (Iwasaki et al. 1971) 
-B. bifidum DSM 20082 (Dumortier et al. 1990) 
-B. bifidum DSM 20125 (Møller et al. 2001) 
-B. longum biotype infantis ATCC15697 (Roy et al. 1992) 
-BIF_00944 
-BIF_00983 
Undecaprenyl-phosphate galac-
tosephosphotransferase 
 
-BIF_01252 β-Galf-β-1,5-Galf transferase / β-
Galf- β-1,6-Galf transferase 
-EC 2.4.1.-/2.4.1.- 
-up-regulated on FOS according to DNA microarrays 
-BIF_01592 Raffinose-binding protein  
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2.3.5. Glucans 
2.3.5.1. Putative glucan-active proteins in BB-12 
Mining the genome sequence of BB-12 for gluco-poly- and oligo-saccharides-related genes 
resulted in the identification of two putative operons that were already listed with respect to GOS 
(Fig. 2.7; section 2.4.2.1.). It is unclear whether the oligo-1,6-glocosidase (BIF_01597) is co-
transcribed with the GOS-related genes. In addition to these operons, a few additional genes (e.g. 
the 1,4-α-glucan branching enzyme [BIF_00132; Table 2.5] are not located in the vicinity of 
sugar-related genes.  
2.3.5.2. Results 
2.3.5.2.1. α-Glucans 
It is evident that malto- or isomalto-oligosaccharides performed relatively well with respect to 
supporting the growth of BB-12 in vitro (Table 2.2) The gene locus malERFG of B. longum 
NCC2705, encoding a predicted maltose transport system, was induced when the bacterium was 
grown on maltose (Parche et al. 2007). The genome of BB-12 contains a gene coding for a 
maltose/maltodextrin-binding protein (BIF_00469) that possesses high sequence similarity to 
malE. In addition, the BB-12 genes coding for a transcriptional regulator of the LacI family 
(BIF_00745) and two multiple sugar transport system permease proteins (BIF_00746 and 
BIF_00747), are homologous with malR, malF and malG, respectively. Another relevant finding 
in this respect is the cloning and characterisation of the α-glucosidases encoded by the aglA and 
aglB genes from B. adolescentis DSM 20083. While the enzyme encoded by the former 
demonstrated high hydrolytic activity towards isomaltotriose and, to a lesser extent, towards 
trehalose, the enzyme encoded by aglB showed higher activity against maltose than sucrose and 
low activity towards maltotriose (van den Broek et al. 2003). In contrast to the growth-stimulating 
gluco-oligosaccharides and despite of the presence of genes encoding a variety of enzymes with 
putative activity against these substrates (Table 2.5), BB-12 is incapable of utilising a battery of 
α-glucans like potato starch, dextrin, cyclodextrin and the disaccharides cellobiose, palatinose and 
trehalose. 
2.3.5.2.2. β-Glucans 
The current in vitro growth studies demonstrated no growth of the bacterium on either oat or 
barley β-glucans, which may be related to the markedly lower number of β-glucosidases in the 
genome of BB-12 conmpared to α-glucosidases. β-glucosidases were identified and characterised 
from B. breve 203 (Sakai et al. 1986) and B. breve clb (Nunoura et al. 1996). The fact that β-
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glucan did not show any bifidogenic properties with respect to BB-12 was also observed by 
Crittenden et al. (2002).  
2.3.6. Mannans  
Despite of the presence of two genes encoding a mannan endo-1,4-β-mannosidase in the genome 
of the bacterium, BB-12 showed no growth on the presence of either guar gum, a partially 
hydrolysed derivative of guar gum (PHGG), or two different preparation of manno-
oligosaccharides (MOS). This is in agreement with an earlier study that reported that dietary MOS 
did not affect the cecal populations of bifidobacteria in ileal and cecal samples taken from turkeys 
Table 2.5. Genes encoding putative gluco-oligosacchridic-acting proteins in the genome of BB-12  
 
Locus tag Description 
Organism where a homologous protein was described (reference) / 
additional information 
- BIF_00132 1,4-α-Glucan branching enzyme -EC 2.4.1.18 
-up-regulated by FOS according to DNA microarrays 
- BIF_00151 
- BIF_00181 
- BIF_01617 
- BIF_02253 
Pullulanase -B. breve strains JCM 7019, CCUG 43878, CCUG 34405, UCC 2003, and  
NCFB 2258 (Ryan et al. 2006, O'Connell-Motherway et al. 2008). 
- B. dentium NCFB 2243 (Ryan et al. 2006). 
-BIF_01617: up-regulated by FOS according to DNA micro-arrays 
- BIF_0469 Maltose/maltodextrin-binding 
protein 
 
-homologous to malE, which belongs to the gene locus malERFG from B. 
longum NCC2705 that is up-regulated by maltose (Parche et al. 2007). 
-homologous to malE from E. coli K-12, which binds malto-oligosaccharides 
(Quiocho et al. . 1997) 
- BIF_00496 
- BIF_00782 
- BIF_02268 
amyB α-amylase; Trehalose-6-
phosphate hydrolase 
-B. adolescentis Int-57 (Rhim et al. 2006). 
-B. adolescentis DSM20083 (van den Broek et al.2003). 
- BIF_00611 
- BIF_01373 
Isoamylase  
- BIF_00745 Transcriptional regulator, LacI 
family 
 
- BIF_00746 Sugar transport system 
permease protein 
 
- BIF_00747 MsmG  
- BIF_00869 
- BIF_01314 
4-α-Glucanotransferase 
 
 
- BIF_01597 Oligo-1,6-glocosidase   
- BIF_01607 β-glucosidase (EC 3.2.1.21) -up-regulated on FOS according to DNA microarrays 
- BIF_01618 Maltodextrin transport system 
permease protein malC 
-up-regulated on FOS according to DNA microarrays 
- BIF_01620 Maltose/malto--dextrin-binding 
protein 
-homologous to the genes coding for the sugar ABC transporter solute-binding 
proteins BL1164 and BL1165 from B. longum LMG 13197, which are up-
regulated by human milk oligosaccahrides (González et al. 2008). 
-up-regulated by FOS according to DNA microarrays 
-homologous to malE from Streptococcus mutans UA159, which binds malto-
oligosaccharides (Webb et al. 2008). 
- BIF_01621 Maltose transport system 
permease protein malG 
 
- BIF_01664 Thermostable β-glucosidase B  
- BIF_02090 α-Glucosidase B. breve UCC2003 (Pokusaeva et al. 2009). 
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(Zdunczyk et al. 2005). Other studies, like those undertaken by Baurhoo et al. (2007a; 2007b), 
showed that MOS-containing carbohydrates gave rise to a significant bifidogenic effect (P < 0.05) 
in the ceca of in broilers. Furthermore, human studies demonstrated a significant increase in both 
the absolute values of fecal counts of Bifidobacterium and their proportion of the total viable 
counts during PHGG- and glucomannan-containing diets (Okubo et al. 1994; Chen et al. 2006).  
2.4. Conclusions 
2.4.1. Correlation between CFU/ml and OD600 
According to the linear correlation obtained in the study, OD600 value of 1 stands for 9.7×108 CFU 
of BB-12 per ml culture, which is in good agreement with the values described by Pérez-Consa et 
al. (2005). The correlation, after removing the outliers, was accompanied by a relatively low 
magnitude of inaccuracy (R2=0.9704), and was independent of both the carbon source and the 
morphology of the cells. 
2.4.2. Growth experiments 
BB-12 was grown in the presence of a broad battery of carbohydrates, including fructans, 
galactans, glucans, mannans and xylans. The results suggest that galacto-, soy-, malto- and 
isomalto-oligosaccharides significantly stimulate the growth of the bacterium (both the growth 
rates and the absolute cell densities were higher than those obtained in cultures grown in the 
presence of glucose). XOS gave rise to mediate growth of BB-12, while fructo-oligosaccharides, 
(where the shorter fructans were favoured over for longer chain inulin or the mixture of the two) 
yielded relatively poor growth. Mannan-based carbohydrates like manno-oligosaccharides and 
guar gum did not result in any growth of BB-12, and neither did oat and barley β-glucan.  
 The relatively higher specific growth rate of BB-12 obtained upon cultivation on GOS, 
FOS, inulin, raffinose and XOS compared to glucose is likely to be related to utilization of 
transport systems for oligosaccharides of superior efficacy compared to glucose. It cannot be 
ruled out that the model for oligosaccharides transport described for a putative ABC-type 
transport system for XOS (Section 3.5) may also apply for the catabolism of other 
oligosaccharidic substrates. 
 The publication of the genome sequences of a few bifidobacterial strains - B. longum 
NCC2705 (Schell et al. 2002) and DJO10A, B. adolescentis ATCC15703, and of the 
Bifidobacterium animalis subsp. lactis strains DSM 10140, AD011, Bl-04, HN019, V9 and BB-
12, has dramatically increased the knowledge of the metabolic capabilities of these members of 
the genus. The available sequences and the rapid development of advanced bioinformatics tools 
have facilitated the unraveling of the versatile metabolic toolbox possessed by bifidobacteria, 
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which encode a variety of glycosyl hydrolyses and sugar transporters. In this study, the genome 
sequences of BB-12 and B. longum NCC2705, as well as a review article on glycoside hydrolases 
(van den Broek et al. 2008b) served as the pillars of a comprehensive listing of prebiotics-related 
proteins in bifidobacteria, as illustrated in Tables 2.3–2.5 and 3.1–3.2.  
 It is noteworthy to stress out, however, that the presence of a gene in a genome of a 
given bacterium does not necessarily mean that the corresponding protein is indeed expressed and 
active. The aforementioned species-specific variation in the metabolic features of the bacteria 
should also be taken into consideration while comparing genes and proteins of different species.  
 Along with the results obtained in the transcriptomic and proteomic analyses performed 
on BB-12 cultures grown in the presence of a few selected prebiotic candidates, the results of the 
screening for growth stimulators for BB-12 are expected to increase the knowledge regarding the 
actual prebiotics-related metabolic capabilities of the bacterium (a detailed study of genes coding 
for XOS-active proteins, as well as a model for their utilization are described in chapter 3).   
2.5. Materials and Methods 
2.5.1. Experimental layout 
The various prebiotic candidates were tested for their ability to support the growth of BB-12 at a 
concentration of 2% w/v, which is the glucose concentration in the commercial MRS medium 
commonly used for cultivation of lactic acid bacteria. The carbohydrates were tested either by 
biological triplicates in 50 ml tubes, duplicates in 10 ml tubes or by viable counts (see Table 2.2). 
2.5.2. Preparation of selective growth medium  
“Home-made”-MRS (HM-MRS) is a reconsistuated glucose-free medium based on the 
commercial MRS-B medium (Difco), whose components are depicted in Table 2.6. below. The 
pH of the medium was adjusted to 6.5 before sterilisation (210 kPa, 121°C, 20 min). 
Carbohydrate solutions were filtered through a 0.22 μm pore size filter and added to the sterile 
broth to obtain a final carbohydrate concentration of 20 g/l.  
2.5.3. Correlation between CFU/ml and OD600 
A dataset of 20 data points, collected from three independent BB-12 cultures, was obtained by 
making duplicated dilutions of designated cultures. The OD600 values of the cultures was 
measured, 80 μl were plated out on Petri dishes containing MRS-agar supplemented with 0.05% 
w/v cysteine-hydrochloride (Cys-HCl), and the plates were incubated for 36 h in an anaerobic 
chamber supplemented with an anaerobic socket.  
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Table 2.6. The constituents of the HM-MRS medium.  
 
 
 
 
 
 
 
2.5.4. Preparation of crbon source solutions 
Readily soluble carbohydrate (# 1-9, 18-22, 25-30, 32-37 and 41 on the carbohydrate list; Table 
2.2) solution containing 2% w/v carbon source were prepared by dissolving the carbohydrates in 
autoclaved HM-MRS medium. The carbohydrate-medium mixtures were then sterile-filtered and 
placed in 37˚C overnight (ON), so that possible contamination could be detected and in order to 
pre-warm the medium to match the temperature the growth experiments were carried out at. 
Hardly-soluble viscous carbohydrates (the rest of the carbohydrates on the list) were weighed and 
dissolved in the pre-heated medium, and then set in 80˚C for 5 min, prior to the addition of the 
overnight inoculum. 
2.5.5. Growth experiments  
An inoculum of BB-12 was added into a tube containing MRS medium, into which Cys-HCl was 
added beforehand to a final concentration of 0.05% w/v, and the culture was incubated overnight 
at 37˚C. In the following morning, Cys-HCl (final concentration 0.05% w/v) was added to the 
carbohydrate solutions. To account for the turbidity originating from the carbon-sources, the 
OD600 of the solutions was measured (background OD) and the overnight inoculum was added to 
a final concentration of 1% v/v, yielding initial OD values that varied between 0.03 and 0.1 (from 
which the background OD was subtracted). The cultures were placed at 37˚C. The growth of the 
bacterium was monitored by OD measurements after 2, 4, 6 , 8, 12, 16, 20 and 24 h (for 
carbohydrates #1, 4, 5, 23, and 28) and to a lesser extent (OD measured after t=24 h) for the rest 
of the materials, which were only tested on a pilot basis. All the growth experiments were 
supplemented with cultures containing 2% w/v glucose (reference carbon-source), cultures into 
which no carbon source was added (designated as “HM-MRS”; negative control) as well as with 
cultures grown on MRS medium (validating that the bacterial inoculum grows as expected by 
culturing it on the medium the bacterium is usually cultured in).  
Component Conc. g/l 
Tryptone  10 
Beef extract 10 
Yeast extract  5 
Tri-ammonium citrate 2 
Sodium acetate 5 
Magnesium sulfate·7H2O 0.1 
Manganase sulfate·H2O 0.05 
Di-potassium phosphate 2 
Tween 80 1 ml 
pH 6.5 
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2.5.6. Growth Rate Calculations  
The carbohydrates that gave rise to viscous opaque solutions, making OD measurements 
unfeasible, were tested by viable counts. These were conducted by two consecutive dilutions of 
80 μl of the cultures at t=0 with 9 ml peptone water, mixing and plating out in Cys-HCl 
containing MRS-agar plates, which were thereafter incubated anaerobically for approx. 36 h at 
37°C. Both the dilutions and the plating were performed in duplicates, and the samples were 
designated as “10^-4”. The same procedure was repeated after the cultures were incubated for 24 
h, supplemented by an additional dilution 5-fold dilution (“10^-5“). The obtained dilution ratios 
were thus 12,822 and 64,411 for the “10^-4” and ”10^-5” samples, respectively. The growth of 
the bacterium was estimated according to the ratio between the viable counts at t=24 and t=0. 
Triplicate growth experiments 
The specific growth rate of BB-12 in the presence of different carbon sources was calculated 
based on the OD600 measurements of 1 h intervals, from 2 h after incubation until 7 h, (the time 
range that gave rise to the best linear correlations, as calculated by a trial and error fashion). The 
calculations are based on the Malthusian growth model, which is commonly applied for microbial 
exponential growth: N = N0×2μt, where μ is the growth rate, N is the cell count (or OD value), N0 
is the initial cell count at t=0 and t is the time. From here, the growth rate and the doubling time 
could be derived by plotting the log10 of the OD values as a function of time, such that a linear 
correlation is obtained in the exponential growth phase. The efficacy of the tested carbohydrates 
in supporting growth of BB-12 was evaluated based on the turbidity after 24 h incubation.  
2.5.7. DNA microarrays analysis  
2.5.7.1 Isolation of total RNA  
At an OD600 of 0.87 and 0.62 (late-exponential growth; 8 h of growth) for the glucose and FOS 
samples, respectively, cultures were collected in RNA protect (Qiagen, Valencia, CA). Total 
RNA was isolated by using an RNeasy minikit (Qiagen) except for the following: 200 μl of TE 
buffer contained 15 mg/ml of lysozyme (L6876, Sigma-Aldrich, Brøndby, Denmark), 15 μl of 
proteinase K (20 mg/ml, Qiagen), and 2 μl of mutanolysin (M9901; Sigma-Aldrich) at 25 U/μl. 
Vortexing was every 10 s at 37°C for 2 min. The quality and concentration of RNA was 
determined by using the RNA 6000 Nano Kit on a Bioanalyzer 2100 instrument (Agilent 
Technologies, Palo Alto, CA). RNA was eluted with 2 x 55 μl of nuclease-free water (NFW), and 
routinely 20 to 50 μg of total RNA was obtained. Only high-quality total RNA, as indicated by 
two sharp rRNA peaks, was used. 
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2.5.7.2. cDNA synthesis and labelling of total RNA 
A total of 10 μg of total RNA was lyophilized in a Speed-Vac. The copying into cDNA and 
labelling with either Cy3 (reference) or Cy5 (test) was performed using the CyScribe post-
labeling kit according to the manufacturer's protocol (Amersham Biosciences, Hillerød, 
Denmark). One microliter of random nonamer from the kit was used for priming.  
2.5.7.3. Hybridization, washing, and scanning of arrays 
According to the Amersham protocol, the Cy3- and Cy5-labeled cDNA were combined and 
lyophilized. Hereafter, they were resuspended in 3 μl of NFW, and 5 μl of hybridization buffer 
(4x) and 12 μl of formamide was added. This 20-μl solution was applied to the array under a 24-
by-24-mm LifterSlip (Erie Scientific Company, Portsmouth, NH) and put in an airtight box 
containing paper towels soaked in NaCl-saturated water. Arrays were hybridized for 16–20 h at 
42°C and then washed using the UltraGAPS protocol (Corning B.V.). Arrays were scanned by 
using a GenePix 4100A personal scanner with GenePix Pro 6.0 software (Axon Instruments, Inc., 
Union City, CA). The photo multiplier tube (PMT) sensitivity values of the scanner software were 
set to with “Auto-PMT” with a “saturation tolerance” of 0.1%. 
2.5.7.4. Preanalysis of arrays 
In GenePix Pro software, a grid with 110-μm spots was superimposed on the array image and 
manually adjusted to fit small irregularities in spotting. Spots clearly covered by, e.g., dust 
particles were flagged as "bad" (equal to a Flag value of –100). The intensities of all the spots 
were then calculated by using the "analyze" function. Spots with very weak signals in both 
channels were also flagged "bad." These were spots where the signal-to-noise ratio was < 1 in 
both channels or the percentage of feature pixels with intensities more than two standard 
deviations above the background pixel intensity was < 20, i.e., (% > B + 2SD) < 20, in both 
channels (see the GenePix Pro manual for details). All other spots were considered "found" and 
had a Flag value of ≥0. All data were exported from GenePix Pro in tab-delimited format. In 
further analyses, the variables of feature (spot) intensity minus the background intensity around 
the spot was used, i.e., (F635 median - B635) = Cy5 and (F532 median - B532) = Cy3. 
Thelog2(ratio) was calculated as log2(Cy5/Cy3). Genes were discarded if the standard deviation of 
the log2(ratio) of the replicate spots on each array was >0.5. Genes were considered to be  
 
regulated when a ׀ fold change׀ > 2 was obtained.
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Chapter 3. Combined transcriptome and proteome analysis of 
Bifidobacterium animalis subsp. lactis BB-12 grown on xylo-
oligosaccharides and a model of their utilisation  
3.1. Summary 
Recent studies have demonstrated that xylo-oligosaccharides (XOS), which are classified as 
emerging prebiotics, selectively enhance the growth of bifidobacteria in general and of B. 
animalis subsp. lactis strains in particular. To elucidate the metabolism of XOS in the well-
documented and widely-used probiotic strain B. animalis subsp. lactis BB-12, a combined 
proteomic and transcriptomic approach was applied, involving DNA microarrays, real-time 
quantitative PCR (qPCR) and two-dimensional difference gel electrophoresis (2D-DIGE) analyses 
of protein extracts obtained from cultures grown on either XOS or glucose. The analyses show that 
9 of the 10 genes that encode proteins predicted to play a role in XOS catabolism (i.e. XOS-
degrading and metabolising enzymes, transport proteins and a regulatory protein) were induced by 
XOS at the transcriptional level, and the proteins encoded by three of these (β-D-xylosidase, sugar-
binding protein, and xylose isomerase) showed higher abundance on XOS. Based on the obtained 
results, a model for the catabolism of XOS in BB-12 is suggested, according to which the strain 
utilises an ABC transport system (probably for oligosaccharides) to bind XOS on the cell surface 
and transport them into the cell. XOS are then degraded intracellularly through the action of 
xylanases and xylosidases to D-xylose, which is subsequently metabolised by the D-fructose-6-P 
shunt. The findings obtained in this study may have implications for the design of a synbiotic 
application containing BB-12 and the XOS used in the present study. 
3.2. Introduction 
Prebiotics are defined as food components that confer a health benefit on the host through 
modulation of the microbiota (WHO/FAO 2007). Among different kinds of prebiotics, special focus 
has been given to non-digestible oligosaccharides (NDOs), which can be fermented by the majority 
of the members of the genus Bifidobacterium. Bifidobacteria degrade NDOs to monosaccharides, 
which in turn are converted into intermediates of the bifid shunt (Section 1.1.1). 
 The most predominant sugar transport systems in bifidobacteria are ABC-type transport 
systems (Section 2.2). The capability of these transport systems to import di- and oligosaccharides 
is in line with the observation that some bifidobacteria obtain higher cell yields and higher specific 
growth rates when cultivated on oligosaccharides, compared to the corresponding monosaccharides 
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(Van der Meulen et al. 2004). These observations may be explained in part by efficient transport 
systems specific for di- and oligosaccharides.  
Xylo-oligosaccharides are NDOs that have received increasing attention as potential 
prebiotic candidates (Roberfroid 2007). XOS are sugar oligomers composed of a β-1,4-linked 
xylopyranosyl backbone that are obtained by either chemical, or more commonly, enzymatic 
hydrolysis of xylan polysaccharides extracted from plant cell wall. The bifidogenic effect of XOS 
was demonstrated both by in vitro studies (Rycroft et al. 2001) and by small scale in vivo human 
studies (Chung et al. 2007), and a recent semi-continuous, anaerobic colon simulator study 
demonstrated that growth on XOS can also result in decreased levels of pathogenic strains 
(Mäkeläinen et al. 2009b). 
  A few XOS-degrading enzymes have been identified and characterised in bifidobacteria. A 
β-D-xylosidase characterised from B. breve K-110 (Shin et al. 2003) was shown to hydrolyse xylan 
to xylose. In a study that tested the activity of arabino-XOS degrading enzymes in B. adolescentis, 
B. infantis and B. bifidum, all species demonstrated intracellular xylosidase and arabinosidase 
activities, whereas no xylanase activity was detected (Zeng et al. 2007). An exo-oligoxylanase 
(RexA) was recombinantly expressed and characterised from B. adolescentis LMG10502. This 
enzyme was acts at the reducing-end and hydrolyses birchwood xylan and oat spelt xylan (Lagaert 
et al. 2007). 
B. animalis subsp. lactis BB-12 is a widely-used commercial probiotic strain isolated in 
1983 by Chr. Hansen A/S. The strain is included in a variety of food applications and dietary 
supplements, and is ascribed various probiotic effects (Ouwehand et al. 2004). In the present study, 
BB-12 was cultivated in a rich broth supplemented with either XOS (DP 2–6) or glucose and the 
obtained samples were compared at both the transcriptional and the translational levels. To our 
knowledge, this is the first study comprising a comprehensive and complementary 
proteomic/transcriptomic approach in bifidobacteria. Based on the obtained results, a model was 
established for the fermentative catabolism of XOS by BB-12. The objective is to broaden the 
insight into the metabolic basis of the use of XOS as a supplement to probiotic preparations 
containing BB-12. 
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Figure 3.1. Growth of BB-12 in a rich broth containing 2% (w/v) glucose or XOS, respectively, as well as a 
control culture where no carbon source was added. Growth studies were carried out in triplicate, and a 
representative data set is shown. Note that without carbon source added there is only limited growth, which is 
presumably due to low amounts of other carbohydrates in the complex components of the MRS. Insert: mean 
values of specific growth rate, maximal cell density, and pH of culture supernatants after 8 h of growth are 
given. 
3.3. Results 
3.3.1. Comparison of growth on glucose and XOS 
To test whether XOS can support the growth of B. animalis subsp. lactis BB-12, the strain was 
propagated in an MRS-reconstituted broth containing 20 g/l of either glucose or XOS for 24 h (Fig. 
3.1). The mean specific growth rates, as calculated from the exponential-phase, were slightly higher 
for the XOS-grown cultures, yet growth on XOS was markedly impaired after 6-7 h, but less so for 
the glucose cultures was lower. Accordingly, the mean turbidity values of the glucose cultures 
measured after 24 h in the glucose cultures (3.5 ± 0.2) were markedly higher compared to XOS (2.2 
± 0.1). Similar experiments conducted with arabinoxylan or xylose resulted in very poor growth 
(data not shown). pH measurements after 8 h of growth showed that the decrease in pH from the 
initial 6.5 in the XOS culture (4.71 ± 0.03) was significantly larger compared with the glucose-
containing cultures (5.03 ± 0.02). This is consistent with the faster growth, and thereby faster 
acidification, seen on XOS. No significant differences were observed in the levels of the primary 
end products of the bifid shunt – acetate and lactate (data not shown).  
 
Carbon 
source 
Specific 
growth rate 
(h-1) 
Maximal cell 
density 
(OD600) 
pH after 8 
h 
of growth 
Glucose 0.65 ± 0.03 3.5 ± 0.2 5.03 ± 0.02 
XOS  0.74 ± 0.02 2.2 ± 0.1 4.71 ± 0.03 
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Figure 3.2. High-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-
PAD) analysis of supernatants of BB-12 cultures propagated on XOS. Concentration of different XOS species in 
the supernatants of BB-12 cultures grown on XOS collected from initially-grown cells and stationary cells, 
respectively, are designated. The results represent mean values and standard error from three biological 
replicates.  
3.3.2. Analysis of culture supernatants by liquid chromatography        
Supernatants of BB-12 cultures grown in the presence of XOS were collected at the stationary 
phase (24 h) and subjected to High performance anion exchange chromatography with pulsed 
amperometric detection (HPAEC-PAD) analysis. The results (Fig. 3.2) showed that the 
concentration of all XOS (DP 2–6) was markedly lower at the stationary phase compared with 
initially-grown cells (93% decrease in total). The concentration of the monomeric D-xylose was 
nearly 6-fold higher, yet this accumulation accounted for less than 20% of the decrease in the total 
XOS conectration. The results also show that the relative decrease in the concentration of XOS of 
different DP decreased with increasing chain length (a decrease of 98, 95, 91, 80 and 77% for 
xylobiose, xylotriose, xylotetraose, xylopentaose and xylohexaose, respectively). The level of 
arabinose in the above-mentioned culture supernatants was very low and the absence of glucose, 
galactose and lactose was by verified by gas chromatography analyses (data not shown). 
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3.3.3. DNA Microarrays analysis 
The expression of genes from exponentially-growing BB-12 cultured in the presence of either 
glucose or XOS were compared using whole genome microarrays. Fourteen genes were found to be 
up-regulated and 10 to be down-regulated on XOS (Table 3.1). Of the genes induced upon growth 
on XOS, 11 are located successively in the genome of BB-12. Nine of these genes, along with 
another gene located elsewhere in the genome, encode proteins likely to be involved in XOS 
catabolism. These proteins consist of XOS-degrading enzymes, transport-related proteins, D-xylose-
metabolising enzymes and a transcriptional regulator, which may play a role in the regulation of the 
genes (Table 3.2). Six of the 10 repressed genes (relative to growth on XOS) code for carbohydrate-
metabolising or binding proteins, e.g. maltose/maltodextrin-binding protein (BIF_00469) and 
sucrose phosphorylase (BIF_02090).  
 
3.3.4. Real-time quantitative PCR analysis 
To verify the results obtained in the microarrays analysis, 11 putative XOS-related genes were 
subjected to qPCR analysis (Table 3.1). The induction of 9 of the 10 genes identified to be up-
regulated in the microarrays analysis was confirmed by qPCR analysis. The exception was the 
transcriptional regulator BIF_00432. The correlation obtained between the up-regulation in the 
microarrays and qPCR analyses was good, yet the fold-change values were higher according to the 
microarrays analysis for 7 of the 9 genes found to be differentially-expressed in both analyses 
(Tables 3.1–3.2). No up-regulation at the transcript level was detected, however, for the gene 
coding for ATP-binding protein BIF_01681 that showed increased abundance at the protein level in 
cultures grown on XOS (Table 3.2). 
3.3.5. Comparative proteome analysis using 2D-DIGE 
Twenty-eight differentially abundant protein spots were identified in total (Fig. 3.4). The proteins in 
all of these spots were identified by MALDI-TOF MS/MS, amounting to 25 unique proteins (Table 
A.2, Appendix). Among these, 8 showed increased spot intensity and seven decreased abundance in 
the XOS cultures compared to the glucose-grown cultures. Three proteins were regulated more than 
five-fold – xylose isomerase (BIF_00501) and sugar-binding protein (BIF_00212) were up-
regulated whereas enolase (BIF_01197) was down-regulated on XOS. Ten additional proteins were 
detected in 7 differentially abundant spots (6 of which were increased) whose analyses gave rise to 
more than a single protein identification, rendering the determination of the level of regulation 
impossible. Carbohydrate-metabolising proteins, including XOS- metabolising proteins and 
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Table 3.1. Relative gene expression according to cDNA microarrays and qPCR analyses. Values of fold-change 
regulation (with glucose as the reference) for the microarrays analysis represent mean of two analyses carried 
out using a dye-swap, and values of the qPCR analysis are mean of 4 values from four biological replicates, each 
run in duplicates. Positive and negative values correspond to up- and down-regulation on XOS, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ID Description 
Fold-change 
DNA 
micro-
arrays qPCR 
Up-regulated genes   
501 Xylose isomerase 33 19+++ 
92 β-Xylosidase/α-L-
arabinofuranosidase 
31 10.3+++ 
212 Sugar-binding protein 29 21+++ 
257 Transporter 25 28+++ 
258 Transporter 18 14+++ 
405 β-Xylosidase/α-L-
arabinofuranosidase 
6.1 3.0++ 
633 Endo-1,4-β-xylanase 6.0 2.1+ 
1688 Hypothetical protein 5.9 n.a 
829 Xylulose kinase 4.8 3.4+++ 
1171 Sialic acid-specific 9-O-
acetylesterase 
3.7 n.a 
1350 NrdI  2.2 n.a. 
928 Endo-1,4-β-xylanase 2.2 2.5+ 
1170 Para-nitrobenzyl esterase 2.1 n.a. 
432 Transcriptional repressor 2.1 1.1 
Unregulated genes 
1629 ABC transporter ATP-
binding protein 
1.2 0.82 
1681 Sugar transport ATP-
binding protein 
1.1 1.1 
ID Description 
Fold-change 
DNA 
micro-
arrays qPCR 
Down-regulated genes     
155 Formate acetyltransferase -4.2 n.a. 
1820 Hypothetical protein -3.5 n.a. 
2081 (S,S)-butane-2,3-diol 
dehydrogenase 
-3.0 n.a. 
800 Glycerol-3-phosphate-binding 
protein 
-3.0 n.a. 
1895 Inosine-uridine preferring 
nucleoside hydrolase 
-2.8 n.a. 
127 LSU ribosomal protein L31P -2.6 n.a. 
712 Pyruvate formate-lyase activating 
enzyme 
-2.3 n.a. 
2090 Sucrose phosphorylase -2.2 n.a. 
289 Multidrug resistance protein B -2.2 n.a. 
469 Maltose/maltodextrin-binding 
protein 
-2.1 n.a. 
+ P<0.05; ++ P<0.01; +++ P<0.001 (Anova one-way test);   
n.a. not analysed. 
Figure 3.3. Proteomic response of BB-12 to growth in a rich 
broth supplemented with glucose or XOS, represented by 
Cy3(green) and Cy5 (red) coloured images, respectively, as 
well as an overlay of the two images. Spots of differentially-
abundant proteins are designated in Fig. 3.4 below. 
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enzymes of the bifid shunt, accounted for the majority of the proteins identified from the 8 proteins 
whose abundance increased in the XOS samples. The results obtained from the proteomic and the 
transcriptomic analyses (Tables 3.1–3.2) demonstrate that proteins encoded by five of the 25 genes 
found to be regulated at the transcript level also had altered abundance at the protein level (yet only 
four of the 15 regulated proteins appeared to be of immediate interest with respect to XOS 
catabolism and thus tested by qPCR).  
 With respect to XOS metabolism, four of the 8 over-expressed proteins may be associated 
with the utilisation of XOS. The genes coding for three of these proteins – sugar-binding protein 
(BIF_00212; Fig. 3.5.A), xylose isomerase (BIF_00501; Fig. 3.5.B) and β-xylosidase (BIF_00405) 
were up-regulated also at the transcriptomic level during growth on XOS. In addition to that, the 
abundance of the ATP-binding protein BIF_01681 was increased when grown in the presence of 
XOS. Another ATP-binding protein, BIF_01629, was identified in a differentially-abundant spot 
also containing another protein. These two proteins may be involved in an ABC-type transport 
system that transports XOS across the bacterial cell membrane.  
Figure 3.4. Image of a representative 2D-DIGE gel. Differentially-expressed protein spots, molecular weight and 
isoelectric point markers are denoted. The proteins identified from the spots are listed in Table A.2 (Appendix). 
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Figure 3.5. Comparison of the protein abundance in BB-12 grown on XOS or glucose (as observed by spot 
patterns on a gel image). Images (from a representative 2D-DIGE gel) were obtained by differential labelling of 
protein samples with fluorescent dyes. Spots A (spot #18) and B (spots # 10-12; see Fig. 3.4 and Table A.2, 
Appendix) correspond to sugar-binding protein (BIF_00212) and xylose isomerase (BIF_00501), respectively. 
3.4. Discussion 
In order to investigate the proteins and enzymes that play a role in the utilisation of XOS in the 
probiotic strain BB-12, comparative transcriptome and proteome analyses of samples derived from 
XOS-grown cultures were carried out. The results of the growth experiments showed that BB-12 
attained slightly higher growth rate but lower growth yield on XOS compared to glucose. Earlier 
studies showed that BB-12 is capable of utilising XOS as a carbon source, but cannot ferment 
xylan, arabinoxylan (Crittenden et al. 2002) or xylose. Vernazza et al. (2006) reported markedly 
lower growth rate of BB-12 on XOS compared to glucose, yet comparison of growth rates and cell 
yields are potentially problematic due to differences in the growth medium and in the XOS used 
between the current study and the study carried out by Vernazza and colleagues. Cessation of 
growth was observed in the XOS-cultivated cultures after 6–7 h, which is probably related to the 
lower pH compared with glucose (4.71 and 5.03, respectively).  
3.4.1. A model for XOS catabolism in BB-12 
The induction of a few putative XOS-related proteins at the transcript and/or protein level supplied 
the basis for the establishment of a model for XOS catabolism in this strain. According to the 
suggested model (Fig. 3.6), the import of XOS and their further degradation take place in a 
multistep mechanism consisting of the following steps: (i) Binding of XOS at the cell surface; (ii) 
Transport across the membrane by ABC-type oligosaccharide transport system(s); (iii) Intracellular 
degradation of XOS to D-xylose by XOS-degrading enzymes; and (iv) Two-step conversion of D- 
xylose to D-xylulose 5-phosphate (X5P).  
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a Gene/protein number (the “BIF_” prefix was removed). b Sequence-based similarities to conserved domains, as 
predicted using BLASTP (Altschul et al. 1997) (expect values and amino acids percent identity are indicated in 
parentheses, respectively) and TCDB (TC numbers are indicated according to the TCDB classification system; 
http://www.tcdb.org/) (Saier et al. 2009). c Relevant organism(s) from which the proteins has been characterised and the 
corresponding reference. d n.d.: Proteins not detected to be up-regulated. For complete data of the analyses see Table 
A.2 (Appendix). 
Binding of XOS at the cell-surface is carried out, according to the suggested model, by the sugar-
binding protein BIF_00212, which is up-regulated on XOS at the transcriptional level. In the 
present study, the abundance of this protein was increased upon growth on XOS, and similar 
observations were recorded in extracellular proteome analysis (O. Gilad, S. Jacobsen, B. Stuer-
Lauridsen and B. Svensson, manuscript in preparation).  
 Transport of XOS into the cells is predicted to be facilitated by an ABC-type sugar 
transport system(s) capable of importing a variety of oligosaccharides, as was postulated (at the 
genus level) by Palframan et al. (2003). The fact that nearly all of the XOS were consumed after 24
h or growth (Fig. 3.2) implies that the oligosaccharides were ta ken up by the cells. 
Ida 
 
 
 
Description 
Fold-change up-
egulation 
Additional informationb 
DNA 
micro-
arrays qPCR 
2D-
DIGE 
501 Xylose  isomerase 32 19 13 - EC 5.3.1.5 
405 β-Xylosidase 
 
6.1 3.0 1.8 - EC 3.2.1.37/3.2.1.55 
- GH 43 (3×10-36) 
92 β-Xylosidase 31 10.3 n.d.d - EC 3.2.1.37/3.2.1.55 
- GH 43 (1×10-84) 
432 Transcriptional 
repressor 
2.1 1.1 n.d. - cd01543, PBP1_XylR, ligand binding domain of DNA transcription 
repressor specific for xylose (1×10-15) 
212 Sugar-binding 
protein 
29 21 6.2 - COG1653, UgpB, ABC type sugar transport system periplasmic 
component (1×10-35) 
- COG2182, MalE, Maltose binding periplasmic proteins/domains (2×10-17) 
257 Transporter 25 28 n.d. - PRK10999, malF, maltose transporter membrane protein (32%, 1×10-13) 
COG1175, UgpA, ABC type sugar transport systems, permease 
components (7×10-58) 
258 Transporter 18 14 n.d. - COG3833, MalG, ABC type maltose transport systems, permease 
component (32%, 7×10-37) 
- TC 3.A.1.1.21 xylobiose porter BxlEFG(K) (31%, 2×10-34) 
633 Endo-1,4-β- xylanase 5.9 2.1 n.d. - EC 3.2.1.8 
- pfam04616, GH 43 (8×10-40) 
928 Endo-1,4-β- xylanase 2.2 2.5 n.d. - EC 3.2.1.8 
829 Xylulose kinase 4.8 3.4 n.d. - EC 2.7.1.17 
1629 ABC transporter 
ATP-binding protein 
1.2 0.82 1.8 - COG1129, MglA, ABC type sugar transport systems, ATPase component 
(7×10-6) 
1681 Sugar transport ATP-
binding protein 
1.1 1.1 1.6 - COG3839, MalK, ABC type sugar transport systems, ATPase components 
(31%, 2×10-34). 
Table 3.2. Proteins/genes predicted to play a role in the catabolism of XOS in BB-12. Fold-change up-
regulation values on XOS compared with glucose, as obtained using microarrays, qPCR and 2D-DIGE analyses 
are listed. Information regarding function predictions. For more detailed description of the protein hits see 
Table A.2 (Appendix). 
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The proteins predicted to take part in XOS transport are the transporter proteins BIF_00257 and 
BIF_00258. The transcription of the genes encoding these permeases was more than 20-fold up-
regulated by XOS (Table 3.1). In addition to this, preliminary data show that both proteins were 
identified in the membrane fraction obtained from BB-12 cultures cultivated on XOS (Gilad et al. 
2012). Sequence similarity searches of BIF_00257 and BIF_00258 (Table 3.2) demonstrate that 
these proteins resemble oligosaccharide transporters. The ATP-binding 
 
Figure 3.6. A model for the catabolism of XOS in BB-12 comprising the following steps: (1) Binding of XOS at  
 
the cell surface by a sugar-binding protein. (2) Transport of XOS by an ABC transport system. (3) Degradation 
of XOS to D-xylose (by a combined action of an endo-1,4-β-xylanase and a β-xylosidase). (4) Conversion of D-
xylose to xylulose-5-P, a key metabolite of the fructose-6-P shunt. (A) Endo-1,4-β-xylanase. (B) β-Xylosidase. (C) 
Xylose isomerase. (D) Xylulose kinase. The numbers indicate the respective genes in the genome of BB-12, 
omitting the “BIF_0”. 
proteins that energise transport of XOS through the ABC transport system may be BIF_01629 and 
BIF_01681, the latter is differentially-expressed in cultures grown on XOS. According to the 
Conserved Domain Database searches (all non-redundant GenBank protein sequences at NCBI; 
http://www.ncbi. nlm.nih.gov/Structure/cdd/cdd.shtml) (Marchler-Bauer et al. 2009), these proteins 
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contain motifs characteristic of ATP binding sites.  
The degradation of XOS transported across the membrane is suggested to be facilitated by 
the action of endo-1,4-β-xylanases (BIF_00633 and BIF_00928) and/or β-xylosidases (BIF_00092 
and BIF_00405). Endo-1,4-β-xylanase cleaves XOS randomly, while β-xylosidase degrades the 
xylo-oligomeric chain at the non-reducing end, releasing D-xylose. The genes encoding these four 
enzymes were induced upon growth on XOS according to both DNA microarrays and qPCR 
analyses. According to the glycoside hydrolase classification system (http://www.cazy.org/ 
Glycoside-Hydrolases.html) (Cantarel et al. 2009), BIF_00633, BIF_00092 and BIF_00405 are 
predicted to belong to glycoside hydrolase family 43 (GH43), which comprises both endo-1,4-β-
xylanases and β-xylosidases. Preliminary data show that recombinant BIF_00092 degrades β-D-
(1,4)-xylo-oligosaccharides of DP 2–5 (xylohexaose was not tested; A. H. Viborg, S. Jacobsen, K. I. 
Sørensen, O. Gilad and B. Svensson, manuscript in preperation). The up-regulation of BIF_00405 
on XOS according to 2D-DIGE analysis provides additional experimental evidence supporting the 
suggested role of the two xylosidases in XOS degradation. 
The final step in the model for XOS catabolism comprises conversion of D-xylose (formed 
by the action of the XOS-degrading enzymes) to X5P, as described for Lactobacillus pentosus 
MD353 (Lokman et al. 1997). D-Xylose is isomerised by xylose isomerase to D-xylulose, which is 
phosphorylated by xylulose kinase to X5P (Fig. 3.6). Xylose isomerase was highly up-regulated at 
both the protein and transcript levels (fold-change 32, 19 and 13 for the microarrays, qPCR and 2D-
DIGE analyses, respectively) in the XOS cultures.  
 The increase in D-xylose concentrations observed in the present study may be associated 
with two alternative mechanisms. The first is related to extracellular degradation of XOS. This 
hypothesis does not seem very likely, however, as BB-12 grows very poorly on D-xylose, but 
demonstrates relatively high growth rate on XOS, suggesting the lack of efficient uptake system for 
the monosaccharide. As a result, the uptake rate of D-xylose monomers released from the action of 
extracellular XOS-degrading enzymes is expected to be low and hence the growth of the bacterium 
will be diminished.  In addition, none of the four XOS-degrading enzymes are predicted to possess 
neither secretion-related sequence motifs nor a membrane/cell wall anchor, such that it is unlikely 
that any of these enzymes act extracellularly, yet it cannot be ruled out that another extracellular 
enzyme is involved in XOS degradation, or that one the above-mentioned enzymes is secreted. The 
second possible explanation to the accumulation of D-xylose could be that this monosaccharide is 
released to the exterior of the cell via diffusion or export mechanisms. Since BB-12 attains 
relatively high growth rate on XOS, it is possible that the incorporation of xylose resulting from 
63
Chapter 3                                                                          Combined Transciptome & Proteome analysis  
53 
 
intracellular XOS degradation into the bifid shunt generates a bottleneck, which gives rise to 
redundancy in the intracellular xylose levels. It is unknown whether an inhibition mechanism is 
involved in this process, yet excess of D-xylose may in this case be exported or diffuse outside the 
cells where its concentration is lower. Growth experiments with radiolabeled XOS may be useful in 
corroborating these hypotheses. 
 The established model for XOS utilisation in BB-12 is currently being subjected to 
verification by comparative proteome analysis of the membrane proteins of the bacterium, as well 
as by characterisation of enzymes predicted to participate in this fermentative pathway. The activity 
and importance of the proteins predicted to play a role in growth on XOS can be verified by knock-
out studies.  
3.4.2. Previous models for XOS catabolism 
The suggested model for XOS metabolism in BB-12 is in agreement with the model for B. 
adolescentis LMG10502 proposed by Lagaert et al. (2007), who postulated that XOS degradation 
by this strain is initiated by transport of XOS into the cell by a MalEFG-type oligosaccharide 
transporter followed by intracellular hydrolysis by a reducing-end exo-oligoxylanase to xylose and 
xylobiose. The latter can be further degraded by β-xylosidase, as previously reported for B. breve 
K-110 (Shin et al. 2003). It can be hypothesised that BB-12 utilises a similar transport system that 
is capable of transporting a variety of di- and oligosaccharides, including XOS and maltose. 
  A somewhat alternative model for XOS utilisation by B. longum biotype longum was 
introduced by van den Broek and co-workers (2008a). According to this model, XOS are degraded 
extracellularly and imported into the cell through a concerted binding-cleavage-transport 
mechanism that involves cleavage by extracellular membrane-anchored endo- and exo-xylanases to 
D-xylose and L-arabinose, which in turn will be transported into the cell by monosaccharide 
transporters. (van den Broek et al. 2008a) . This model differs from the model described in the 
present study, where XOS are taken up by the cells via ABC-type transport system(s) and degraded 
intracellularly to D-xylose.     
3.4.3. XOS as a prebiotic candidate 
XOS are expected to be resistant to degradation by the human upper GIT and to reach the colon, 
where they are preferentially fermented by bifidobacteria. As the nutrients levels in the colon are 
scarce, a daily dose of a few grams of XOS can boost the growth of bifidobacterial strains like BB-
12. An experimental evidence supporting this notion can be found in a human intervention study 
(Chung et al. 2007), where administration of XOS resulted in significant increase in bifidobacterial 
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populations (as analysed from human feces), an increase that was diminished after the 
administration was halted.  
               With regard to the potential applications of XOS in a synbiotic preparation combined with 
BB-12, the present results show that the bacterium possesses the metabolic capacity to utilise XOS 
as primary carbon source. Mäkeläinen and colleagues (2009b) tested the effect of XOS of varying 
DP on the microflora in the lower GIT using a simulated colon model. The study showed that 
supplying the simulator with different types of XOS (including the XOS used in the present study) 
not only triggered an increase in the total counts of bifidobacteria and lactobacilli, but also caused a 
reduction in the total counts of clostridia (and, to a lesser extent, of bacteroides).  The authors also 
observed that upon growth on the XOS tested, the levels of short-chain fatty acids increased and the 
concentrations of branched-chain amino acids decreased, data that indicate a balanced microflora. 
Taken together, these results exemplify the potency of XOS as prebiotics that selectively stimulate 
the growth of lactobacilli and particularly bifidobacteria. Since XOS was specifically efficient in 
promoting the in vitro growth of the B. animalis subsp. lactis taxon, e.g. BB-12, a synbiotic 
preparation containing a combination of the two may be taken into consideration.  
 
3.5. Materials and methods  
3.5.1 Strain and growth medium 
Bifidobacterium animalis subsp. lactis strain BB-12 (BB-12 is a registered trademark of Chr. 
Hansen A/S) was obtained from Chr. Hansen A/S (Hørsholm, Denmark). Glucose was purchased 
from Merck Chemicals (Darmstadt, Germany). XOS powder (DP 2–6) was obtained from 
Shandong-longlive (Qindago, China), and contained (according to HPAEC-PAD) 90% XOS (of 
which 3.7% accounted for xylose, 1.0% arabinose, 34.6% xylobiose, 36.6% xylotriose, 10.6% 
xylotetraose, 10.2% xylopentaose and 3.3% xylohexaose ) and 10% mono- and disaccharides. The 
fermentation medium was MRS (de Man 1960) made from its individual components, except from 
glucose that was omitted. The pH of the medium was adjusted to 6.5 before sterilisation (210 kPa, 
121°C, 20 min). Carbohydrate solutions were filtered through a 0.22 μm pore size filter and added 
to the sterile broth to obtain a final carbohydrate concentration of 20 g/l. 
3.5.2 Growth experiments 
Stationary-phase precultures in MRS medium (Oxoid, Basingstoke, United Kingdom) supplemented 
with 0.05% (wt/vol) cysteine-chloride were harvested by centrifugation (3,200×g for 10 min at 4°C) 
and washed in 5 ml 0.9 g/l sodium chloride. The glucose- or XOS-containing broths and a control 
without added carbon source were inoculated with the washed pre-cultures to an OD600 of 0.05. 
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Hereafter the inoculated media were divided in two (for duplicate measurements). Growth was 
monitored for 24 h by manual OD600 measurements. Growth experiments were carried out in 50 ml 
centrifuge tubes in a water bath at 37°C. These cultures were used for microarrays and qPCR 
analyses. Identical setups of samples (in three biological replicates) were harvested for 2D-DIGE 
and HPAEC-PAD analyses. 
3.5.3. Liquid chromatography  
The analysis was undertaken on supernatants of BB-12 cultures grown on XOS collected after 0, 3 
and 24 h of growth (samples for pH measurements were collected after 8 h). Due to technical 
problems the samples at t=0 h could not be analysed. Since there was limited growth and relatively 
low cell density at t=3 h, the samples at this time point were used as an approximation to the XOS 
baseline values. Chromatography was performed using a Dionex AS3500 instrument (Dionex, 
Sunnyvale, CA) for separation of carbohydrates on a CarboPac PA-100 column (4×250 mm, p/N 
43055), in combination with a CarboPac PA-100 guard column (4×50 mm). Chromatography was 
performed as previously described (Gullón et al. 2008), with the following modifications: Samples 
were diluted 1:20 in Milli-Q water, the analyses were carried out by using a step-wise gradient at a 
flow rate of 0.8 ml/min and a total analysis time of 40 min. D-Xylose (Sigma), xylobiose, 
xylotriose, xylotetraose, xylopentaose and xylohexaose (Megazyme, Bray, Ireland) were used as 
internal standards for quantification. All analyses were made in triplicate.  
 
3.5.4. DNA microarrays  
The design of the 65-75mer oligonucleotides for the BB-12 whole genome microarray platform was 
done as described previously (Pedersen et al. 2008) on a draft genome sequence of BB-12 (56 
contigs). The platform specifications are available at the NCBI Gene Expression Omnibus (GEO) 
under platform accession no. GPL10040. The completed genome sequence of BB-12 can be found 
under GenBank accession no. CP001853. Isolation of total RNA, RNA quality control, microarray 
spotting, cDNA synthesis and labeling of total RNA, hybridisation, washing and scanning of arrays 
and pre-analysis of arrays was done as described previously (Pedersen et al. 2008) with the 
following modifications: hybridization was performed with 60% instead of 40% (vol/vol) 
formamide due to the relatively high GC-content of BB-12; microarray scanning was performed 
with “Auto-PMT” (Photo Multiplier Tube) set to a “saturation tolerance” of 0.1% instead of user- 
set PMT settings; genes were discarded if the standard deviation of the log2(ratio) of the replicate 
spots on each array was > 0.5 rather than > 0.8; only genes where data was obtained from both the 
standard array and dye-swap array were included. The details are described at the NCBI Gene 
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Expression Omnibus (GEO) under the series accession no. GSE20322. 
 
3.5.5. Quantitative real-time PCR 
Primer sequences for genes analysed by qPCR expression assays were designed using the Primer3 
software (27). cDNA synthesis was carried out as described previously (Pedersen et al. 2008) with a 
total RNA input of 675 ng and done in duplicates for each of the four biological replicates. The 
obtained cDNA samples were diluted 1:72.5 in nuclease-free water. qPCR was carried out on an 
ABI 7500 qPCR machine (Applied Biosystems, Foster City, CA) using SYBR Green mastermix 
(Applied Biosystems) with 465.5 pmol/μl cDNA and 6 pmol/μl of each primer pair. PCR conditions 
used were as described previously (Pedersen et al. 2008). At the end of each reaction, cycle 
threshold (Ct) was manually set at the level that reflected the best kinetic PCR parameters and the 2-
ΔΔCt method of relative quantification (Livak 2001) was used to obtain expression values. The five 
genes (out of 8 genes tested) that gave rise to the most consistent expression, as analysed by the 
GeNorm software (Vandesompele et al. 2002), were used for normalisation of the results. The 
relative expression of each gene represented a mean of the values obtained for each of the four 
replicates, each being run in duplicates. A gene was considered to be regulated when |fold change| > 
2, P < 0.05 in a one-way ANOVA test. 
 
3.5.6. Extraction of intracellular proteins 
Cells for proteome analyses were harvested after 8 h of growth by centrifugation (3,200×g for 
10 min at 4°C) at OD600 of 1.0 and 1.4 for the glucose and XOS cultures, respectively. Cell pellets 
were washed twice with 50 mM potassium phosphate buffer pH 7.0 and kept frozen until disruption 
by passage through a French press (Duragauge P1603-136, Struers, Denmark) at 8,270 kPa. 
Cytosolic protein fractions were obtained as described (31), and the determination of protein 
concentration was performed using the Popov method (Popov et al. 1975). 
3.5.7. Two-dimensional difference gel electrophoresis (2D-DIGE) 
Volumes corresponding to 50 μg protein from each of the samples (three biological replicates of 
cells grown on glucose or XOS, respectively), as well as an internal standard obtained by pooling 
aliquots containing 25 μg protein from each sample, were precipitated with chloroform/methanol 
(Wessel and Flügge 1984). Precipitates were dissolved in a buffer containing 15 mM Tris, pH 8.5 
and 8 M urea. Protein samples were labelled with fluorescent cyanine dyes as previously described 
(Ruiz et al. 2009), with the exception that 4 nmol dye (rather than 400 pmol) was used to label each 
of the samples. The labelled internal standard and the corresponding labelled samples for each gel 
67
Chapter 3                                                                          Combined Transciptome & Proteome analysis  
57 
 
were pooled and the volume was made up to 350 μl by addition of rehydration buffer (0.2% [v/v] 
carrier ampholytes, 0.4% [w/v] 3-[3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
[CHAPS] and 50 mM DTT). Isoelectric focusing was run using immobilised pH gradient strips 
(linear pH grade 4–7, 18 cm; GE Healthcare, Piscataway, NJ). Polyacrylamide gel electrophoresis 
was performed using 10% (wt/vol) polyacrylamide gels on an EttanTM DALT-6 Electrophoresis 
Unit (GE Healthcare) overnight at 1 W/gel until the dye front reached the base of the gel. 
Fluorescence gel images were acquired by a Typhoon 9410 Variable Mode Imager (GE Healthcare) 
at excitation and emission wavelengths of 488/520 nm (Cy2), 532/580 nm (Cy3) and 633/670 nm 
(Cy5) and a 100 μm resolution. Subsequent to fluorescence scanning, gels were stained using 
colloidal Coomassie Brilliant Blue (Rabilloud and Charmont 2000). 
 
3.5.8. Image analysis 
Analysis of the gel images was undertaken using Progenesis SameSpots software version 3.3 
(Nonlinear Dynamics, Newcastle upon Tyne, UK). The gel images were aligned by automated 
calculation of alignment vectors after assigning 20–30 landmark vectors. The scanned gels were 
analysed by intra-gel (methodological variance) and inter-gel (biological variance) analyses. A 
threshold of 1.5-fold for spot volume ratio change (in cases where proteins were identified from 
more than a single spot, the highest fold-change values were considered) and an ANOVA statistical 
significance test (P < 0.05) were chosen to identify differentially-expressed protein spots, excluding 
spots giving rise to more than a single protein hit, as determined by mass spectrometry. 
 
3.5.9. In-gel digestion and protein identification by mass-spectrometry 
Differentially-expressed protein spots from the 2D-DIGE analysis were manually excised and 
subjected to in-gel tryptic digestion as described (Rosenfeld et al. 1992) with minor modifications   
(Zhang et al. 2007), excluding the reduction and alkylation steps (already performed in the 
equilibration step of the 2D-DIGE). Tryptic peptides were analysed by an Ultraflex II MALDI-TOF 
mass spectrometer (Bruker-Daltonics, Bremen, Germany). Spectra were obtained as a summation of 
10 individual spectra in positive reflector mode and externally calibrated using a tryptic digest of β-
lactoglobulin (5 pmol/μl). Internal calibration was performed by using trypsin autolysis products 
and keratin contaminants that were subsequently removed from the peak list. The FlexAnalysis 
3.0.96 and Biotools 3.1 software (Bruker-Daltonics) were used to analyse the recorded spectra. 
Protein identification was performed by using the protein sequence database program MASCOT 
(http://www.matrixscience.com) with the genome sequence of BB-12 (represented by the locus tag 
identifiers BIF_0XXXX that correspond to the GenBank accession no. CP001853) (Garrigues et al. 
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2010) as taxonomy entry. The following search parameters were used in all Mascot searches: 
carbamidomethylation and methionine oxidation were taken into account as fixed and variable 
modifications, respectively, tolerance of one missed cleavage, and a maximum error tolerance of 80 
ppm and 0.7 Da in the MS and tandem MS data, respectively. No restrictions with respect to protein 
mass and pI were made. Protein/ion scores with P < 0.05 were considered significant.
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Chapter 4. The extracellular proteome of Bifidobacterium animalis 
subsp. lactis BB-12 reveals proteins with putative roles in probiotic 
effects 
4.1. Summary 
Probiotics are live microorganisms that exert health-promoting effects on the human host, as 
demonstrated for numerous strains of the genus Bifidobacterium. To unravel the proteins involved 
in the interactions between the host and the extensively used and well studied probiotic strain 
Bifidobacterium animalis subsp. lactis BB-12, proteins secreted by the bacterium, i.e. belonging to 
the extracellular proteome present in the culture medium, were identified by 2-DE coupled with 
MALDI-TOF MS. Among the 74 distinct proteins identified, 31 are predicted to carry out their 
physiological role either outside the cell or on its surface. These proteins include solute-binding 
proteins for oligosaccharides, amino acids and manganese, cell wall-metabolizing proteins, and 18 
proteins that have been described to interact with human host epithelial cells or extracellular matrix 
proteins. The potential functions include binding of plasminogen, formation of fimbriae, adhesion 
to collagen, attachment to mucin and intestinal cells as well as induction of immunomodulative 
response. These findings suggest a role of the proteins in colonization of the gastrointestinal tract, 
adhesion to host tissues, or immunomodulation of the host immune system. The identification of 
proteins predicted to be involved in such interactions can pave the way towards well targeted 
studies of the protein-mediated contacts between bacteria and the host, with the goal to enhance the 
understanding of the mode of action of probiotic bacteria.   
4.2. Introduction   
Bifidobacteria are anaerobic, non-gas producing, non-motile, non-sporulating and saccharoclastic 
Gram-positive bacteria that are highly represented in the microbiota of the human gastrointestinal 
tract (GIT) (Ventura et al. 2007b). The genus Bifidobacterium comprises of a multitude of strains 
that have been assigned a variety of health-promoting (probiotic) properties mediated through 
interactions between bacterial cells in the human GIT and the cells of the host. Due to these 
beneficial effects (e.g. modulation of host immune responses and enhancement of the competitive 
exclusion of pathogens [Marco et al. 2006]), probiotic Bifidobacterium strains are included in a 
variety of food applications and dietary supplements (Masco et al. 2005). 
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The interactions that mediate probiotic effects have in some cases been reported to be facilitated by 
the action of proteins or peptides exported by (among others) bifidobacteria (Sánchez et al. 2010b). 
These proteins are either secreted to the exterior of the cell or remain attached to the bacterial cell 
wall or membrane, as conferred by export-associated sequence motifs and/or cell wall anchoring 
motifs (Sánchez et al. 2010b). Other secreted proteins are classified as cytosolic, but are via a 
hitherto unknown mechanism, displayed at the cell surface or being exported outside the cell. These 
proteins are also known as “moonlighting proteins” (Jeffery 2003).  
 In a preliminary study of Bifidobacterium longum NCIMB8809, 14 unique secreted 
proteins were identified, including three hypothetical solute-binding proteins (SBPs) of ATP-
binding cassette (ABC) transporters, which are homologous to an invasion associated protein, as 
well as putative enzymes catalyzing cell wall turnover (Sánchez et al. 2008b). Analysis of the cell 
envelope proteome of the same strain resulted in identification of 128 distinct proteins, including 
characteristic cell wall proteins, ribosomal proteins and a few moonlighting proteins that may be 
important for interaction with the host (Ruiz et al. 2009). 
 In the present study, extracellular proteins from the extensively used commercial probiotic 
strain Bifidobacterium animalis subsp. lactis BB-12 were identified by 2-DE followed by MALDI-
TOF MS. Despite the differences in the biological conditions which the bacterium is exposed to 
under monoculture growth in a rich broth compared with growth in the GIT, the knowledge 
regarding proteins present in the extracellular proteome of the bacterium identified in the present 
study will increase the understanding of the molecular mechanisms of the possible interactions 
between the bacterium and the human host. 
4.3. Results and Discussion 
4.3.1.  Identification of extracellular proteins from Bifidobacterium animalis subsp. lactis BB-
12 culture supernatants 
To shed more light on the proteins secreted by BB-12, a proteomic analysis of the extracellular 
fraction from the bacterial cultures was performed. A total of 124 protein spots were detected by 2-
DE (Fig. 4.1), which is several fold more than in a similar study of B. longum NCIMB 8809 
(Sánchez et al. 2008b). Using MS, proteins were identified in 96 spots (four of which gave rise to 
statistically significant protein hits with sequence coverage ≤ 15%) corresponding to 74 unique 
proteins (Table 4.1 & A.2). The identification of 23 proteins from several spots on the gel may 
result from post-translational modifications that alter the Mr and/or the pI of proteins and hence 
their migration through the gel, as was previously reported for B. longum NCC2705 (Yuan et al. 
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2006). For 25 of the identified proteins, homologous proteins (50–90% sequence identity) were 
found in either the extracellular or the cell envelope fractions of B. longum NCIMB 8809 [6–7]. 
This similarity implies that BB-12 and NCIMB 8809 may share some common features with respect 
to the proteins that are in contact with the environment. 
 
Figure 4.1. A representative gel image of the extracellular protein fraction of Bifidobacterium animalis subsp. 
lactis BB-12. Molecular weight (Mw) and isoelectric point (pI) markers are denoted, as well as numbered protein 
spots corresponding to those listed in Table 7.3. 
 
4.3.2. Bioinformatic analysis of the identified proteins  
Prediction of structural elements of the proteins identified in the present study, and of those of the 
predicted proteome of BB-12, showed that 10 and 14 proteins contained a signal peptide and TMSs, 
respectively. The secretion of these proteins is likely to take place by translocation across the cell 
membrane facilitated by the secA translocase (BIF_00806), which has been identified in the 
membrane fraction of BB-12 (Gilad et al. 2012). Eighteen of the 20 proteins predicted to be 
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subjected to non-classical (i.e. signal peptide-independent) secretion have been found to exhibit 
moonlighting functions in other bacteria, or may be involved in other non-cytoplasmic processes 
like cell wall metabolism and binding of sugars and amino acids, as indicated by sequence 
similarity searches.  
 Even though it cannot be ruled out that some of the proteins identified in the present study 
were detected extracellularly as a result of non-specific release of cytoplasmic components by cell 
autolysis, the 2-DE spots pattern of the secretome differs notably from the 2-DE pattern of the 
intracellular proteome analyzed under similar conditions (Fig. 4.2), as confirmed by software-based 
comparative image analysis (data not shown). This implies that the presence of cytoplasmic proteins 
in the culture supernatants was probably not primarily a result of autolysis and subsequent spill out 
of cytoplasmic proteins, but occurred to significant extent by selective secretion or passive diffusion 
of the proteins.  
 The COG functional classification of the identified proteins, and of the total proteome of 
the bacterium, respectively (Fig. 4.2), showed an overrepresentation of proteins classified within the 
categories “Post-translational modification, protein turnover, chaperones” (protein fate) and “Cell 
wall/membrane/envelope biogenesis” among the identified extracellular proteins. Whereas this is 
anticipated with regard to cell envelope-metabolizing proteins, the relatively large number of 
proteins involved in protein fate is surprising, but can partly be explained by the presence of 
chaperone proteins GROES, GROEL and DnaK (BIF_01614; the two latter are putative 
moonlighting proteins) predicted to have an extracellular role (Section 3.3.3.2), and two peptidyl-
prolyl isomerases that may also act extracellularly. An expected underrepresentation of intracellular 
functions like transcription and replication was confirmed. The relatively high number of proteins 
that were not assigned to a category, or whose functional annotation was classified as general or 
hypothetical (18 proteins, nearly a fourth of the unique proteins identified) may be due to the 
limited knowledge of secreted and cell surface proteins in bifidobacteria. 
assigned a cellular localisation). Another predicted cytoplasmic protein (hypothetical protein 
BIF_00480) includes a transmembrane domain.  
Seven proteins were predicted to contain a signal peptide and their secretion is likely to 
take place via translocation across the cell membrane by the secA tranlocase (BIF_00806), which, 
along with other proteins associated with the tranlcation machinery, was also identified in the 
membrane fraction of BB-12 (Chapter 5). Twenty of the 27 proteins predicted to be subjected to 
non-classical (i.e. signal peptide independent) secretion were described to exhibit moonlighting  
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Table 4.1. Predictions of subcellular localisation and structural features of proteins identified in the 
extracellular fraction of BB-12, compared with the total proteome. 
* Predictions carried out using PSORTb 3.0.1; † The presence of transmembrane domain(s) (TMD(s)) was predicted 
with TMHMM; § Predictions obtained using SignalP 3.0; ¶ Predictions of performed with SecretomeP 2.0. 
functions in other organisms or may have a non-cytoplasmic function, as indicated by sequence 
similarity searches. 
 
The patterns of 2-DE spots obtained for the protein samples are accordingly notably 
different compared to the 2-DE patterns of intracellular proteins analysed under similar conditions 
(Fig. 4.2). The absence of DNA in the medium is supportive evidence for the notion that the 
presence of cytoplasmic proteins in the culture supernatant was due to a result of nonspecific release 
of cytoplasmic components by autolysis, but apparently occurred by selective secretion or passive 
diffusion of proteins. The COGs functional classification of the proteins identified and of the total 
proteome of the bacterium, respectively (Fig. 4.3), showed an overrepresentation of the identified 
extracellular proteins for proteins associated with posttranslational modifications, protein turnover 
and chaperones (protein fate) and proteins involved in cell wall/membrane/envelope biogenesis 
While this is not unanticipated with regard to cell envelope-metabolising proteins, the relatively 
large number of proteins involved in protein fate can be explained by the presence of two putative 
moonlighting chaperone proteins (GROEL and DnaK) that are predicted to possess an extracellular 
role, and three peptidyl-prolyl isomerases, which may act extracellularly. An expected 
underrepresentation of the intracellular cellular functions like transcription and replication was 
observed. The overrepresentation of proteins associated with nucleotide transport and metabolism  
Subcellular component 
prediction* 
Identified extracellular 
proteins (82) 
Whole Proteome 
(1612) 
number of 
proteins 
% of total 
proteins 
number of 
proteins 
% of total 
proteins 
Cytoplasmic 53 64.6 939 58.3 
Membrane 11 13.4 422 26.2 
Cell wall 2 2.4 8 0.5 
Extracellular 2 2.4 9 0.6 
Unknown 14 17.1 233 14.5 
Structural features     
Proteins with TMD(s)† 14 17.1 400 24.8 
Proteins with Signal pepetide§ 7 8.5 69 4.3 
Proteins secreted via non-classical 
secretion¶ 
27 32.9 465 28.8 
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Figure 4.2. Gel images of the inctracellular (A) and the extracellular fraction (B) protein fractions of 
Bifidobacterium animalis subsp. lactis BB-12. Iso-electric point and molecular weight markers are designated, as 
well as spots corresponding to some of the most abundant proteins. PSG: Phosphoglycerate kinase; GA3PD: 
Glyceraldehyde-3-phosphate dehydrogenase.  
 
may be related to the non-cytoplasmic localization of some of the proteins involved in the uptake 
and transport of nucleotides. The relatively high number of proteins that were not assigned to any.  
category, or whose functional annotation was classified as general or hypothetical (25 proteins, 
30.4% of the unique proteins identified) may be explained by the fact that many of the proteins 
secreted into the medium or bound at the cell surface are poorly characterised. 
 In a study that compared proteins expressed by B. longum NCC2705 under in vivo growth 
in a rabbit intestinal simulator with those expressed during growth in vitro, 19 up-regulated proteins 
were identified (Yuan et al. 2008). In the current study, homologs from BB-12 (50-93% sequence  
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Table 4.2. Unique proteins of BB-12 identified by MALDI TOF MS from the spots of the gel shown in Fig. 4.1. 
For more detailed description of the protein hits (including accession numbers) see Table A.3. (Appendix). 
Locus GB acc. #Protein ID Com* 
Structural 
features† COG¶ 
Identified 
B. longum 
homolog‡ 
Homologous 
protein 
identified in 
earlier 
studies‡ 
BIF_00045 Protein Translation Elongation Factor G (EF-
G) 
Cyt  J BL1098 IV, CE, ME 
BIF_00066 Alkanesulfonates transport ATP-binding 
protein 
Mem  P   
BIF_00083 ABC transporter ATP-binding protein Mem  P   
BIF_00116 Type I restriction-modification system DNA Cyt  S   
BIF_00120 Trigger factor, ppiase Cyt  O BL0947 IV, CE 
BIF_00129 GTP-binding protein era Mem  R   
BIF_00203 DNA polymerase III, delta' subunit Cyt  L   
BIF_00207 Bile salt hydrolase Ukn  M BL0796 IV, CE, ME 
BIF_00212 Sugar-binding protein Ukn NCS G BL1163 EX 
BIF_00213 LSU ribosomal protein L5P Cyt NCS J BL1592 CE, ME 
BIF_00277 Phosphoglycerate kinase Cyt  G BL0707 IV, CE 
BIF_00278 Hypothetical cytosolic protein Cyt  S   
BIF_00293 Dipeptide transport ATP-binding protein; 
DppF 
Mem  R BL1348 ME 
BIF_00315 Division specific D,D-transpeptidase Mem 1 (NTA) M BL1317 EX 
BIF_00317 Methylenetetrahydrofolate reductase Cyt SP, NCS E   
BIF_00325 Adenylate kinase Cyt  F   
BIF_00348 Glutamine synthetase Cyt  E BL1076 IV, CE, ME 
BIF_00364 Transcriptional regulator, LysR family Cyt  K   
BIF_00377 Probable glutamate-ammonia-ligase Cyt  O, T   
BIF_00400 60 kDa chaperonin GROEL Cyt  O BL0002 IV, CE 
BIF_00414 Hypothetical cytosolic protein Cyt  R   
BIF_00469 Maltose/maltodextrin-binding protein Ukn  G   
BIF_00480 Hypothetical protein Cyt 1 (NTA), 
NCS 
None   
BIF_00497 Peroxiredoxin Cyt NCS O BL0615 ME 
BIF_00539 ATP-binding protein (contains P-loop) Cyt  R   
BIF_00592 Oxalyl-CoA decarboxylase Cyt  H, E BL0296 ME 
BIF_00608 1-hydroxy-2-methyl-2-(E)-butenyl 4-
diphosphate 
Cyt  I   
BIF_00644 Thioredoxin peroxidase Cyt  O   
BIF_00678 UDP-N-acetylenolpyruvoylglucosamine 
reductase 
Cyt  M   
BIF_00679 Inosine-uridine preferring nucleoside 
hydrolases 
Cyt  F   
BIF_00682 Arginine repressor Cyt  K   
 
BIF_00737 
 
Oligopeptide-binding protein 
 
   Ukn 
  
     E 
 
BL1386 
 
EX, ME 
BIF_00758 Hypothetical exported protein Ukn SP, 1 NTA), NCS F   
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BIF_00784 Hypothetical cytosolic protei Ukn NCS S   
BIF_00823 Cell division ATP-binding protein Mem NCS D   
BIF_00825 Immunogenic secreted protein Ex 1 (NTA), 
NCS 
R BL1181 EX 
BIF_00860 Diaminopimelate epimerase Cyt 2 (NTA, 
CTA), NCS 
E   
BIF_00888 O-Acetyltransferase (cell wall biosynthesis) Cyt  R   
BIF_00936 Two component system histidine kinase Mem 1 (NTA) T   
BIF_00963 Transketolase Cyt  G BL0716 IV, CE 
BIF_00973 Peptidyl-prolyl cis-trans isomerase Cyt  O BL0354 ME 
BIF_00998 Collagen adhesion protein Cw 2 (NTA, 
CTA), SP, 
NCS, SRM 
None   
BIF_00999 Hypothetical protein Ukn 2 (NTA, 
CTA), SRM 
None   
BIF_01012 23S rRNA methyltransferase Cyt SP, NCS J   
BIF_01067 hypothetical signal transduction protein Cyt  T   
BIF_01084 Tetrapyrrole (Corrin/Porphyrin) methylase 
family protein 
Cyt  R   
BIF_01087 Manganese-binding protein Mem 1 (NTA) P   
BIF_01115 Inorganic pyrophosphatase Cyt NCS C   
BIF_01132 Glycerol dehydrogenase Cyt NCS C   
BIF_01172 Thioredoxin Cyt  O   
BIF_01173 Hypothetical protein Ukn 1 (NTA) None BL0352 IV, ME 
BIF_01178 Fibronectin-binding protein Ukn 2 (NTA, 
CTA), SRM 
None   
BIF_01197 Enolase Cyt NCS G BL1022 CE, ME 
BIF_01234 Manganese-binding protein Mem 1 (NTA) P   
BIF_01290 Membrane-bound transglycosylase Ukn NCS S   
BIF_01318 ClpB Cyt NCS O   
BIF_01349 Ribonucleoside-diphosphate reductase α 
chain 
Cyt  F   
BIF_01353 Formate-tetrahydrofolate ligase Cyt  F BL0478 CE, ME 
BIF_01394 hypothetical protein Ukn  S   
BIF_01396 Ketol-acid reductoisomerase Cyt  H BL0530 CE, ME 
BIF_01398 Immunogenic secreted protein Ex  R   
BIF_01486 Arginyl-tRNA synthetase Cyt NCS J   
BIF_01492 Glycosyltransferase Cyt  M   
BIF_01521 α-1,3-Galactosyltransferase Cyt  M   
BIF_01523 UDP-glucose 6-dehydrogenase Cyt  M   
BIF_01563 Monosaccharide translocase (flippase type) Mem 4 S BL0476 ME 
BIF_01565 Hypothetical protein ylxX/ylxW Ukn NCS S   
BIF_01597 Oligo-1,6-glucosidase Cyt NCS G   
BIF_01614 DnaK Ukn NCS O BL0520 CE 
BIF_01620 Maltose/maltodextrin-binding protein Ukn NCS G   
BIF_01641 UDP-galactofuranosyltransferase Cyt NCS R   
BIF_01657 Iron-binding ferritin-like antioxidant protein Cyt  P   
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*Cellular localisation of proteins was predicted using Psortb. Cyt: cytoplasmic; Mem: membrane; Ukn: 
unknown; Ex: extracellular; Cw: cell wall. † predictions of structural features: SP, signal peptide; NTA and 
CTA: N- and C-terminal membrane anchor, respectively; NCS: non-classical secretions; SRM: sortase 
recognition motif. Numbers designate the number of predicted trans-membrane domain. ¶ COG functional 
classification: For the letters category key see Fig. 4.3 or http://www.ncbi.nlm.nih.gov/COG/. ‡ Homologous 
proteins from B. longum (according to the genome sequence of the NCC2705 strain) that were up-regulated 
during in vivo growth (IV) in a rabbit intestinal colon model compared to in vitro growth (Yuan et al. 2008), or 
identified in cell envelope (CE), membrane (ME) or extracellular (EX) fractions (Ruiz et al. 2009; Sánchez et al. 
2008b).  
identity) were identified for 10 of these proteins (designated with “IV” in Table 7.3). Six of these 
proteins – choloylglycine hydrolases (BIF_00207), phosphoglycerate kinase (BIF_00277), factor 
Tu (EF-TU; BIF_01972), glutamine synthetase (BIF_00348), 60 kDa chaperonin GROEL 
(BIF_00400) and transketolase (BIF_00963) – were ascribed moonlighting functions associated 
with host interactions (discussed in sections 4.3.3.1-2). The remaining proteins were oligopeptide-
binding protein (BIF_00737), protein translation elongation factor G (BIF_00045) trigger factor, 
ppiase (BIF_00120), and a hypothetical protein (BIF_01173). With the exception of BIF_00737 and 
BIF_01173, the remaining 8 proteins have a cytoplasmic function. The in vivo up-regulation of 
these proteins, which are postulated to play a central role in the adaptation of the bacterium to the 
GIT environment, may provide the biological rationale for their presence in the extracellular 
fractions of BB-12, as secreted proteins are those expected to come in contact with the host 
intestinal cells. 
4.3.3. Proteins with predicted non-cytoplasmic functions 
According to sequence homology-based predictions, 31 of the proteins identified in the present 
study exert their function outside the bacterial cell or at its surface (Tables 4.2–4.5). These proteins 
are roughly divided into three main groups: solute-binding proteins, cell wall-metabolizing proteins, 
and proteins with putative host interacting roles. A few proteins were assigned to more than a single 
group; i.e. the two manganese-binding proteins (BIF_01087 and BIF_01234) and the three cell 
BIF_01677 Rpf protein precursor Cw 1 (NTA) S BL0658 EX 
BIF_01746 Peptidyl-prolyl cis-trans isomerase Cyt NCS O   
BIF_01863 Hypothetical protein Cyt  S   
BIF_01914 Cell wall-associated hydrolase Mem 1 (NTA) M BL1663 EX 
BIF_01915 Uridylate kinase Cyt NCS F BL1505 ME 
BIF_01972 Protein Translation Elongation Factor Tu Cyt  J BL1097 CE, ME 
BIF_02023 Transposase Cyt  L   
BIF_02033 Hypothetical protein Cyt  S   
BIF_02061 Hypothetical protein Cyt  None   
BIF_02065 Aspartyl-tRNA synthetase Cyt  J BL0018 CE, ME 
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wall-metabolizing proteins (BIF_01523, BIF_01677 and BIF_01914), which may also be involved 
in host-interactions (Fig, 4.4). 
4.3.3.1. Solute-binding proteins 
Four SBPs were identified in the extracellular fractions of BB-12 (Table 4.3), i.e. two pairs of 
maltose/maltodextrin-binding proteins (BIF_00469 and BIF_01620) and manganese-binding 
proteins (BIF_01087 and BIF_01234), respectively. Two additional SBPs, a sugar-binding protein 
(BIF_00212) and an oligopeptide-binding protein (BIF_00737) were identified in a similar study of 
BB-12 cultures grown on xylo-oligosaccharides (XOS) as carbon source (unpublished data). In 
accordance with the identification of SBPs in the present study, 15 and three SBPs were previously 
identified from the extracellular and cell envelope proteomes of B. longum NCIMB 8809 (Sánchez 
et al. 2008b; Ruiz et al. 2009), respectively. Of special notice is the identification of BIF_00212, 
whose abundance increased in the intracellular fraction of BB-12 grown on XOS compared to 
glucose, a finding verified by transcriptional analyses (Gilad et al. 2010). According to the model 
for XOS catabolism suggested in the latter study, binding of XOS by BIF_00212 at the cell surface 
is the first step in XOS utilization. The fact that BIF_00212 was found in XOS grown culture 
supernatants supports this model.  
 The presence of two manganese-binding proteins in the extracellular fraction of BB-12 is 
in agreement with the pivotal role that manganese homeostasis plays in a variety of bacterial 
cellular processes, including sensory mechanisms, virulence and adhesion [16]. In addition, these 
proteins may be involved in adhesion to host cells, as inferred by homology to adhesive 
streptococcal proteins (Table 4.5).  
 Another identified protein, oligo-1,6-glucosidase (EC 3.2.1.10; BIF_01597), may be 
involved in utilization of oligosaccharides. This enzyme belongs to the α-amylase family (known 
also as the glycoside hydrolases family 13, which has the ability to hydrolyse starch and its 
degradation products The secretion of this enzyme may not only enhance the nutrient uptake 
capacity of the bacterium, but also have implications for the generation of short chain fatty acids 
that are shown to have a beneficial effect on the human intestinal epithelium (Sánchez et al. 2008a). 
BIF_01597, and the oligosaccharide-binding proteins identified in the present study are assumed to 
contribute to the survival and adaptation of the bacterium to the GIT through the degradation and 
uptake of oligosaccharides, which are common carbon-sources in this milieu.  
 The presence of two manganese-binding proteins in the extracellular fraction of BB-12 is 
in agreement with the pivotal role that manganese homeostasis play in a handful of bacterial cellular 
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Figure 4.3. COG functional classification of the proteins identified in the extracellular fraction of 
Bifidobacterium animalis subsp. lactis BB-12, compared with the total proteome. Values in parentheses 
designated at the end of each functional category represent the number of proteins assigned to this category, 
which were identified in this study. 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Venn diagram describing the distribution of the proteins identified in this study which are 
predicted to have an non-cytoplasmic function within the designated functional groups. Numbers refer to the 
Bifidobacterium animalis subsp. lactis BB-12 locus tags (as annotated in GenBank accession num. CP001853), 
where the BIF_0 prefix was removed.  
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.Table 4.3. Solute-binding proteins identified in the extracellular fraction of BB-12. 
 
mechanisms, including sensory mechanisms, virulence and adhesion (Kehres and Maguire 2003). 
These proteins are also homologous to adhesive streptococcal proteins (section 4.3.3.3.2.). 
4.3.3.2. Cell wall-metabolising proteins 
In the present study, 11 proteins whose function is related to cell wall biogenesis or modification 
were identified (Table 4.3). Among these proteins, 5 were annotated as transferases – four 
glycosyltransferases (BIF_00315, BIF_01290, BIF_01492 and BIF_01641) and a single 
acetyltransferase (BIF_00888).  
 The identified cell wall-metabolizing proteins also include two proteins containing a 
transpeptidase domain (division specific D,D-transpeptidase [BIF_00315] and hypothetical exported 
protein [BIF_00758]), an epimerase (BIF_00860), and two enzymes involved in reduction of 
intermediates of cell wall building blocks (UDP-N-acetylenolpyruvylglucosamine reductase 
[BIF_00678] and UDP-glucose 6-dehydrogenase [BIF_01523]). The product of the reaction 
catalyzed by BIF_01523, UDP-glucuronic acid, is an important component of antiphagocytic 
capsular structures composed of exo- and lipopolysaccharide (EPS and LPS, respectively). Deletion 
of the gene encoding a protein from the Gram-negative pathogen Proteus mirabilis homologous to 
Locus Protein ID 
Homologous 
protein 
Acc. 
num. 
% 
seq. 
ID 
Experimentally-
documented 
fnunction Organism Reference 
BIF_00212 Sugar-binding 
protein 
maltose/malto-
dextrin-binding 
protein 
AAZ51685 25 critical for maltose 
utilization and effects 
colonization of mouse 
ropharynx 
Streptococcus 
pyogenes 
MGAS5005 
Shelburne 
et al. 2006 
BIF_00469 Maltose/malto-
dextrin-binding 
protein 
Maltose-binding 
periplasmic 
protein 
P0AEX9 21 binding linear malto-
oligosaccha-rides and 
maltodextrins 
E. coli K-12 Quiocho et 
al. 1997 
BIF_00737 Oligopeptide-
binding protein 
dipeptide-bind-ing 
protein dppE 
P26906 27 essentiel for di-peptide 
transport 
Bacillus 
subtilis 
Mathiopoul
os et al. 
2006 
BIF_01087 Manganese-binding 
protein 
Periplasmic chelated 
iron-binding protein 
yfeA 
Q56952 23 transporting iron and 
manganese ions 
Yersinia pestis Bearden and  
Perry 2002 
BIF_01234 Manganese-binding 
protein 
Zinc-binding 
lipoprotein AdcA 
O05703 24 Encoded by a gene that  is a 
part from an operon vital for  
transport of Mn2+ and Zn2+  
ions 
Streptococcus 
pneumonia 
Dintilhac et 
al. 1997 
BIF_01620 Maltose/malto-
dextrin-binding 
protein 
maltose/malto-
dextrin-binding 
protein 
AAN59213 28 Involved in transport of 
malto-dextrins (up to 7 
glucose units) 
Streptococcus 
mutans UA159 
Webb et al. 
2008 
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BIF_01523 decreased the expression of virulence factors and the ability of the bacterium to invade 
human urothelial NTUB1 cells [17]. This finding, along with the up-regulation of the gene coding 
for BIF_01523 under incubation of BB-12 with Caco-2 cells (Valina et al., submitted for 
publication) implies that exposure to host intestinal cells may induce production of EPS and LPS 
that assist in adhesion and colonization. 
 Two additional proteins that may play a role in peptidoglycan (PG) modification or 
autolysis that were identified in the present study are the cell wall-associated hydrolase 
(BIF_01914) and Rpf (resuscitation promoting factor) protein precursor (BIF_01677). These 
proteins may also be associated with adhesion to host intestinal cells (section 4.3.3.3.2). 
 
4.3.3.3. Host interacting proteins 
Based on experimental evidence from studies of similar proteins in (mostly) Gram-positive bacteria, 
18 of the identified proteins may play a role in interactions with human intestinal cells or with 
constituents of the extracellular matrix (ECM) of the GIT (Table 4.5). These interactions involve 
the following features: (i) binding to plasminogen (plg); (ii) adhesion to intestinal cells or proteins 
of the ECM; (iii) elicitation of immunogenic response. 
4.3.3.3.1 Plasminogen-binding proteins 
Plasminogen is the proenzyme of plasmin, a serine protease that plays an important role in 
fibrinolysis, homeostasis and degradation of ECM proteins [18]. Due to its versatile proteolytic 
features and high abundance in human plasma and extracellular fluids, plg is commonly bound to 
the cell surface of pathogenic bacteria (Li  et al. 2011). The subsequent conversion of plg to active 
plasmin  
supplies these bacteria with a variety of proteolytic activities that facilitate their movement across 
physical and molecular barriers during colonization (Lahteenmaki et al. 2005).  
 Investigation of the binding of bifidobacterial strains demonstrated that five 
Bifidobacterium animalis subsp. lactis BI-07 proteins bind to human plg at the cell surface (Candela 
et al. 2007) and four of these – choloylglycine hydrolase (BIF_00207), glutamine synthetase 
(BIF_00348), enolase (BIF_01197) and DnaK (BIF_01614) – were identified in the present study 
(Table 2). Based on the high homology (87–100% DNA sequence identity) within the B. animalis 
subsp. lactis taxon, and the fact that another B. animalis subsp. lactis strain (DSM 10140) also binds 
plg (Candela et al. 2007), it is hypothesized that these proteins may promote the colonization of 
BB-12 in the GIT via capture of human plg.  
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Table 4.4. Proteins identified in the extracellular fraction of BB-12 that may possess cell wall-metabolising 
functions. 
Locus Protein ID 
homologous 
protein acc. # 
% 
seq. 
ID 
Experimentally-documented 
fnunction Organism Reference 
BIF_00315 
Division 
specific D,D-
transpeptidase 
transpeptidase 
involved in septal 
peptidoglycan 
synthesis 
(penicillin-
binding protein 3) 
AAC73195 30 
Peptidoglycan transglycosylase 
activity 
E. coli K-12 
substr. 
MG1655 
Uehara and 
Park 2008 
BIF_00678 
UDP-N-
acetylenolpy-
ruvylglucos-
amine 
reductase 
n.i. 
reducing UDP-N-
acetylglucosamine 
enolpyruvate with the 
concomitant oxidation of 
NADPH 
S. pneumonia Sylvester et al.  2001 
BIF_00758 
Hypothetical 
exported 
protein 
n.i. 
L,D-transpeptidase that gives 
rise to an alternative pathway 
for peptidoglycan cross-linking 
Enterococcus 
faecium 
Biarrotte-
Sorin et al, 
2006 
BIF_00860 Diaminopime-late epimerase 
Diaminopimelate 
epimerase (dapF) AAC22409 29 
amino acid racemase, inverting 
the configuration at the α-
carbon of aPG diaminopimelic 
acid  
Haemophilus 
influenzae 
 
Lloyd et al. 
2004 
BIF_00888 
O-
acetyltransfe- 
rase (cell wall 
biosynthesis) 
Maltose O-
acetyltransferase NP_414992 46 
acetyl CoA-dependent 
acetylation of the 6-hydroxyl 
group of their respective sugar 
substrates. 
E. coli K-12 
substr. 
MG1655 
Lo 
Leggio et 
al. 2003 
BIF_01290 
Membrane-
bound trans-
glycosylase 
n.i. 
cleaving β-1,4-glycosidic bond 
between N-acetyl-muramic 
acid  and N-acetyl-D-
glucosamine  
S. pneumonia Bateman et al. 2005 
n.i. 
possess a lysozyme-like 
domain thought to be involved 
in cell wall modification 
through the hydrolysis of the 
glycan backbone of 
peptidoglycan 
Mycobacteriu
m tuberculosis 
H37Rv 
Cohen-
Gonsaud et 
al. 2004 
BIF_01492 
Glycosyl-
transferase 
Amylovoran 
biosynthesis 
glycosyltrans-
ferase AmsE 
Q46635 
 31 
involved in amylovora EPS 
biosynthesis  
Erwinia 
amylovora 
Bernhard et 
al. 1993 
BIF_01523 
UDP-glucose 
6-dehydro-
genase 
UDP-glucose 6-
dehydrogenase AAK34829 53 
biosynthesis of UDP-
glucuronic acid, an important 
building block of 
antiphagocytic EPS and LPS 
capsular structures 
Streptococcus 
pyogenes M1 
GAS 
Campbell 
et al. 1997 
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BIF_01641 
UDP-galacto-
furanosyltrans
-ferase 
bifunctional 
UDP-
galactofuranosyl 
transferase GLFT 
CAA17872 25 
transfers Galf to a range of 
both β-(1,5) and β-(1,5) linked 
digalacto-furanosyl 
neoglycolipid acceptors  
M. tuberculosis 
H37Rv 
Alderwick 
et al. 2008 
BIF_01677 Rpf  protein 
precursor 
resuscitation-
promoting factor 
rpfB 
CAB08136 23 
possess a lysozyme-like 
domain thought to be involved 
in cell wall modification 
through the hydrolysis of the 
glycan backbone of 
peptidoglycan 
M. tuberculosis 
H37Rv 
Cohen-
Gonsaud et 
al. 2004 
BIF_01914 
Cell wall-
associated 
hydrolase 
invasion-
associated protein 
p60 
CAC98661 40 involved in cell division and actin-based motility 
Listeria 
monocytogenes 
EGD-e 
Pilgrim et 
al. 2003 
n.i.: not identified 
4.3.3.3.2. Adhesion-promoting proteins 
Adhesion of bacteria to human intestinal cells or ECM proteins is a vital step for transient intestinal 
colonization. Bifidobacteria have been shown not only to adhere to a variety of epithelial cells in 
vitro, but also to inhibit adhesion of pathogenic enterobacteria (Liu et al. 2010). Homologs to 9 of 
the proteins identified in the extracellular proteome of BB-12 have been described to be involved in 
adhesion to human intestinal cells or to different components of the ECM (Table 2)
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Collagen is one of the major proteins of the ECM and is susceptible to invasion of pathogenic 
Gram-positive and -negative bacteria under injury (Shen and Ljung 1993). Adhesion of probiotic 
bacteria to collagen is predicted to interfere with colonization and invasion of pathogenic bacteria. 
A few bifidobacterial strains, including BB-12, have been shown to bind different types of collagen, 
though in relatively low rates (Ouwehand et al. 2004) . The protein BIF_00998 shares homology 
with the collagen adhesion protein from Streptococcus pyogenes MGAS10394, and with a few other 
cell surface adhesion-related proteins from S. pyogenes strains. The fact that the recombinant 
MGAS10394 protein was described to attach to type I and type IV collagen (Kreikemeyer et al. 
2005) suggests that BIF_00998 also possesses collagen binding capacity. 
 Bacterial fimbriae are long fibrous structures composed of pilus subunits, which serve as 
adhesive anchors that facilitate attachment to host cells and have been associated with biofilm 
formation (Proft et al. 2009). The assembly of fimbriae is catalyzed by sortase, a membrane-
anchored transpeptidase that recognizes a sequence motif in the pilus subunits, binds them together 
via intermolecular isopeptide bonds and covalently anchors the fimbriae oligomer into the cell wall 
PG (Ton-That et al. 1999). Fibrous structures were observed on the surface of Lactobacillus 
rhamnosus GG (LGG), whose binding to human mucus was found to depend strongly on the 
expression of one of the pilus subunits (Kankainen et al. 2009). Preliminary electron micrographs 
revealed fimbriae-like structures also on the surface of B. longum (Schell et al. 2002).  .  
In the present study, two proteins (BIF_00998 and BIF_00999) that possess a C-terminal sortase 
recognition motif (Fig. 4.5) were identified from a protein spot with an Mr > 200 (Fig. 4.1, spot #1 
& Table A.2). The sequence coverage of the protein hit corresponding to BIF_00998 is 11%). 
 
 
 
 
 
 
 
Figure 4.5. Schematic illustration of the organisation of the genes coding for proteins predicted to be involved in 
fimbriae formation in Bifidobacterium animalis subp. lactis BB-12. Fimbrial structures may be produced by 
generation of oligomeric structures of fimbriae subunits containing a sortase recognition motif – hypothetical 
protein (BIF_00999) and collagen adhesion protein (BIF_00998). A sortase protein (BIF_01042) is predicted to 
cleave these proteins at their recognition site, bind them together through intermolecular isopeptide bonds and 
covalently anchor the resulting fimbriae oligomer into the cell wall peptidoglycan. The function of BIF_02156 is 
unclear. 
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Moreover, the genes coding for these proteins are separated by a single ORF of 120 nucleotides, 
and a gene encoding a sortase (BIF_01042) is located immediately upstream of the gene coding for 
BIF_00998 (Fig. 4.5). All three proteins are homologous to proteins documented to play a role in 
fimbriae formation and and/or collagen-binding in Gram-positive bacteria (Table 4.5), and the 
positioning of these genes resembles the fibronectin-binding, collagen-binding, T antigen (FCT) 
genomic region identified in Streptococcus pyogenes, whose gene products were reported to be 
associated with human infection (Kratovac et al. 2007). In light of these observations, it can be 
postulated that BIF_00998 and BIF_00999 are substrates for the sortase and are involved in 
fimbriae formation and subsequent adhesion to host proteins like collagen and fibronectin, another 
important ECM protein. Another protein potentially involved in fibronectin binding and/or fimbriae 
formation is the fibronectin-binding protein BIF_01178 that contains a repeated conserved domain 
from S. pyogenes M1 GAS. This domain is characteristic of adhesion and signaling (Whittaker et al. 
2002), biofilm formation, and attachment to human pharyngeal cell lines (Manetti et al. 2007).  
 Finally, three additional proteins predicted to play a role in adhesion are the oligo-1,6-
glucosidase (BIF_01597) and the chaperones GROEL (also called 60 kDa chaperonin) and EF-TU, 
the two latter are regarded as moonlighting proteins. An amylopullulanase from Streptococcus suis 
P1/7 that shares sequence similarity with BIF_01597 promoted adhesion to porcine epithelium and 
mucus in vitro (Ferrando et al. 2010). The GROEL and EF-TU homologs from Lactobacillus 
johnsonii NCC 533 were reported to attach to human mucus (Granato et al. 2004) and the 60 kDa 
chaperonin triggered aggregation of the pathogen Helicobacter pylori. EF-TU from Mycoplasma 
pneumoniae M129, which is also homologous to the BB-12 protein, was reported to bind human 
fibronectin [34]. It can be hypothesized that the GROEL and EF-TU of BB-12 demonstrate similar 
adhesive and immunogenic properties. 
 
4.3.3.3.3. Immunogenic proteins 
One of the central claims attributed to probiotic bacteria is their ability to modulate the immune 
response of the host through the interaction with important elements in the maintenance of gut 
homeostasis like intestinal epithelial cells (IECs) and dendritic cells (DCs). Immunomodulating 
effects were observed in a variety of bifidobacterial strains in general and in BB-12 in particular 
[35–36]. Administration of the strain was shown to alleviate the inflammatory response in eczema 
patients [37] and to enhance phagocytosis of Escherichia coli sp. by leukocytes isolated from 
the blood [38]. Another study demonstrated that individuals who received BB-12 experienced a 
decrease in the level of tumor necrosis factor (TNF)-α, as well as a reduction of interleukin-10 (IL-
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10), which are pro- and anti-inflammatory cytokines, respectively. The biological mechanism 
behind the decrease in the concentration of IL-10 has yet to be deciphered [35].  
 In the current study, 6 proteins with potential immunogenic properties were identified 
(Table 4.5). The chaperonic protease ClpB shares 47% sequence identity with the corresponding 
protein of Campylobacter jejuni, which triggers the immune system during host-pathogen 
interactions [39]. The Rpf protein precursor from BB-12 (BIF_01677) possesses a G5 protein 
family domain, which is found in a wide range of extracellular peptidases that cleave human IgA 
[40]. Accordingly, immunogenic properties were documented in Rpf-like proteins from 
Mycobacterium tuberculosis H37Rv with sequence similarity to BIF_01677 [41]. These proteins 
were also suggested to be associated with cell wall adhesion and biofilm formation [42]. 
 The surface antigen protein and the cell wall-associated glycoside hydrolase (NLP/P60 
protein) of Lactobacillus rhamnosus GG (LGG), known as p40 and p75, respectively, stimulate the 
activation of Akt (protein kinase B protein family) in IECs and inhibit TNF-induced IEC apoptosis 
[43]. Sequence alignments revealed that p40 is similar to regions near the C-terminus of the 
immunogenic secreted proteins BIF_00825 and BIF_01398 identified in the present study. Similar 
segments of BIF_00825 and BIF_01398 are homologous with the immunogenic secreted protein 
precursor-like protein from S. pyogenes MGAS315 that was shown to trigger appearance of 
antibodies in human serum after infection by the bacterium [44]. The cell wall-associated hydrolase 
(BIF_01914) is homologous with p75 and may thus exhibit immunomodulating features. Finally, 
the presence of the key glycolytic enzyme transketolase (BIF_00963) in the extracellular protein 
fraction of BB-12 is probably another example of a moonlighting protein, as seen for 
Staphylococcus aureus MRSA-M2, where it was described to bind goat anti-rabbit IgG antibody 
[45].  
 Taken together, these findings imply that BB-12 is secreting immunomodulative proteins 
that, along with the proteins predicted to facilitate adhesion to host intestinal cells and ECM 
proteins of the GIT, assist in identification of proteins that may be involved in interactions of the 
bacterium with the host at the molecular level.  
 
4.4. Conclusions 
The present analysis of the extracellular proteome of Bifidobacterium animalis subsp. lactis BB-12 
gave rise to several noteworthy observations. First, the presence of cell wall- or membrane-
anchored SBPs was reported, including proteins predicted to bind di- and oligosaccharides at the 
cell surface, as well as manganese-binding proteins shown to play a central role in a variety of 
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cellular processes. Second, the identification of a considerable number of cell wall-metabolizing 
enzymes suggested to be associated with modification of PG that, apart from being essential for cell 
division, also results in release of PG fragments that may have influence on host intestinal cells. 
Third, a most remarkable finding in this work is the identification of 18 proteins that possibly play a 
role in interaction with or adhesion to host intestinal cells, through recruiting of plasminogen, 
adhering to collagen and mucin or by eliciting immunomodulatory effects. 
 The present findings can be used to target studies to corroborate the putative functions 
ascribed to the identified proteins. This for example can be facilitated through the use of binding or 
immunogenic assays combined with mutations/deletions of the genes coding for these proteins. 
Deciphering the factors that play a role in bacteria-host interactions is expected to deepen the 
insight into the molecular mechanisms underlying the beneficial effects exerted by probiotics in 
general and by bifidobacteria in particular. 
 
4.5. Materials and methods 
4.5.1. Experimental design 
Extracellular proteins obtained from B. animalis subsp. lactis BB-12 culture supernatants (three 
biological replicates, harvested after 8 h of growth, i.e. late exponential growth phase at an OD600 of 
1.3) were analyzed by 2-DE. Each electrophoresis experiment was run in duplicate. Protein spots 
from a representative 2D gel were excised and subjected to in-gel digestion followed by MALDI-
TOF MS. The proteins identified from these spots are presented. 
 
4.5.2 Strain and growth medium 
Bifidobacterium animalis subsp. lactis BB-12 (BB-12 is a registered trade mark of Chr. Hansen 
A/S) was cultured at Chr. Hansen A/S, Hørsholm, Denmark. Growth experiments were performed 
in a reconstituted MRS medium containing 0.05% cysteine-hydrochloride at 37 °C as previously 
described [8].  
 
4.5.3 Extraction of extracellular proteins and two-dimensional gel electrophoresis 
Cell-free samples for proteome analysis were collected by recovering the supernatants of the 
bacterial cultures by centrifugation (10 min, 4 ˚C, 3,200×g) followed by filtration (0.22 μm pore 
size). To provide a sufficient amount of proteins for 2-DE and to discard salts and bacterial 
polysaccharides, filtered supernatants (40 ml) were subjected to two steps of chloroform/methanol 
precipitation – the first with 4:4:1 (v/v) sample:methanol:chloroform and the second with 1:4:1:3 
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(v/v) sample:methanol:chloroform:water [9]. Precipitates were dissolved in 15 mM Tris, pH 8.5, 8 
M urea, and subjected to protein quantification [10]. Prior to 2-DE, carrier ampholytes, CHAPS and 
DTT were added to final concentrations of 0.2%, 0.4% and 50 mM, respectively, and the volume 
was adjusted to 200 μl (corresponding to 50 μg protein). IEF (using 11 cm IPG strips, linear pH 
gradient 4–7, 18 cm [GE Healthcare, Piscataway, NJ]), reduction and alkylation were performed as 
previously described [8]. Electrophoresis in the second dimension was carried out using Criterion 
Tris-HCl (12.5% polyacrylamide) precast gels (Bio-Rad) run on a Criterion Dodeca Cell 
electrophoresis unit (Bio-Rad) at 200 V for 1 h, followed by fixation and staining with colloidal 
CBB-G250 as previously reported [8]. 
 
4.5.4 In-gel digestion and protein identification by mass spectrometry 
Protein spots from the 2-D gels were manually excised and subjected to in-gel tryptic digestion as 
described [11] with a few modifications [12], leaving out the reduction and alkylation steps 
performed already prior to 2-DE. MS was carried out on an Ultraflex II MALDI-TOF instrument 
(Bruker Daltonics, Bremen, Germany) as described [8], and the obtained spectra were analyzed 
using the FlexAnalysis 3.0.96 program (Bruker Daltonics). Peak lists were acquired using the 
Biotools 3.1 software (Bruker Daltonics), subjected to Tophat baseline substraction, internal 
calibration using trypsin autolysis products and keratin contaminants, (which were subsequently 
discarded) and searched using the Mascot database search algorithm 
(http://www.matrixscience.com) embedded within Biotools. Mascot searches against the genome 
sequence of BB-12 (GenBank accession no. CP001853, 1612 ORFs, 587905 amino acid residues) 
[13] as taxonomy entry, as well as against a decoyed version of the same database,  were done with 
carbamidomethylation (Cys) and oxidation (Met) as fixed and variable modifications, respectively, 
with tolerance of one missed cleavage and a maximum error tolerance of 80 ppm in the MS data. 
The peak signal-to-noise ratio was set to 6 and was lowered to 3 when the obtained values for PMF 
score or the sequence coverage were lower than 60 and 16%, respectively. No restrictions with 
respect to protein mass and pI were made. Protein hits with P < 0.05, corresponding to score > 45, 
and with sequence coverage > 15% (when score < 60) were considered significant. In addition, 
protein hits for which the Mascot database search resulted in a decoy hit with a score > 45 were 
discarded. 
 
4.5.5 Bioinformatic analyses of the identified proteins 
Signal peptide predictions were obtained using SignalP 3.0 server (http://www.cbs.dtu.dk/services/  
91
Chapter 4                                                                                                                      Extracellular proteome analysis 
 
 
81 
 
SignalP/) with Gram-positive bacteria selected as the organism group and a maximal truncation of 
70 residues to each sequence. Predictions were considered positive when the presence of a signal 
peptide was suggested according to both the D mean score of the neural networks based model and 
the hidden Markov models. The presence of transmembrane section(s) (TMS(s) was predicted using 
TMHMM version 2.0 (http://www.cbs.dtu.dk/services/TMHMM/). Prediction of non-classically 
secreted proteins was performed using SecretomeP 2.0 Server 
(http://www.cbs.dtu.dk/services/SecretomeP/) with Gram-positive bacteria selected as the organism 
group. Functional classification of proteins according to Clusters of Orthologous Groups (COGs) 
was obtained using the KOBAS (KEGG orthology based annotation system) server 
(http://kobas.cbi.pku.edu.cn/) using default parameters. Protein sequence alignments of the proteins 
identified by MS were carried out using BLASTP [14] 2.2.23 at NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the non-redundant protein sequences (nr) database. 
Conserved protein domains were detected as a part of the BLASTP searches, and homologies to 
protein families were detected using Pfam 24.0 (http://pfam.sanger.ac.uk/). Accession numbers 
listed refer to GenBank identifiers. 
 
 
 
 
 
 
 
 
 
92
Chapter 5                                                                                                        Membrane proteome analysis 
 
82 
 
Chapter 5. Insights into physiological traits of Bifidobacterium 
animalis subsp. lactis BB-12 through membrane proteome analysis  
5.1. Summary 
Bifidobacterium animalis subsp. lactis BB-12 is a widely used probiotic strain associated with 
avariety of health-promoting traits. There is, however, only limited knowledge available 
regardingthe membrane proteome and the proteins involved in oligosaccharide transportin BB-12. 
We applied two enrichment strategies to improve the identification of membraneproteins from BB-
12 cultures grown on glucose and on xylo-oligosaccharides, the latter being an emerging prebiotic 
substrate recently reported to be fermented by BB-12. Our approachencompassed consecutive steps 
of detergent- and carbonate-treatment in order togenerate inside-out membrane vesicles and to 
interfere with binding of membraneassociatedproteins to the membrane, respectively. Proteins in 
the enriched membranefraction and membrane-associated fraction were digested by lysyl 
endopeptidase and trypsinfollowed by peptide sequencing by LC-ESI-Q-TOF MS/MS. Ninety of a 
total of 248 identifiedunique proteins were predicted to possess transmembrane segments (TMSs), 
and 56 ofthese have more than one TMS. Seventy-nine of the identified proteins are annotated to 
beinvolved in transport of amino acids, oligosaccharides, inorganic ions, nucleotides, phosphateor 
exopolysaccharides, or to belong to the F1F0-ATP-synthetase complex and the proteintranslocation 
machinery, respectively. 
5.2. Introduction 
Bifidobacteria constitute one of the major genera in the microbiota inhabiting the human 
gastrointestinal tract (GIT) (Ventura et al. 2007b). Due to their health-promoting (i.e. probiotic) 
properties, e.g. host immunomodulation and induction of anti-pathogenic defense mechanisms 
(Marco et al. 2006) bifidobacteria are commonly used both in food applications and as dietary 
supplements (Masco et al. 2005). 
 Membrane proteins (MP) account for approximately 30% of all predicted proteins in 
proteomes (von Heijne et al. 2007). Due to their key roles in numerous cellular processes, e.g. 
metabolite transport, inorganic ion homeostasis, expulsion of toxins and antibiotics, energy 
metabolism, communication with the surrounding environment, and cell wall modification and 
biogenesis, MP are essential for the survival of bifidobacteria in the GIT. Additionally, MP are 
involved in bacteria-host interactions and contribute to the molecular basis for health-beneficial 
effects exerted by probiotic bacteria (Sánchez et al. 2008). 
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The first studies concerning MP from bifidobacteria focusedon antibiotic resistance and bile 
tolerance, and consistedof biochemical analysis of recombinantly producedtransport proteins, as 
well as comparative analysis of membraneprotein profiles by using SDS-PAGE (Margolles et al. 
2006, Margolles et al. 2003). Recently, biletolerance was examined in Bifidobacterium longum 
NCIMB 8809 grown in an in vitro bile environment by cell-envelopeproteome analysis using 2D-
DIGE and SILAC. This resulted inidentification of 218 proteins, of which 141 were present inthe 
membrane protein fraction, including 78 transportrelatedproteins constituting a large proportion of 
the transportersannotated in the genome (Ruiz et al. 2009).  
 Mining the genome sequence of B. longum NCC2705 for carbohydrate transport systems 
identified 19 predicted sugaractiveoperons, including 13 ATP-binding cassette (ABC)-
typetransport systems − containing putative permeases for lactose,maltose, raffinose, and fructo-
oligosaccharides (FOS), and three major-facilitator superfamily (MFS) transporterspredicted to 
import sucrose, lactose and glucose/galactose (Parche et al. 2007). In addition, growth experiments 
and microarray analysesconfirmed that the various predicted substrates were utilizedby the 
bacteriumand that all carbohydrate catabolism-relatedgenes were expressed, some being induced 
upon growth on lactose, raffinose or FOS (Parche et al. 2007).  
 Recently, transcriptomic and proteomic analysis of thewidely used probiotic strain B. 
animalis subsp. lactis BB-12 grown on xylo-oligosaccharides (XOS) suggested that XOS uptake is 
facilitated via an ABC transport system whose constituentsare induced by XOS (Gilad et al. 2010). 
To increase the coverage of identification of transport proteins in bifidobacteria, membrane 
fractions prepared from BB-12 grown on either glucoseor XOS were analyzed using a gel-free 
approach, consistingof lysyl endopeptidase and trypsin digestion of suspended membrane fractions 
followed by liquid chromatography/electrosprayionization quadrupole time-of-flight-tandem mass 
spectrometry (LC-ESI-Q-TOF-MS/MS). This first LC–MS/MSbased membrane proteome analysis 
in bifidobacteria demonstrated the presence of a large number of putative transport systems in BB-
12 at the protein level. 
5.3. Results and Discussion 
5.3.1 Bioinformatic analysis of the identified proteins  
A total of 248 proteins were identified in the membrane fractionsby LC–MS/MS and sequence 
database searching (Supplemental Table A.4) and classified with respect to Subcellular component, 
Biological processes and Molecular functions based on Gene Ontology (GO) classification (Fig. 
5.2). Nearly half of the proteins (132) were assigned to more than one category within the three GO  
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Figure 5.1. Schematic illustration of the protocol used to in membrane protein fractions from B. animalis subsp. 
lactis BB-12.   
classification domains. Ninety-one, accounting for 36.7% of all identified proteins, were classified 
as MP, whereas cytoplasmic proteins (CP) and ribosomal proteins (RP) represented 31.5% and 
18.1%, respectively (all RP were also classified as CP) and 36.7% of the proteins were not 
assigned to a cellular localization category. 
 Membrane samples containing CP and RP commonly appearin membrane proteomics 
(Klein et al. 2005, Li et al. 2011], and were previously reported to each account for 16.3% of the 
proteins identified from the membrane fraction of a bifidobacterial strain (Ruiz et al. 2009). RP 
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may be associated – directly or indirectly – to membrane proteinsor to the lipid bilayer (Rabilloud 
2007), and have been shown to be involvedin translocation of MP and secreted proteins (Luirink 
and Sinning 2004), sensing of environmental changes in bacteria like E. coli (Van Bogelen and 
Neidhardt 1990) and to exhibit immunomodulatory properties associated with gonococcal invasion 
(Spence and Clark 2000). These findings concur With the identification of RP on bacterial cell 
envelope (Tjalsma et al. 2008). An alternative explanation for the presence of ribosomal proteinsin 
membrane samples which should be considered in the present study was suggested by Klein et al. 
(Klein et al. 2005), who documented a specific binding of ribosomal contaminants to the 
membranes, hypothesized to be caused by low ionic strength throughout membrane isolation 
facilitating electrostatic/hydrophobic association of RP with membranes. 
 The identification of CP (e.g. enolase, glyceraldehyde 3-phosphate dehydrogenase and 
elongation factor Tu) in the membrane fractions is in agreement with these proteins beingregarded 
as moonlighting proteins, i.e. CP displayed at the cellsurface or being secreted through a yet 
unidentified mechanism (Jeffery 2003) and which are reported to act as mucosa adhesion 
promoting factors in other bifidobacteria (reviewed in [Sánchez et al. 2010]). 
 In addition to the presence of CP and RP in the membrane samples, resolving membrane 
proteomes are not a trivialtask. Common challenges are related to solubilizing of highly 
hydrophobic proteins, especially while utilizing an in-solution digestion approach. The 
amphipathic nature of MP that protrude outside the membrane can also cause undesired 
precipitation in both 
hydrophobic and hydrophilic solvents (Rabilloud 2007), and application of detergents that facilitate 
solubilization of hydrophobic proteins is in most cases incompatible with subsequent reverse- 
phased-based chromatographic fractionation like LC–MS (Rabilloud 2007) and ionic detergents 
like SDS that interfere with fractionation using IEF.  
 In the present study, two consecutive approaches aimed to enrich for membrane proteins 
were applied. These approaches conferred treatment of the crude membrane samples with the 
detergent Brij 58, with the purpose to obtain inside-out vesicles (Johansson et al. 1995) that 
increase the exposure of membrane-associated proteins to the carbonate buffer they are 
subsequently washed with. The latter interferes withthe attachment of these proteins to the 
membrane and thusreduces their occurrence in the resulting membrane samples (Molloy 2008). 
The present study originally conferred comparative analysis of the protein content of the EMF and 
the category names correspond to the number of category assignments and the percentage of 
assignments assigned to the different categories of the total number of proteins identified. 
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Figure 5.2. Gene Ontology classifications of the proteins identified from the membrane fractions of B. animalis 
subsp. lactis BB-12. A, Subcellular component; B, Biological processes; C, Molecular functions. Proteins were in 
some cases (82 of the proteins indentified) assigned to more than a single category. Numbers and percentage 
designated to the right of Figure 5.2. Gene Ontology classifications of the proteins identified from the membrane 
fractions of B. animalis subsp. lactis BB-12. A, Subcellular component; B, Biological processes; C, Molecular 
functions. Proteins were in some cases (82 of the proteins indentified) assigned to more than a single category. 
Numbers and percentage designated to the right of the category names correspond to the number of category 
assignments and the percentage of assignments assigned to the different categories of the total number of 
proteins identified. 
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MAF, which was expected to demonstrate enrichment for integral membrane proteins in the former 
compared with the latter. Unfortunately, inconsistent quality of the obtained tandem MS spectra  
made such a comparison infeasible. Comparing the number of TMSs-containing proteins as a part 
of the total proteins identified in the merged EMF and MAF to those of the total proteome – 36.3% 
and 25.1%, respectively,which are similar to the 36.2% and 26.2%, respectively,obtained in a 
previous analysis of membrane fractions of B. longum NCIMB 8809 (Ruiz et al. 2009) – shows 
that the applied experimental protocol gave rise to enrichment for membrane proteins. One can 
presume that this enrichment would have been even more distinct if the protein content in the EMF 
and MAF could have been analyzed separately, as observed in spectra of satisfying quality (Gilad 
et al., unpublished data), implicating the efficacy of the protocol for membrane proteinisolation.  
 The biological processes GO classification (Fig. 5.2B) showed that the majority of the 
identified proteins are assigned to the categories – in decreasing order of occurrence – “metabolic 
processes”, “transport” and “cell organization and biogenesis”. Similar results were obtained in a 
study of the liposoluble proteome of Mycoplasma agalactiae, where nearly 40% of the proteins 
identified were classified under various metabolic processes and approx. 16% of the proteins 
identified were classified under the “transport” category (Cacciotto et al. 2010). Noticeably, nearly 
onefourth of the identified proteins are unannotated. The predominance of proteins associated with 
metabolic processes stems from assignment of RP to this category and from the presenceof CP in 
the membrane fractions, including nearly all the enzymes of the fructose-6-phosphate shunt, also 
known as the bifid shunt,which is the central pathway of carbohydrate catabolismin bifidobacteria. 
Proteins predicted to play a role in cell wall biosynthesis account for 5 of the 11 proteins in the 
“cell organization and biogenesis” category. In addition to the 55 proteins belonging to transport 
processes (hence MP), manual inspectionof identified remaining proteins not annotated to this 
category by the GO classification showed that when other components of transport systems (like 
ATP- and solute-binding proteins [SBP]) are included, the number of transport-related proteins is 
67 (Section 5.3.2; Tables 5.1–5.2). When including alsothe 12 proteins involved in protein 
translocation (Table 5.3), thetotal amount of identified MP is 79, which is comparable to 78 
transport-related proteins identified in the membrane fraction of B. longum NCIMB 8809 (Ruiz et 
al. 2009). Of the 79 identified BB-12 transport-related proteins (Tables 1–2), 37 were homologous 
(BLASTP sequence alignment E values < 1×10−10) to identified B. longum NCC2705 transport-
related proteins (Supplemental Table A.4).  
 The GO classification Molecular functions (Fig. 5.2C) gave rise to a large number of 
proteins associated with the “catalytic activity” and “transport” categories. The high representation 
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in the categories “structural molecule activity” and “RNA binding ”is associated with the large 
number of RP assigned tothese categories. The “nucleotide binding” category consists of ATP-
binding proteins, chaperons such as DnaK, DnaJ andthe 60 kDa chaperonin GROEL, as well as 
proteins involved in transcription and translation, e.g. elongation factor Tu, DNA topoisomerase I, 
tyrosyl-tRNA synthetase and HelY (helicase). The distribution of the number of TMSs among the 
identified proteins is listed in Table 5.4. The tendency of the distribution of TMSs was found to be 
similar to that found for the whole membrane proteome of the bacterium, as exemplified by the 
relatively large number of proteins with 6 predicted TMSs (Table 5.4) that coincides with the large 
number of ABC permeases usually having 6 TMSs (Biemans-Oldehinkel et al. 2006). Of the 
identified TMSs-containing proteins, 34.2% are predicted to possess only 1–2 TMS(s) (Table 5.4), 
including SBP belonging to ABC transporter systems, and adhesion proteins typically having either 
a C- or an N-terminal anchor, or anchors at both termini. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3. Distribution of the GRAVY scores (obtained at www.gravy-calculator.de/) of the transmembrane 
segments-containing proteins from B. animalis subsp. lactis BB-12 identified in the present study. 
 
The GRAVY scores of the identified proteins (Fig. 5.3) indicate their hydrophobicity (Kyte and 
Doolittle 1982). More than two thirds of the identified proteins are not classified as MP, therefore 
the majority have negative GRAVY scores; the overall average value is −0.2. The most 
hydrophobic protein identified is the hypothetical membrane spanning protein (BIF_01840) 
predicted to have 6 TMSs, which attained a score of 0.99, whereas the proteinwith most TMSs (14) 
− MviN (virulence factor; BIF_01669), obtained a score of 0.13. This incompatibility between the 
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number of predicted TMSs and GRAVY scores of these two proteins is related to the fact that even 
though BIF_01669 has more than twice as many TMSs, the markedly smaller size of BIF_01840 
(less than one sixth of the number of amino acids of BIF_01669), gives rise to a higher occurrence 
of TMSs per amino acid in BIF_01840, and hence a higher GRAVY score. A similar observation 
was reported by Santoni et al. (2000). 
5.3.2 Transport proteins identified in BB-12 
The predominant groups of 79 proteins identified in the membrane fractions and predicted to play a 
role in transport is described below according to their predicted substrates.  
5.3.2.1. Oligosaccharide transport  
Twelve proteins – all ABC transporters – are predicted to beinvolved in oligosaccharide uptake 
(Table 1), comprising fiveSBP, five permeases and two ATP-binding proteins. Along with the 
genes (BIF_00257 and BIF_00258) coding for permease proteins, the gene (BIF_00212) encoding 
a sugar-binding protein belongs to a putative cluster containing 9 genes encoding proteins related 
to XOS catabolism. Eight of these genes were up-regulated when BB-12 was grown with XOS 
compared with glucose as carbon source, and the abundance of three of the corresponding proteins, 
including the gene product ofBIF_00212, was differentially increased (Gilad et al. 2010). 
 The genes coding for the permeases MalC and MalG (BIF_1619 and BIF_01618, 
respectively) and the maltose/maltodextrin-binding protein (BIF_01620) are positioned in tandem 
on the chromosome of BB-12. These genes are partof a predicted gene cluster whose constituents 
are related to utilization of oligosaccharides. Noticeably, the transcription of the genes encoding for 
MalC and MalG increased 6-and 13-fold, respectively, in BB-12 grown on FOS compared with 
glucose (Gilad O, unpublished data). Their homologs from B. longum NCC2705 belong to putative 
oligosaccharide operons and also the gene coding for a sugar ABC transporter solute-binding 
protein (BL1164) homologous to BIF_01620, was up-regulated on FOS (Parche et al. 2007). Based 
on these observations, it was hypothesized that the corresponding proteins participate in 
oligosaccharide uptake. A fifth permease, MsmG (BIF_00747), is homologous to a Streptococcus 
mutans transporter involvedin uptake of melibiose, raffinose, and isomaltotriose (Russell et al. 
1992). A B. longum NCC2705 gene encoding a protein homologous to MsmG was up-regulated on 
maltose (Parche et al. 2007), implying the potential oligosaccharide transport activity of this BB-12 
permease. 
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Table 5.1. B. animalis subsp. lactis BB-12 proteins identified in the present study and predicted to be involved in 
oligosaccharide transport. 
Footnotes: a Proteins whose homologs were identified in the cell-envelope of B. longum NCIMB 8809 (Ruiz et al. 
2009). b The glycerol-binding protein Bla_0461 belongs to B. animalis subsp. lactis AD011, a strain highly 
related to BB-12, but BLASTP search of the amino acid sequence of the protein does not give any result from 
the latter strain.  
Locus tag 
Acc. 
number Description 
B. longum homolog    
(BLASTP E value) Additional information 
BIF_01681a ADC84994 Sugar transport ATP-
binding protein 
BL0673 (0), msiK, ATP 
binding protein of ABC 
transporter for sugars 
Up-regulated on XOS compared to glucose in 
intracellular 2D-DIGE analysis (Gilad et al. 
2010); Homologous (7E130) to msiK from 
Streptomyces coelicolor A3(2),  a  universal 
ATPase of several ABC-type carbohydrate 
transporters (Russell et al. 1992) 
BIF_01629a ADC84915 ABC transporter 
ATP-binding protein 
BL0197 (2E-30), possible 
ATP binding protein of ABC 
transporter  
 
BLA_0461b ACL28760 Probable solute 
binding protein of 
ABC transporter 
system for sugars 
BL1164 (0), probable solute 
binding protein of ABC 
transporter system for sugars  
bl1164 was up-regulated on FOS and is predicted 
to belong to FOS/lactose operon (Parche et al. 
2007)  
BIF_00212a ADC85538 Sugar-binding protein BL1163 (5E-16), probable 
solute binding protein of 
ABC transporter system for 
sugars  
bl1163 is located vicinal to bl1164, which was 
up-regulated on FOS (Parche et al. 2007)   
BIF_00257 ADC85539 Transporter BL0189 (5E-37), sugar 
permease of ABC transporter 
system  
bif_00257 up-regulated on XOS (Gilad et al. 
2010) 
BIF_00258 ADC85540 Transporter BL1523, msmG (4E-34), 
sugar permease of ABC 
transporter system  
bif_00258 up-regulated on XOS (Gilad et al. 
2010); bl1523 up-regulated on raffinose (Parche 
et al. 2007) and GOS (Wang and Reeves 1994) 
BIF_01620 ADC84948 Maltose/malto-
dextrin-binding 
protein 
BL1164 (9E-11), probable 
solute binding protein of 
ABC transporter system for 
sugars  
b1164 up-regulated on FOS (Parche et al. 2007)  
BIF_01619 ADC84947 MalC BL0424 (3E-20), sugar 
permease of ABC transporter 
system  
bl0424 belongs to a FOS operon, vicinal gene 
up-regulated on FOS (Parche et al. 2007) 
BIF_01618 ADC84946 MalG BL0190 (2E-30), sugar 
permease of ABC transporter 
system  
bl0190 belongs to an ABC transporter-type 
operon with unknown function (Parche et al. 
2007) 
BIF_00747 ADC84953 MsmG BL0144 (1E-145), permease 
of ABC transporter possibly 
for oligosaccharides  
Homologous (5E-35) to msmG from 
Streptococcus mutans, which is involved in 
uptake of melibiose, raffinose, and isomaltotriose 
(Santoni et al. 2000); bl0144 up-regulated on 
maltose (Parche et al. 2007)  
BIF_00469 ADC84507 Maltose/malto-
dextrin-binding 
protein 
BL0141 (1E-140), possible 
solute binding protein of 
ABC transporter  
bl0141 up-regulated on maltose (Parche et al. 
2007)  
BIF_01592 ADC84981 Raffinose-binding 
protein 
BL1521, msmE (0), sugar 
binding protein of ABC 
transporter system  
bl1521 up-regulated on lactose (Parche et al. 
2007)  
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Finally, 15 ABC transporter ATP-binding proteins were identified (Tables 5.1–5.2). Two of these 
are the ABC transporter ATP-binding protein (BIF_01629) and sugar transport ATP-binding 
protein (BIF_01681). The latter is a homolog of the ABC transporter ATP-binding protein of 
Streptomyces coelicolor A3(2) that acts as ATPase subunit in several ABC sugar transporters  
(Bertram et al. 2004). Since BIF_01681 was over-produced on XOS, although induction at the 
transcriptomic level was not observed (Gilad et al. 2010), it is possible that this protein has a 
similar role in BB-12. 
5.3.2.2. Miscellaneous transport proteins 
Apart from proteins predicted to be involved in oligosaccharide uptake, another 63 transport 
proteins were identified (Table 5.2), which are associated with amino acid, inorganic ion 
(manganese, copper, potassium and calcium), nucleotide and phosphate transport. A few of the  
SBP identified in the present study, i.e. BIF_00212, BIF_00469, BIF_01620, BIF_01087, 
BIF_01234 and BIF_00737, were also identified in the extracellular proteome of BB-12 (Gilad et 
al. 2011). Accordingly, these proteins arepredicted to contain N-terminal membrane-anchors.A 
noteworthy finding is the detection of 7 of the 8 subunitsof the F1F0-ATP-synthetase complex (with 
the exception of the C chain subunit). This membrane-embedded enzyme complex, encoded by the 
ATP operon, which is highly conserved among bacteria (Ventura et al. 2004) catalyzes the ATP-
driven translocation of protons to the exterior of the cell. The identification of this complex is in 
agreement with other studies where the acid inducibility of the ATP operon and the increased 
production and activity of the enzyme complex under acidic conditions in B. animalis subsp. lactis 
strains reflected a crucial role in responseand tolerance to low pH (Matsumotoet al. 2004). The 
ATP-synthetase complex was also documented to be involved in bile salt tolerance (Sánchez et al. 
2006). The dependence, however, of the acid tolerance of BB-12 on the ATPase complex has yet to 
be corroborated by functional studiesof the ATP operon. 
Another important industrial application-related property of BB-12 is the biosynthesis and 
secretion of polymeric capsule like structures composed of exopolysaccharides (EPS). These 
biopolymers possess texture enrichment and stabilizing properties desirable in a variety of 
fermented milk products. Some EPS demonstrated in vitro health-promoting effects like antitumor 
and immunomodulatory activities (Ruas-Madiedo et al. 2002). Studies that aimed at deciphering 
their role in bacterial adhesion to human intestinal mucus, showed, however, that EPS interfere 
with adhesion of probiotic bacteria and to enhance adhesion of pathogenic bacteria (Ruas-Madiedo  
al. 2006). In the present study, four proteins potentially involved in export and biosynthesis of EPS 
were identified, including a polysaccharide export permease protein (BIF_01639), an ATP binding  
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Table  5.2. Transport-related proteins identified in the membrane fractions of B. animalis subsp. lactis BB-12. 
Locus tag 
Acc. 
number Description 
Amino acid transport 
BIF_00040a ADC84522 OppC (oligopeptide transport system permease protein) 
BIF_00083a ADC86102   ABC transporter ATP-binding protein 
BIF_00164 ADC85464 Glutamate/gamma-aminobutyrate antiporter 
BIF_00455a ADC84651 Glutamine-binding protein 
BIF_00580a ADC85577 Amino acid ABC transporter permease protein 
BIF_00737a ADC84524 OppA (oligopeptide-binding protein) 
BIF_00778a ADC85696 Glutamate-binding protein 
BIF_00779a ADC85695 GluA (glutamate transport ATP-binding protein) 
BIF_00905 ADC85575 ABC transporter amino acid-binding protein 
BIF_01038a ADC85578 Amino acid transport ATP-binding protein 
BIF_01105a ADC84669 OppA (oligopeptide-binding protein) 
BIF_01811 ADC85576 ABC transporter amino acid-binding protein 
BIF_01969 ADC85179 ABC transporter ATP-binding protein 
BIF_02143a ADC84521   OppD (oligopeptide transport ATP-binding protein) 
Inorganic ion transport 
BIF_00250a ADC84989 Calcium-transporting ATPase 
BIF_00651a  ADC85772 CorA 
BIF_00921 ADC85757 KtrA (potassium uptake protein) 
BIF_01086 ADC86007 Manganese transport system ATP-binding protein 
BIF_01087 ADC86005 Manganese-binding protein 
BIF_01137a ADC85118 Transporter 
BIF_01143 ADC86059 Copper-exporting ATPase 
BIF_01234 ADC85371 Manganese-binding protein 
BIF_01626 ADC84918 Kup system potassium uptake protein 
BIF_01656 ADC85070 CorC (magnesium and cobalt efflux protein) 
BIF_01885 ADC84866 PacS (cation-transporting ATPase) 
Nucleotide transport 
BIF_00363a ADC85734 Hydroxymethylpyrimidine transport ATP-binding protein 
BIF_01727a ADC86064 Uracil permease 
Phosphate transport 
BIF_00142a ADC85369 PstB (phosphate transport ATP-binding protein) 
BIF_01096 ADC85367 PstC (phosphate transport system permease protein) 
BIF_01097a ADC85366 Phosphate-binding protein 
Exopolysaccharide secretion and biosynthesis  
BIF_01639 ADC84907 Polysaccharide export ATP-binding protein 
BIF_01640 ADC84908 Polysaccharide export ABC transporter permease protein 
BIF_01476 ADC84799 Chain length regulator (capsular polysaccharide biosynthesis) 
BIF_00944 ADC84780 Undecaprenyl-phosphate galactosephosphotransferase 
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ATPase complex subunits  
BIF_00327a ADC84817 ATP synthase B chain 
BIF_00544 ADC84818 ATP synthase gamma chain 
BIF_01337a ADC84823 ATP synthase A chain 
BIF_01338a ADC84821 ATP synthase B chain 
BIF_01339a ADC84820 ATP synthase delta chain 
BIF_01340a ADC84819 ATP synthase alpha chain 
BIF_01897 ADC84816 ATP synthase epsilon chain 
Miscellaneous transport proteins 
BIF_00037a ADC84681 Multidrug/protein/lipid ABC transporter family, ATP-binding and permease protein 
BIF_00411a ADC85528 Transporter 
BIF_00625 ADC85619 Transporter 
BIF_00659a ADC85833 Aquaporin 
BIF_00743a ADC84628 Transporter 
BIF_00823a ADC85571 FtsE (cell division protein) 
BIF_00824a ADC85572 FtsX (cell division protein) 
BIF_01025 ADC85485 Transporter 
BIF_01533 ADC84682 Multidrug resistance ABC transporter ATP-binding and permease protein 
BIF_01630a ADC84914 ABC transporter permease protein 
BIF_01747a ADC86103 ABC transporter substrate-binding protein 
BIF_01969 ADC85179 ABC transporter ATP-binding protein 
 
Footnotes: a Proteins whose homologs were identified in the cell-envelope of B. longum NCIMB 8809 (Ruiz et al. 
2009). b BIF_00327 is annotated as an ATP synthase B chain, yet it differs from the β chain protein of B. lactis 
DSM 10140, a strain very closely related to BB-12, in only two amino acids, such that this may be an imprecise 
annotation. 
 
protein (BIF_01640), a chain length regulator (BIF_01476) and an undecaprenyl-phosphate 
galactosephospho-transferase (BIF_00944; EC 2.7.8.6) that is predicted to catalyze transfer 
ofgalactose from UDP-galactose to a polyprenyl carrier (Wang and Reeves 1994). 
 
5.3.2.3. Proteins of the translocation machinery 
In addition to transport proteins, another remarkable finding was the detection of 12 of the 20 
proteins predicted to be associated with the protein translocation machinery (Table 5.3) that is 
conserved in numerous Gram-positive bacteria (MacConaill et al. 2003). In the present study, 
corresponding identified proteins include translocase subunits, chaperones, peptidyl-prolyl cis-trans 
isomerase (also identified in the extracellular proteome of BB-12 (Gilad et al. 2011) and a trigger 
factor. Using random translational fusions between potential translocation signals, and an export-
specific reporter protein designed to capture genes coding for secreted proteins, MacConaill et al. 
(MacConaill et al. 2003) demonstrated the functionality of this translocation machinery in B. breve 
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UCC2003. Since homologous proteins were found for the majority of the proteins that embody this 
translocation system, we postulate that a similar mechanism is also active in BB-12. 
 
Table 3. Proteins of the putative translocation machinery in B. animalis subsp. lactis BB-12. Proteins identified 
in the present study are designated in boldface. 
Footnotes: a Proteins whose homologs were identified in the cell-envelope of B. longum NCIMB 8809 (Ruiz et al. 
2009). bBIF_01746 was identified in extracellular proteome analysis of B. animalis subsp. lactis BB-12 (Sánchez 
et al. 2010). 
5.3.2.4. Proteins associated with bacteria–host interactions 
Eight of the 19 proteins secreted from cultures of BB-12 and postulated (based on sequence 
homology) to be involved in bacteria–host interactions (Gilad et al. 2011) were also identified in 
the present study (the corresponding proteins are designated in parenthesis below). These 
interactions consist of (among others) recruitment of human plasminogen (enolase and DnaK) that 
was demonstrated to play a role in binding of a highly-related bifidobacterial strain to human GIT 
(Gonzalez et al. 2008), attaching to human mucus and fibronectin (EF-Tu), adhesion to epithelial 
cells (a pair of manganese-binding proteins) or collagen (collagen adhesion protein), 
immunomodulatory effects (Transketolase) and fimbriae formation (collagen adhesion protein and 
hypothetical protein BIF_0999),which was shown to facilitate murinegut colonization in vivo [43]. 
 
Locus tag 
 
 
Description 
Homology to B. breve  
UCC2003 protein  
Acc. number 
Sequence 
identity (%) E value 
BIF_00806a ADC86126 SecA  81    0 
BIF_01461 ADC85333 SecE 77      4E-38 
BIF_01902 ADC85864 SecG 77      1E-41 
BIF_00901a ADC85423 Secy 85    0 
BIF_01141 ADC85321 Putative signal peptidase I 57      4E-92 
BIF_00335 ADC84614 Lipoprotein signal peptidase  59      3E-61 
BIF_01611 ADC84939 DnaJ 66    5E-137 
BIF_01614 ADC84941 DnaK 89    0 
BIF_00120 ADC86094 Trigger factor, ppiase 76    0 
BIF_00400 ADC85681 60 kDa chaperonin GROEL  90    0   
BIF_00675 ADC85383 10 kDa chaperonin GROES 85      4E-60 
BIF_01612 ADC84940 GrpE (Heat shock molecular chaperone) 69      2E-77 
BIF_00707 ADC85298 Signal recognition particle, subunit Ffh/Srp54  84    0 
BIF_01431 ADC85211 FtsY 77    3E-173 
BIF_01832a ADC85839 YajC (protein translocase subunit) 59      2E-53 
BIF_01208a ADC85012 Inner membrane protein (OxaA/YidC) 68    2E-173 
BIF_01746b ADC86104 Peptidyl-prolyl cis-trans isomerase 77      3E-98 
BIF_00973 ADC84814 Peptidyl-prolyl cis-trans isomerase 51      4E-99 
BIF_01042 ADC84873 Sortase 62    3E-144 
BIF_00667 ADC84738 Sortase 39      2E-67 
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The identification of these proteins,which are predicted to take part in adhesion to host tissues or 
toexert immunomodulatory response in host cells, is in agreement with their presence in the cell 
envelope recorded in the previous study (Gilad et al. 2011). 
 
Table 4. Distribution of the number of transmembrane segments (TMSs) predicted (obtained by TMHMM2 at 
http://www.cbs.dtu.dk/services/TMHMM/) in the identified proteins and the predicted membrane proteome of 
B. animalis subsp. lactis BB-12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4. Conclusions 
The present study aimed at resolving the membrane proteome of the important probiotic strain B. 
animalis subsp. lactis BB-12, with emphasis on proteins involved in oligosaccharide uptake. A 
considerable number of MP were identified by LC-ESI-Q-TOF MS, including 41 proteins 
potentially involved inthe transport of oligosaccharides, amino acids, inorganicions, phosphate and 
nucleotides. In addition, 23 identified MP were predicted to participate in pivotal cellular processes 
like protein translocation, acid tolerance and EPS biosynthesis, as well as 13 MP associated with 
miscellaneous transport systems and 8 moonlighting and cell-envelope proteins predicted to play a 
role in bacteria-host interactions. The identification of these proteins may – supported by functional 
Number 
of TMSs  
Number of proteins  
Present 
study 
Total 
membrane 
proteome 
Percent of 
protein 
identified 
  1 34 119 28.6 
  2 14   49 28.6 
  3   1   26   3.8 
  4   4   38 10.5 
  5   4   33 12.1 
  6 15   45 33.3 
  7   2   14 14.3 
  8   1   15   6.7 
  9   3   12 25.0 
10   4   16 25.0 
11   1     7 14.3 
12   3   23 13.0 
13   3    6 50.0 
14   1    8 12.5 
15   0    0 - 
16   0    1   0.0 
Total 90      412 21.8 
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studies – contribute to the comprehension of the molecular mechanisms underlying some of the 
central physiological traits associated with probiotic bacteria, i.e. utilization of a variety of 
nutrients (e.g. oligo-saccharides, amino acids, inorganic ions, nucleotides and phosphate) available 
in the host GIT through a battery of transport systems with diverse substrate specificity, 
maintaining viable cellular pH by an ATP-driven proton pump and reducing adhesion of probiotic 
strains to host cells via secretion of EPS. Better insight into mechanisms can assist in designing 
probiotic strains with desirable physiological characteristics, i.e. improved acid and bile tolerance 
and lower production of EPS, as well as enhanced health-promoting properties, which can serve as 
a platform for the design of a so-called “super” probiotic strain. 
5.5. Materials and methods 
5.5.1. Experimental design 
Cultures of B. animalis subsp. lactis BB-12 (3×1 L) were grown in a de Man, Rogosa and Sharpe 
(MRS)-reconstituted medium supplemented with 2% of either glucose or XOS as described (Gilad 
et al. 2010) and harvested at late-exponential phase and an OD of 1.1 (8 h growth with XOS and 9 
h with glucose). Enriched membrane fractions (EMF) and membrane-associated fractions (MAF) 
were isolated (see Section 5.5.2 and Fig. 5.1) and analyzedby LC–MS/MS. Tandem MS peak lists 
files obtained forthe different samples were merged into a single peak list which was used for 
protein identification using Mascot Daemon (Matrix Science Ltd., London). 
5.5.2. Isolation of membrane fractions 
Cells were harvested (6600×g, 20 min; all centrifugations werecarried out at 4 °C), washed twice in 
25 mM potassium phosphate pH 7.0 and kept at −80 °C. Pellets were resuspended in 5 mL 
homogenization buffer (0.2 M Tris–HCl pH 7.5, 4.2 mM EDTA, 42% glycerol), added with glass 
beads (425–600 μm, Sigma-Aldrich) and subjected to cell disruption (5 cycles of 1 min whirling at 
12,000 rpm and 1 min cooling on ice between cycles). Subsequently, homogenization buffer (15 
mL) was added to increase the sample volume and thereby reducing loss of membrane vesicles in 
the centrifugation (8000×g, 15 min), followed by ultracentrifugation (100,000×g, 60 min; Ti60 
rotor; Beckman-Coulter, Fullerton, CA) of the supernatant. To improve efficacy of the subsequent 
carbonate wash, inside-out membrane vesicles were prepared by resuspending the pellet containing 
crude membrane fraction in 1 mL “inside-out buffer” (150 mM KCl, 25 mM sodium acetate pH 
4.0, 0.01% Brij 58 [Sigma-Aldrich, Saint Louis, MI] [11]), kept onice for 30 min, and 
ultracentrifuged (100,000×g, 30min). The resulting pellet containing “inside-out vesicles” was 
resuspended in 2 mL freshly made 0.1 M Na2CO3 using a manual homogenisator, transferred to 2 
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mL tubes, kept on ice (30 min) and centrifuged (20,000×g, 30min). A volume of 1.5 mL 
resuspension buffer (20% glycerol, 0.1 M Tris–HCl pH 7.5, 1 mM EDTA) was added to the pellet 
containing integral MP and membrane-associated proteins not removed by the two washing steps 
(designated as “Enriched Membrane Fraction ”[EMF]) and, along with the supernatant that 
contained membrane-associated proteins (designated as “Membrane-Associated Fraction” [MAF]), 
the samples were subjected to protein determination (Bradford 1976). The isolation of EMF and 
MAF is schematically depicted in Fig. 5.1. 
5.5.3. Protease digestion 
EMF andMAF (20 μg) isolated fromthe XOS and glucose cultureswere precipitated in 
chloroform/methanol (Wessel and Flügge 1984), resuspended in 40 μL 6 M urea, 2 M thiourea, 20 
mM DTT and reduced and alkylatedas described (Thingholm et al. 2008). Forty-five microliter 100 
mM NH4HCO3 were added to the samples prior to incubation with 0.4 μg lysylendopeptidase 
(Wako pure Chemical Industries LTD, Osaka, Japan) at room temperature (RT) for 3 h, followed 
by ×5 dilution with 50 mM NH4HCO3, addition of 0.4 μg of modified trypsin (Promega) and 
incubation at RT for 16 h. Concentration and desalting of peptides was performed as described for 
R3 Columns (Thingholm et al. 2008) using POROS Oligo R3 Reversed-Phase resin dissolved in 
acetonitrile (ACN) and packed on topof a C18 membrane disk into a P10 pipette tip. Columns were 
washed with ACN and equilibrated with 0.1% [v/v] TFA (all the percent values given in Sections 
2.3–2.4 are in [v/v]). Digests were acidified with formic acid (FA), loaded on to the columns, 
washed with 0.1% TFA and eluted in two steps by 30 μL 50% ACN/0.5% TFA followed by 30 μL 
70% ACN/0.5% TFA. The two eluates were pooled, lyophilized, resuspended in 1 μL 100% FA 
and diluted with 19 μL water prior to LC–MS. 
5.5.4. Liquid chromatography coupled with tandem massspectrometry 
Peptide separation was achieved using an LC-Packings Ultimate3000 nanoflow system (LC 
Packings, Amsterdam). Peptides were loaded at a flow rate of 5 μL/min onto a custom-made 1 cm 
precolumn (100 μm inner diameter) of fused silica with kasil-frits retaining the Reprosil C18, 3.5 
μm reversed-phase particles (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany). Nanoflow RP-
HPLC was then performed at a flow of 0.25 μL/min through a custom-made 12 cm analytical 
column (75 μm in nerdiameter), packed with Reprosil C18, 3.5 μm reversed-phase particles. 
Peptides were eluted directly into the ESI source of a Q-TOF Premier tandem mass spectrometer 
(Waters/Micromass,Manchester, UK) using a 0–35% gradient of solvent A (0.1% FA) and solvent 
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B (95% ACN, 0.1% FA) applied for either 30, 60, or 120 min. Mass- and charge-dependent 
collision energies were used for peptide fragmentation. 
5.5.5. Data analysis  
Peak list files were created using VEMS v 3.0 (Matthiesen et al. 2005) and merged into a single 
peak list that was searched against the genome sequence of BB-12 (GenBank accession no. 
CP001853, 1612 ORFs, 587,905 amino acid residues) (Garrigues et al. 2010) as taxonomy entry, 
using anin-house licensed Mascot server version 2.2 (29th September 2010). The search parameters 
applied allowed a single missed cleavage, cysteine carbamidomethylation as fixed modification 
and methionine oxidation as variable modification. Peptide and fragment ion mass tolerance were 
set at ±20 ppm and ±0.2 Da, respectively. No restrictions with respect to protein mass andpI were 
made. A protein hit was taken into consideration when two unique peptides with statistically 
significant scores (P<0.05) were obtained. The false discovery rate for peptides above identity 
threshold was calculated using the decoy feature of Mascot and resulted in a value of 1.68%. For 
cases with only two peptides, the identification was validated manually basedon visual inspection 
of the tandem spectra. 
5.5.6. Bioinformatic analysis 
The proteomics data mining andmanagement software ProteinCenter (Proxeon Bioinformatics, 
www.proxeon.com) was used to sort the identified proteins with respect to their predicted Cellular 
components, Molecular functions and Biological processes according to The Gene Ontology (GO; 
(Ashburner et al. 2000) classification system. Protein Center also supported prediction of the 
presence of signal peptide and transmembrane segments (TMSs). GRAVY scores are calculated 
according to the sum of hydropathy values of all amino acids divided by the protein length were 
obtained at www.gravy-calculator.de/. Protein sequence alignments were performed using 
BLASTP 2.2.25 with the All non-redundant Gen-Bank CDS translations+PDB+SwissProt+PIR+ 
PRF (excluding environmental samples from WGS projects) database. The BLASTP scores of the 
proteins predicted to be involved in the translocation machinery (Table 5.3) represent alignments 
with proteins from Bifidobacterium breve UCC2003. Since the genome sequence of B. longum 
NCIMB 8809 is not publicly accessible, B. longum NCC2705 was used for comparison with BB-12 
(Supplemental Table 2). GenBank accession numbers of the proteins are designated in Tables  
 
5.1−5.3 and Supplemental Tables A.4 –A5. 
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Concluding remarks and perspectives 
Due to their various health-benefiting effects, probiotic bacteria in general and bifidobacteria in 
particular have been attracting growing interest from both the scientific and industrial communities. 
In spite of extensive studies of a multitude of aspects concerning the physiology of these bacteria 
and the mode of action underlying probiotic effects, these mechanisms are still far from deciphered. 
 The present PhD study had two primary, and to some extent, interconnected objectives. 
The first aimed at broadening the knowledge regarding the proteins involved in interactions 
between the probiotic strain Bifidobacterium animalis subsp. lactis BB-12, and prebiotic 
carbohydrates that specifically stimulate the growth of probiotic bacteria in the human GIT. The 
second objective was to utilise proteome analysis in order to identify the proteins exported by the 
bacterium and those embedded in its membrane, respectively, and thereby shed more light into the 
proteins that come in contact with the environment surrounding the bacterium and are thus 
predicted to be associated with probiotic effects, as well as membrane proteins that take part in 
physiological processes essential for the survival of the bacterium in the GIT.   
 The present study began with screening of a wide battery of more than 40 carbohydrates 
for their ability to support the growth of BB-12. The results showed that BB-12 can ferment 
oligosaccharides like gluco- galacto- and to a lesser extent xylo- and fructo-oligosaccharides. 
Another noticeable finding was the higher growth rate obtained on all these substrates compared to 
glucose, which may be related to the utilisation of more efficient uptake of these oligosaccharides 
compared to glucose. 
 In the second phase of the study, cultures of BB-12 cultivated on XOS (an emerging 
prebiotic candidate chosen for further analysis) and glucose were subjected to comparative 
transcriptome and proteome analysis, supplemented with liquid chromatography- based analysis of 
XOS consumption. Based on the results, that showed up-regulation of a putative XOS-active gene 
cluster during growth on XOS, and on sequence homology searches, a model for XOS catabolism in 
BB-12 was established.  
 The third step in the study conferred extracellular proteome analysis, where the protein 
content of culture supernatants of BB-12 was mapped. This analysis gave rise to the identification 
of numerous proteins that were documented to be involved in host-interactions, as well as proteins 
associated with essential cellular processes as nutrient uptake and cell wall biogenesis and 
modification. 
 Finally, the membrane proteome of BB-12 was resolved using a gel-free approach that 
employed in-solution digestion accompanied with LC-MS/MS. Coinciding with the results of the 
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extracellular proteome analysis, proteins predicted to play a role in crucial physiological 
mechanisms such as acid tolerance, protein translocation, carbohydrate, amino acid an inorganic 
ions uptake and EPC biosynthesis were detected in the membrane fractions. 
 Regarding potential future perspectives of the present study, apart from the above-
mentioned industrially-related elements, many aspects of various important biological processes in 
BB-12 are yet to be investigated. Such investigations can for instance confer studying some of the 
transport systems or the translocation machinery identified in the present study by recombinant 
production in a bifidobacterial plasmid or in Lactococcus lactis, coupled with activity assays. 
Similar methodologies may be applied for studies concerning the verification of the suggested 
model for XOS utilisation in BB-12, as well as investigation of the putative gene cluster by primer 
walking and Northern blotting. 
 With respect to the industrially-applicable significance of the present industrial-PhD 
project, the importance of the findings obtained in the present study can be roughly related to 
different components. Firstly, the knowledge regarding the carbohydrate fermentative capabilities 
of BB-12 can (and is practically already being used) for selecting potential substrates to be used 
either as prebiotic supplements in combination with BB-12 (a synbiotic preparation), or as growth 
stimulants at the production phase. Secondly, the considerable number of proteins identified in the 
extracellular and membrane proteome analyses can be used as promising targets for further 
investigation of the involvement of these proteins in probiotic effects or in some of physiological 
traits exhibited by BB-12 (e.g. acid tolerance and EPS production). This can also include mapping 
the proteins and enzymes involved in cell wall metabolism and their catalytic activities, as this 
process is of outmost importance to cell division, antibiotic resistance, immunomodulation, 
adhesion and also to texture-enrichment of dairy products by EPS. Elucidation of these mechanisms 
may have a substantial impact, both with respect to providing documentation for the molecular 
basis behind these effects, and with regard to the development of novel probiotic strains with 
enhanced physiological properties or the improvement of existing strains by genetic engineering. 
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Appendix 
- Publications included in the dissertation (See attached CD-ROM): 
 
x Gilad O., Jacobsen S., Stuer-Lauridsen B., Garrigues C., Pedersen M. B., and Svensson B., 
Combined transcriptome and proteome analysis of Bifidobacterium animalis subsp. lactis BB-12 
grown on xylo-oligosaccharides and a model of their utilization. Applied and Environmental 
Microbiology 76:7285-7291. 
 
x Gilad O., Jacobsen S., Holm Viborg A, Stuer-Lauridsen B., and Svensson B. Extracellular 
proteome analysis of Bifidobacterium animalis subsp. lactis BB-12 reveals proteins with putative 
roles in probiotic effects. Proteomics 11:2503-2514.   x Gilad O., Hjernø K., Østerlund E.C., Margolles A., Svensson B., Stuer-Lauridsen B., Møller A.L.B. 
and Jacobsen S., Insights into physiological traits of Bifidobacterium animalis subsp. lactis BB-12 
through membrane proteome analysis. J. Proteomics 75:1190-1200. 
 
- Table A.1. Up-regulated genes (fold change FOS/glucose > 2) and down-regulated genes (fold change glucose/ 
FOS > 2) according to DNA microarrays analysis of samples derived from BB-12. See attached CD-ROM. 
BL-Gene designates homologous proteins from B. longum NCC2705. #N/A: not annotated. 
- Table A.4 (Supplemental Table 1 in the 3rd publication): Protein identified in membrane fractions 
of B. animalis subsp. lactis BB-12  – see attached CD-ROM.  
Key for Gene Ontology (GO) classifications: M, membrane; C, cytoplasm; E, extracellular; CS, cell surface; s, signal 
sequence; T, transport; MP, metabolic process; CD, cell division; R, regulation of biological process; Rep, reproduction; 
OB, cell organization and biogenesis; RS response to stimulus; H, cellular homeostasis; CA, catalytic activity; MI, metal ion 
binding; RB, RNA binding; ST, signal transducer activity; TA, transporter activity; AA, antioxidant activity; DB, DNA 
binding; ER, enzyme regulator activity; PB, protein binding; NB, nucleotide binding; SM, structural molecule activity; TR, 
transcription regulator activity. 
 
- Table A.5 (Supplemental Table 2 in the 3rd publication): Comparison of the membrane proteomes 
of B. animalis subsp. lactis BB-12 and B. longum NCC2705 – see attached CD-ROM.  
Footnotes: Proteins designated in boldface were identified in the present study (BB-12) or in the study described in Ruiz et 
al. (2009; B. longum). The designated numbers of TMS(s) were determined using TMHMM2 according to the BB-12 
proteins, unless no BB-12 homolog was found for the B. longum proteins. 
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Table A.3. Proteins of BB-12 identified by MALDI TOF MS from the protein spots on the gel whose image is shown 
in Figure 4.1. 
 
Spot 
# Locus GB acc. # Protein ID 
Mascot 
PMF 
Scorea E value 
Sequence 
coverage 
(%) 
# of 
matched 
peptides 
# of 
searched 
peptides 
1 BIF_00999 ADC84870 Hypothetical protein    72 (32) 1.0e-04 23   9   55 
1 BIF_00998 ADC84872 Collagen adhesion protein    46 (32) 4.4e-02   11c   8   55 
2 BIF_01178 ADC85287 Fibronectin-binding protein  148 (43) 2.6e-12 14 30   54 
3 BIF_00998 ADC84872 Collagen adhesion protein  117 (36) 3.2e-09 23 15   42 
3 BIF_01318 ADC84867 ClpB    67 (36) 3.1e-04 17 11   42 
4 BIF_00045 ADC85644 Protein Translation Elongation Factor G (EF-G)  144 (38) 6.4e
-12 35 20   61 
4 BIF_00998 ADC84872 Collagen adhesion protein    69 (38) 2.2e-04 18 12   61 
5 BIF_00998 ADC84872 Collagen adhesion protein    99 (32) 1.9e-11 13   9   17 
6 BIF_00998 ADC84872 Collagen adhesion protein    92 (32) 8.1e-10 12   8   15 
7 BIF_00998 ADC84872 Collagen adhesion protein    76 (31) 4.3e-05 16 11   34 
7 BIF_01614 ADC84941 Chaperone protein  100 (31) 1.8e-07 32 11   34 
8 BIF_00963 ADC85857 Transketolase    67 (43) 3.4e-04 16   9   50 
9 BIF_00120 ADC86094 Trigger factor, ppiase  125 (39) 5.1e-10 42 15   58 
9 BIF_00400 ADC85681 60 kDa chaperonin GROEL    51 (39) 1.2e-08 20   9   58 
9 BIF_00315 ADC84590 Division specific D,D-transpeptidase    73 (39) 8.1e-05 24 12   58 
10 BIF_00592 ADC84840 Oxalyl-CoA decarboxylase  164 (38) 6.4e-14 32 14   28 
11 BIF_01677 ADC84998 Rpf protein precursor  152 (38) 1.0e-12 26 14   30 
12 BIF_00315 ADC84590 Division specific D,D-transpeptidase  196 (35) 4.0e-17 46 20   49 
13 BIF_00784 ADC85219 Hypothetical cytosolic protein    51 (44) 1.3e-02 40   7   73 
14 BIF_00825 ADC85573 Immunogenic secreted protein     59 (45) 1.9e-03  14c   7   30 
14 BIF_00823 ADC85571 Cell division ATP-binding protein    47 (45) 3.5e-02 16   6   30 
15 BIF_01972 ADC85645 Protein Translation Elongation Factor Tu  147 (40) 3.2e
-12 46 14   41 
16 BIF_00999 ADC84870 Hypothetical protein    54 (37) 6.7e-03 19   8   44 
17 BIF_00348 ADC85723 Glutamine synthetase      48 (42) 2.6e-02 27   7   72 
18 BIF_00608 ADC84634 1-Hydroxy-2-methyl-2-(E)-butenyl 4-
diphosphate synthase 
   46 (36) 4.3e-02 23   5   45 
19 BIF_00998 ADC84872 Collagen adhesion protein    61 (39) 1.3e-03 15 10   47 
20 BIF_00315 ADC84590 FtsI; Cell division protein   212 (45c) 1.3e-16 38 19   47 
20 BIF_01492 ADC84894 Glycosyltransferase     53 (45c) 3.3e-02 24   8   47 
21 BIF_00469 ADC84507 Maltose/maltodextrin-binding protein   89 (29) 1.9e-06 39   8   29 
22 BIF_01197 ADC86032 Enolase   193 (40) 8.1e-17 48 19   51 
23 BIF_00999 ADC84870 Hypothetical protein   49 (40) 2.3e-02 17   7   49 
24 BIF_00277 ADC85866 Phosphoglycerate kinase   63 (45)   7.4e-03 19   7   28 
25 BIF_01620 ADC84948 Maltose/maltodextrin-binding protein   74 (35) 6.6e-05 21  6   38 
26 BIF_00825 ADC85573 Immunogenic secreted protein   89 (41) 1.9e-06 29 12   46 
26 BIF_01863 ADC84622 Hypothetical protein   61 (41) 1.2e-03 35   6   46 
26 BIF_00758 ADC85937 Hypothetical exported protein   51 (41) 1.2e-02 18   8   46 
27 BIF_01972 ADC85645 Protein Translation Elongation Factor Tu   93 (34) 7.7e
-07 39 11   48 
27 BIF_00825 ADC85573 Immunogenic secreted protein   87 (34)   3.1-06 26 12   48 
28 BIF_00999 ADC84870 Hypothetical protein   68 (31) 2.6e-04 23 10   46 
29 N.S.b        
30 BIF_01597 ADC84973 Oligo-1,6-glucosidase     61 (37) 1.2e-03 16   7   23 
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30 BIF_01172 ADC84811 Thioredoxin   53 (37) 7.4e-03 21   5   23 
31 BIF_00287 ADC85858 Transaldolase    60 (44) 1.6e -03 24   8   63 
32 N.S.         
33 BIF_00998 ADC84872 Collagen adhesion protein    60 (40) 1.5e -03 19   6   68 
34 N.S.         
35 BIF_01087 ADC86005 Manganese-binding protein   85 (38) 5.3e-06 39 11   49 
35 BIF_01173 ADC84812 Hypothetical protein   70 (38) 1.8e-04 31 10   49 
36 BIF_00066 ADC86035 Alkanesulfonates transport ATP-binding protein   60 (42) 1.5e
-03 19   6   34 
37 N.S.        
38 BIF_01173 ADC84812 Hypothetical protein   73 (33) 7.9e-05 32 12   65 
38 BIF_00066 ADC86035 Alkanesulfonates transport ATP-binding protein     64 (33) 6.4e
-04 35 10   65 
39 BIF_01173 ADC84812 Hypothetical protein   115 (32) 5.1e-09 37 13   51 
40 BIF_00679 ADC84889 Inosine-uridine preferring nucleoside hydrolase     50 (42) 2.9e
-03 24   6   43 
41 BIF_01290 ADC84758 Membrane-bound transglycosylase   83 (33) 8.7e-06 28   9   49 
42 BIF_00207 ADC85878 Choloylglycine hydrolase 119 (31) 2.0e-09 42 10   31 
43 BIF_00973 ADC84814 Carbamoyl-phosphate synthase large chain     89 (35) 2.3e
-06 31 10   57 
44 BIF_01290 ADC84758 Membrane-bound transglycosylase     83 (36) 8.7e-06 28   9   48 
45 BIF_00825 ADC85573 Immunogenic secreted protein   80 (33) 1.8e-05 23 10   38 
46 BIF_01234 ADC85371 Manganese-binding protein   71 (30) 1.4e-04 39   7   36 
47 BIF_01290 ADC84758 Membrane-bound transglycosylase 169 (43) 2.0e-14 27 10   14 
48 BIF_01914 ADC85476 Cell wall-associated hydrolase   46 (39) 4.1e-02  19   4   29 
49 BIF_00936 ADC85685 Two component system histidine kinase   55 (44) 4.9e
-03  26   9  94 
50 BIF_00888 ADC84510 O-Acetyltransferase (cell wall biosynthesis)   47 (37) 3.3e
-02 19   7 36 
51 BIF_00825 ADC85573 Immunogenic secreted protein   56 (38) 4.0e-03  17   7  27 
52 BIF_00825 ADC85573 Immunogenic secreted protein   58 (37) 2.5e-03   14c   6  22 
53 BIF_01084 ADC84928 Tetrapyrrole (Corrin/Porphyrin) methylase family protein   80 (31) 1.8e
-05 26   6 12 
54 N.S.        
55 BIF_01914 ADC85476 Cell wall-associated hydrolase   75 (34) 5.6e-05 27   6 37 
56 N.S.         
57 N.S.        
58 N.S.        
59 BIF_02083 ADC86083 Smf protein   52 (34) 1.1-02 19   4 17 
60 N.S.        
61 BIF_00825 ADC85573 Immunogenic secreted protein   54 (32) 7.0e-03 14    6 16 
62 N.S.  
 
     
63 N.S.        
64 BIF_01523 ADC84776 UDP-glucose 6-dehydrogenase   50 (35) 1.6e-02 30    8 75 
65 BIF_01997 ADC84674 Isoleucyl-tRNA synthetase   52 (39) 1.1e-02 19 16 97 
66 BIF_01565 ADC85095 Hypothetical protein ylxX/ylxW   58 (40) 2.8e-03 19    6 36 
67 BIF_00497 ADC85881 Peroxiredoxin   74 (42) 5.9e-05 37   7 39 
68 BIF_01115 ADC84845 Inorganic pyrophosphatase 127 (32)   3.2e-10 40   8 20 
69 BIF_01657 ADC85069 Iron-binding ferritin-like antioxidant protein 107 (37) 3.2e
-08 58 10 57 
70 BIF_02033 ADC85125 Hypothetical protein   46 (38) 4.0e-02 24   5 63 
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71 N.S.        
71 N.S.        
72 BIF_00860 ADC84647 Diaminopimelate epimerase   52 (40) 1.1e-02 19   6 93 
73 BIF_02065 ADC85691 Aspartyl-tRNA synthetase   62 (39) 9.7e-04 16 11 49 
74 BIF_01746 ADC86104 Peptidyl-prolyl cis-trans isomerase   55 (40) 5.0e-03 36   4 43 
75 BIF_00682 ADC85747 Arginine repressor   54 (32) 6.3e-03 46   4 25 
76 BIF_01398 ADC85475 Immunogenic secreted protein   72 (41) 1.1e-04 32   7 44 
77 BIF_01067 ADC85105 Hypothetical signal transduction protein 112 (37) 4.0e
-10 43 12 54 
77 BIF_01394 ADC85165 Hypothetical protein   62 (37) 1.6e-03 54   6 84 
78 BIF_00400 ADC85681 60 kDa chaperonin GROEL   84 (30) 5.9e-06   14c   7 17 
79 BIF_01290 ADC84758 Membrane-bound transglycosylase   79 (34) 3.8e-05 21   7 24 
80 BIF_01290 ADC84758 Membrane-bound transglycosylase   69 (40) 1.1e-05 33 10 86 
81 BIF_01398 ADC85475 Immunogenic secreted protein   92 (36) 1.1e-05 30   7 33 
82 N.S.        
82 N.S.        
82 N.S.        
83 BIF_01398 ADC85475 Immunogenic secreted protein   79 (38) 2.0e-05 42   9 46 
84 BIF_01290 ADC84758 Membrane-bound transglycosylase   49 (26) 1.1e-04 35 10 84 
85 BIF_01915 ADC85796 Uridylate kinase   82 (36) 1.0e-02 16   4 14 
86 BIF_01398 ADC85475 Immunogenic secreted protein 121 (34) 6.4e-09 46 11 34 
87 BIF_01398 ADC85475 Immunogenic secreted protein   84 (35) 6.3e-06 42 10 38 
88 BIF_01398 ADC85475 Immunogenic secreted protein 104 (41) 2.6e-07 49 12 61 
89 N.S.        
90 N.S.        
91 N.S.        
92 N.S.        
93 BIF_00325 ADC85424 Nucleoside-diphosphate kinase   79 (38) 2.2e-05 44    8 69 
94 BIF_01641 ADC84909 UDP-galactofuranosyltransferase   47 (40) 3.5-02 16    7 49 
95 BIF_00644 ADC85907 Thioredoxin peroxidase 205 (35) 5.1e-19 79 14 53 
96 BIF_01290 ADC84758 Membrane-bound transglycosylase   83 (34) 8.5e-06 20   6 20 
97 BIF_00414 ADC85770 Hypothetical cytosolic protein   68 (40) 2.5e-04 38   5 40 
98 BIF_01914 ADC85476 Cell wall-associated hydrolase   50 (42) 5.0e-03 16   5 36 
98 BIF_00377 ADC85900 Probable glutamate-ammonia-ligase adenylyltransferase   46 (42) 4.4e
-02     7c   5 14 
99 N.S.        
100 BIF_02023 ADC84801 Transposase   47 (37) 3.5e-02 25   7 64 
101 N.S.        
102 BIF_00377 ADC85900 Probable glutamate-ammonia-ligase adenylyltransferase   54 (36) 6.3e
-03 19 15 93 
102 BIF_00678 ADC85385 UDP-N-acetylenolpyruvoylglucos amine reductase   54 (36) 6.9e
-03 33 10 93 
103 N.S.        
104 N.S.        
105 BIF_01398 ADC85475 Immunogenic secreted protein   84 (38) 3.2e-05 34   9 33 
106 N.S.        
107 BIF_02023 ADC84801 Transposase    53 (37) 7.5e-03 27   9 70 
108 N.S.        
109 BIF_01398 ADC85475 Immunogenic secreted protein   75 (38) 5.7e-05 30   7 15 
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110 N.S.        
111 BIF_01290 ADC84758 Membrane-bound transglycosylase   83 (33) 8.3e-06 16  6 14 
112 N.S.        
112 BIF_00066 ADC86035 Alkanesulfonates transport ATP-binding protein  49 (40) 2.1e
-02 16  4 18 
113 BIF_00377 ADC85900 Probable glutamate-ammonia-ligase adenylyltransferase    47 (41) 3.3e
-02   15c 12 82 
114 BIF_01290 ADC84758 Membrane-bound transglycosylase   48 (32) 2.6e-02   14c   4 14 
115 BIF_01012 ADC84864 23S rRNA methyltransferase   50 (43) 1.5e-02 28   6 62 
116 BIF_01289 ADC84757 Thioredoxin 129 (43) 1.0e-10 66 11 59 
117 BIF_00278 ADC85867 Hypothetical cytosolic protein   46 (35) 4.0e-02 35   8 73 
118 BIF_02020 ADC85288 RecG   53 (43) 7.5e-03 36   5 95 
119 N.S.        
120 BIF_00644 ADC85907 Thioredoxin peroxidase   68 (42) 5.9e-05 56   7 56 
121 N.S.        
122 BIF_01132 ADC85609 Glycerol dehydrogenase   52 (36) 1.0e-02 24   6 59 
123 BIF_01054 ADC84884 SSU ribosomal protein S6P   78 (44) 1.6e-05 67   6 44 
124 BIF_00675 ADC85383 10 kDa chaperonin GROES 112 (41) 1.0e-08 78   8 87 
X1 BIF_00737 ADC84524 Oligopeptide-binding protein 153 (41) 8.1e-13 30   5 11 
X2 BIF_00212 ADC85538 Sugar-binding protein 178 (28) 2.6e-15 37 14 26 
a Peptide mass fingerprinting (PMF) score obtained using the protein sequence database program Mascot 
(http://www.matrixscience.com) with the genome sequence of Bifidobacterium animalis subsp. lactis BB-12 as taxonomy 
entry. Scores > 45 are statistically significant, and the scores obtained for identical searches against a decoyed database 
are designated in parenthesis. Spot numbers refer to the spots designated in Figure 1. Spots X1 and X2 were identified 
in gels derived cultures grown on xylo-oligosaccharides. b No statistically significant MS hit obtained. c Sequence 
coverage ≤ 15. 
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